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The reaction of (η5-C5H5)Ru(CO)2I and AgBF4 in the ratio of 1:1 in methylene chloride afforded 
the iodo-bridged ruthenium complex, [(η5-C5H5)Ru(CO)2]2I. Two polymorphs, I and II, of the 
complex [(η5-C5H5)Ru(CO)2]2I were isolated. Polymorph I crystallized in the monoclinic P2/c 
space group with a = 12.0982(5) Å, b = 9.7923(4) Å, c = 15.5321(6) Å, β = 102.9880(10)°, 
while polymorph II crystallized in  the monoclinic P21/c with a = 7.00560(10) Å, b = 
14.1446(3) Å, c = 18.2226(3) Å, β = 96.2390(10)°. The reaction of (η5-C5H5)Ru(CO)2I and a 
slight excess of AgBF4 in methylene chloride afforded the Lewis acid, [CpRu(CO)2]+BF4, which 
was subsequently reacted with slight excesses of 1-alkanamines, RNH2, in dry dichloromethane 
affording the new water-soluble 1-alkanaminedicarbonyl(η5-cyclopentadienyl)ruthenium(II) 
tetrafluoroborate complexes, [CpRu(CO)2NH2R]+BF4- (Cp = η5-C5H5; R = CH3, C2H5, C3H7, 
C4H9, C5H11 and C6H13). Complexes  of the type, [CpRu(CO)2L]+BF4-, (L = C6H11NH2, 
C6H5CH2NH2, C6H5CH(CH3)NH2, (CH3)2CHNH2, CH2CHCH2NH2, NH2CH2(C6H4)OCH3, 
NH2CH2C6H4CN, NH2(CH3)3C6H2) were also synthesized by the reaction of the Lewis acid, 
[CpRu(CO)2]+BF4, with the ligands, L.  
The reaction of (η5-C5(CH3)5)Ru(CO)2I and a slight excess of AgBF4 in methylene chloride 
afforded the Lewis acid, [Cp*Ru(CO)2]+BF4 (Cp* = η5-C5(CH3)5), which was subsequently 
reacted with slight excesses of 1-alkanamine, RNH2 (R = CH3, C2H5, C3H7, C4H9, C5H11), in dry 
dichloromethane affording the new water-soluble complex salts, [Cp*Ru(CO)2NH2R]+BF4- 
The α,αʹ-diaminoalkane-bridged diruthenium complex salts [Rp2NH2(CH2)nNH2]Y2 (Rp = 
CpRu(CO)2, where Cp = η5-C5H5; n = 2, 3, 4 and 6; Y = BF4 or SO3CF3) were synthesized by 
the reaction of the acetonitrile complexes, [RpNCCH3]Y and NH2(CH2)nNH2 (n = 2, 3,4 and 6) 
in the ratio of 2:1.  
All the complexes synthesized in this study are new and were fully characterized by IR, NMR, 
elemental analysis and melting point. The crystal structures of 12 complexes were determined; 
they all feature a “pseudo-octahedral three-legged piano stool” structure in which the ruthenium 
centre was coordinated through a sigma bond to the amine N atom and two carbonyl ligands at 
the base of the stool and the cyclopentadienyl ring as the apex of the stool. 
Antimicrobial susceptibility tests were done for the α,αʹ-diaminoalkane-bridged diruthenium 
compounds, and some mononuclear complexes, [CpRu(CO)2L]+BF4-. Good antimicrobial 
activity against Gram-positive and Gram-negative bacteria, as well as mycobacterium, was 
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achieved. Furthermore, the complexes synthesized showed excellent catalytic activity in the 
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This thesis focuses on the synthesis, characterization and structural elucidation of η5-
cyclopentadienyldicarbonylruthenium(II) amine complexes, and their possible application as 
catalysts in the oxidation of styrene using sodium periodate as the oxidant. Their possible 
activity as antimicrobial agents against Gram positive and Gram negative bacteria has also been 
explored. The thesis has been written according to format 4 as stipulated in the guidelines from 
the College of Agriculture, Engineering and Science. The chapters consist of an overall 
introduction, discrete research papers and a final discussion. Some of the research papers have 
been published in internationally recognized, peer-reviewed journals. 
 
Chapter one of the thesis reviews literature about ruthenium as an element and its special 
characteristics that make it suitable for application in various fields such as medicine and 
catalysis.  Importance and coordination modes of the cyclopentadienyl, carbonyl and nitrogen 
containing ligands used in this work are briefly discussed. The chapter also gives a brief 
introduction to the chemistry of η5-cylopentadienyldicarbonylruthenium complexes and 
application of ruthenium complexes in homogenous catalysis with catalytic oxidation of olefins 
being the main focus. Application of ruthenium complexes in medicine is also reviewed, with 
possible uses as antimicrobial agents being the main focus. The aim and specific objectives of 
the project are given at the end of this chapter. The results of the study are presented in chapter 
two to six in the form of five discrete papers. Each chapter consist of an abstract, introduction, 
experimental, results and discussion, conclusion and references 
 
Chapter two of the thesis is a published paper on the synthesis, characterization and crystal 
structure of two polymorphs of a tetrafluoroborate salt of a cationic iodo-bridged η5-
cyclopentadienyldicarbonylruthenium dimer. The formation of this product during the synthesis 
of the amine complexes directed the procedure adopted for the synthesis of the ruthenium amine 
complexes in this work. Chapters three (published paper) and four (manuscript) presents the 
synthesis and characterization of new, water-soluble 1-aminoalkane complexes of η5-
cyclopentadienylruthenium(II) and η5-pentamethycyclopentadiellruthenium(II) dicarbonyl 
respectively. The fifth chapter (submitted paper) covers the synthesis and characterization of a 
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series of new dinuclear diaminoalkane-bridged dicarbonyl(cyclopentadienyl)ruthenium(II) 
complex salt. The antibacterial activity of the dinuclear complexes synthesized and those of 
some monouclear ruthenium amine complexes have been determined. The sixth chapter presents 
the preparation and determination of catalytic activity of cyclopentadienyl ruthenium dicarbonyl 
complexes of functionalized amine ligands. Finally, the main conclusion of this thesis is 
presented in Chapter 7. The appendices are presented in a Compact Disk (CD). 
 
1.1 Ruthenium  
 
Ruthenium is a rare transition metal with the symbol         ([Kr]4d
75s1), and is inert to most 
chemicals. It was the last of the six platinum group metals to be isolated, and was discovered in 
1844 [1]. Ruthenium exhibits characteristics universal to both early and late-transition metals, 
bringing together desirable properties optimal for catalysis and other applications. For instance, 
the elements to its left in the periodic table are highly reactive, while those to its right are Lewis 
acidic in nature and less oxophilic [2]. Ruthenium displays the widest range of oxidation states; 
from RuVIII (d0) as in RuO4 [3] and RuVII as in RuO- to Ru-II as in Ru(CO)42- (d10) [4]. Higher 
oxidation states are stabilized by good σ-donors such as F−, O2− and N3− while low oxidation 
states are stabilized by effective π-acceptors such as CO and NO+. Ruthenium also displays 
various coordination geometries in each electron configuration. For instance, ruthenium 
complexes adopt the trigonal-bipyramidal and octahedral geometries in the primary lower 
oxidation states of 0, II, and III [4].  
 
The chemistry of ruthenium is of great interest, mainly because ruthenium complexes have a 
range of valuable features, which include high Lewis acidity, high electron transfer ability, low 
redox potentials, and ability to form stable reactive metallic species such as metallacycles, 
oxometals, and metal carbene complexes. Thus such a variety of ruthenium complexes may 
possibly be utilized in new catalytic reactions, synthetic methods and in pharmaceuticals. 
Therefore, there is a need to explore the possibility of designing new ruthenium complexes with 
the potential to catalyze important organic processes, such as oxidation of olefins. Furthermore, 
they may find application in medicine as antimicrobial and therapeutic agents.  
 
1.2 Ruthenium(II) complexes 
 
A metal complex or a coordination complex is a species which has a central metal atom or ion 
to which a number of other molecules or ions, referred to as ligands, are bonded by co-ordinate 
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bonds [5]. The RuII cation ([Kr]4d6) has empty molecular orbitals into which ligands can donate 
their lone pairs of electrons and form coordinate bonds.  
 
The most common precursor in the synthesis of ruthenium complexes is the synthetically 
versatile ruthenium trichloride [6]. Ruthenium complexes can be roughly grouped into oxo, 
carbonyl, tertiary phosphines, cyclopentadienyl, arenes and dienes, according to their supporting 
ligands [7,8]. Several ruthenium(II) complexes with nitrogen donor atoms have been 
synthesized; [Ru(NH3)5N2]2+ [9], [Ru(NH3)5NCC6H5]2+ [10], η5-C5H5(Ru(CO)(CH3CN)2]+ and 
complexes of pyridine derivatives [11-13]. These complexes have multiple applications in many 
different scientific fields, ranging from pharmaceuticals to catalysis [14-17], hence the great 
interest in developing organometallic chemistry of ruthenium complexes further.  
 
The ruthenium(II) complexes synthesized in this study mainly contain the carbonyl, 
cyclopentadienyl and nitrogen containing ligands. A brief discussion of the three types of 
ligands is, therefore, given.  
 
1.2.1 The carbonyl ligand 
 
Transition metal complexes with coordinated carbon monoxide as a ligand are called metal 
carbonyls. Bonding of carbon monoxide to transition metals has two components arising from: 
an overlap of a lone pair of electrons on the carbon atom with empty hybridized d, s, and p 
orbitals on the metal forming a σ-bond; and π-backbonding or π-back-donation where filled d-
orbitals on the metal overlap with an empty π* orbital protruding from the carbon of the CO, 
forming a π-bond. It is important to note that for π -backbonding to occur, the metal should be 
in relatively low oxidation state, +2 and below, and must have d-electrons.  
 
The carbonyl group, CO, is an important ligand in organotransition metal chemistry, because it 
stabilizes transition metal complexes in low oxidation states. The high catalytic activity of 
carbonyl compounds and their use as precursors in organometallic syntheses can be attributed to 
the nature of the bonding in low-oxidation state transition-metal carbonyl complexes. Addition 
or loss of CO to or from a metal centre is a requisite step in many transition metal catalyzed 
processes [18-20].  
 
Furthermore, the carbonyl group has been shown to have physiological effects that are well 
described in literature [21-25]. Metal carbonyls are potential CO-releasing molecules (CO-
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RMs); coordination complexes such as η4-(4-bromo-6-methyl-2-pyrone)tricarbonyliron(0) [26], 
tricarbonyldichlororuthenium(II) dimer [24], dimanganese decacarbonyl [24] and 
tricarbonylchloro(glyconato)ruthenium(II) [24] have been shown to promote vasodilatory, 
cardioprotective and anti-inflammatory activities. Pathogenic bacteria such as Escherichia coli 
and Staphylococcus aureus are rapidly killed by carbon monoxide delivered through 
organometallic CO-RMs [27,28]. CO preferentially bound to the ferrous iron of heme protein 
causes the increased activity of CO against bacteria under anaerobic and aerobic conditions 
[27,28]. Metal carbonyl compounds have also found application as tracers in 
carbonylmetalloimmunoassay procedures as an alternative to radioimmunoassay procedures in 
molecular recognition [29,30], due to the characteristic νCO bands appearing in the 1800–2200 
cm-1 region, where few other functional groups absorb.  
 
Coordinating the carbonyl ligand to the ruthenium centre in the complexes synthesized in this 
work was assumed to lead to the formation of potentially effective ruthenium complex catalysts. 
It was also assumed that the inclusion of the carbonyl ligand would afford complexes that are 
active antimicrobial and chemotherapeutic agents.   
 
1.2.2 The cyclopentadienyl ligand 
 
The cyclopentadienyl anion, ([C5H5]- (Cp)), on the other hand is a ubiquitous and important 
ligand [31,32] that is quite inert to most nucleophiles and electrophiles and hence functions 
solely to stabilize the metal complex. The Cp ligand often bonds to the metal in a η5 
(pentahapto) fashion by contributing 5 electrons; four from the two double bonds and one 
electron from the negative charge. Cyclopentadienyl ruthenium complexes mainly exhibit the 
pseudo-octahedral “piano stool” structure, CpRuLn (n = 2, 3 or 4) (Fig. 1) with the Cp ligand 
forming the ‘seat’ and the ligands forming the ‘legs’ of the stool. The hybridization of s–p or s–
p–d orbitals of the metal has been shown to relate to both donor–acceptor properties and 














The steric and electronic properties of the cyclopentadienyl metal complexes can easily be 
modified by changing the ring substituents, thus making cyclopentadienyl one of the most 
important ligands in organometallic chemistry. There are a large number of substituted 
analogues with the pentamethylcyclopentadienyl derivative, denoted by Cp*, being more 






R = H; Cp
R = CH3; Cp*
R = H, CH3, Phenyl etc.; Cp'
 
Figure 2: Cyclopentadienyl ligand and its derivatives 
 
Ruthenium complexes containing the cyclopentadienyl group are important because they can be 
used as starting materials in organometallic syntheses, and are widely applied in transition 
metal-catalyzed [42-50], as well as in stoichiometric [51-54] organic syntheses. Catalytic 
activity of the η5-cyclopentadienyl ruthenium complexes ranges from hydrogen transfer to ring 
closing metathesis [55,56]. The multiple, hence strong bonding of the Cp` fragment relative to 
the co-ligands in a metal complex, renders the cyclopentadienyl moiety a non-participant in 
catalytic transformations.  
 
1.2.3 Nitrogen containing ligands 
 
The majority of organic molecules, pharmacophores [57] and proteins in biological systems 
contain carbon and nitrogen. Microbial, vegetable and animal metabolisms generate amine 
functionalities found in biogenic molecules. Some biogenic molecules containing the amine 
functionality are illustrated in Figure 3. Most of the molecules function as regulators of various 
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(9) - neropinephrine              
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HO NH2
(10) - Dopamine  
Figure 3: Molecules 1-10 are some biogenic amine molecules                
                   
Many nitrogen containing compounds have been demonstrated to be important in pharmacology 
as well as in catalysis. Amine-containing drugs are a very important class of therapeutic agents, 
with the majority of all drugs containing at least a nitrogen atom in their structure. α,ω-
Diaminoalkanes are a significant and versatile class of compounds with significant applications 
and roles in various fields. For instance in pharmaceutical chemistry, 1,2-ethylenediamine has 
been shown to be responsible for the action of ethambutol, a front-line drug, in the  treatment of 
tuberculosis (TB) [59,60]. Studies done on anti-tubercular activity of α,ω-diaminoalkanes have 
shown that long chain α,ω-diaminoalkanes, H2N(CH2)nNH2 (n = 9 – 12) exhibit good activity, in 
the range 2.5 – 3.12 µg/mL, against Mycobacterium tuberculosis [61]. Another analogue of 
ethambutol, bis-glycosylated diamino alcohol, has also been shown to demonstrate good activity 
against the multi-drug resistant (MDR) strain of M. tuberculosis [62]. Diethylcarbamazine 
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(DEC) (N,N-diethyl-4-piperazine-1-carboxamide) is a synthetic derivative of piperazine used in 
the treatment of filariasis in humans, dogs and cats. Tertiary amines, as well as secondary 
amines, such as N-hexylcyclohexylamine, exhibited microfilaricidal response against 
Acanthocheilonema viteae [63].  
 
Furthermore, the readily available and highly versatile primary amines have emerged as very 
effective catalysts in asymmetric synthesis. They have exhibited effective catalysis in several 
enantioselective organic reactions [64,65]. For instance, primary amino acids such as proline are 
good organocatalysts with the primary amino group providing unique reactivity and 
stereoselectivity in asymmetric aldol and Mannich reactions [66]. Bidentate primary amines 
coordinated to metal Lewis acids are efficient catalysts in the direct asymmetric aldol reactions 
of ketones offering excellent stereoselectivity [67].  
 
Even though the amine functionality has been shown to play a great role in catalysis, 
pharmacology and physiology, the coordination of simple amine ligands to transition metals is 
an area that has not been widely studied [68-72]. By combining the catalytic and medicinal 
properties of the [CpRu(CO)2] fragment with those of nitrogen containing ligands such as 
amines, it was hoped that the complexes synthesized in this work would have good catalytic and 
antibacterial activities. In this study, η5-cyclopentadienyldicarbonylruthenium(II) complexes of 
various primary amines were synthesized and characterized, and their catalytic and 
antimicrobial activities investigated. 
 
1.2.4 The chemistry of η5-cyclopentadienyldicarbonylruthenium(II) complexes 
 
The cyclopentadienyl metal dicarbonyl fragment, CpM(CO)2, is a common constituent of a 
large class of complexes. The fragment is commonly denoted as ‘Mp’, where M varies with the 
metal; for instance, Rp = CpRu(CO)2 and Fp = CpFe(CO)2. The complexes are fairly stable 
towards air, moisture and temperature. They can be characterized readily by IR and NMR 
spectroscopy based on simple spectroscopic features, such as two strong v(C≡O) absorptions in 
the region 1800 – 2200 cm–1  and a single Cp resonance in the 1H and 13C NMR spectra. 
 
Ruthenium complexes containing both cyclopentadienyl and carbonyl ligands have been in 
existence for more than five decades. The first cyclopentadienyl ruthenium dicarbonyl dimeric 
complex, [CpRu(CO)2]2, was synthesized by Fischer and Volger by treating the polymers, 
[Ru(CO)2I2]n and [Ru(CO)2Cl2]n with sodium cyclopentadienide, NaCp [73]. Since then, the 
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ruthenium dimer, CpRu(CO)2]2, has been extensively used as a precursor in the synthesis of η5-
cyclopentadienyldicarbonylruthenium(II) complexes. The complexes are obtained from the 
ruthenium dimer either by oxidative or reductive cleavage of the Ru—Ru bond. Reductive 
cleavage mainly involves monoelectronic reducing agents such as Li, Na and K in THF leading 
to the anionic complex [CpRu(CO)2]-, while oxidative cleavage is achieved by the halide ions, 
X (Cl-, Br- and I-) leading to the complexes [CpRu(CO)2X]. Treatment of [CpRu(CO)2]2 with 
sodium amalgam [74] or potassium amalgam [75] gives the complex anion, [CpRu(CO)2]-. The 
reaction of the complex anion [CpRu(CO)2]- with C6F5COCl afforded the para-disubstituted 
diruthenium complex, [CpRu(CO)2C6F4CORu(CO)2Cp]. The propionyl complex 
CpRu(CO)2COC2H5 was prepared by treating the sodium salt, Na+[CpRu(CO)2]-, with propoinyl 
chloride in THF [75]. The complex [CpRu(CO)2Me] was synthesized by refluxing 
K+[CpRu(CO)2]- and methyl iodide in THF at 45 °C for several days [76]. Brookhart and co-
workers [77] used the anionic complex, [CpRu(CO)2]- to synthesize ruthenium 
cyclopropylcarbene complexes shown in Figure 4. 
 
The dimer [CpRu(CO)2]2 can also be synthesized by refluxing cyclopentadiene and Ru3(CO)12 
in heptanes [78,79];  depending on the workup, CpRu(CO)2H is synthesized by a similar 
procedure. Shvo and co-workers used the complex Ru3(CO)12 as a precursor in the synthesis of 
the dimeric hydrogenation catalysts, [(η4-Ph4C4CO)(CO)2Ru]2 and [(η4-Me2Ph2C4CO)(CO)2Ru]2 




























































Figure 5: Shvo's hydrogenation catalysts 
 
The dimer [CpRu(CO)2]2 has been widely used as a precursor for the synthesis of the halo 
cyclopentadienyl dicarbonyl ruthenium complexes, CpRu(CO)2X and [CpRu(CO)2]2X (X = Cl, 
Br or I) (Equations 1 and 2) [81]. 
 









These halide complexes, CpRu(CO)2X, have been extensively used as precursors in the 
synthesis of both neutral and cationic complexes of the type CpRu(CO)2L and [CpRu(CO)2L]Y 
(L = ligand; Y = counter anion) respectively. Jungbauer and Behrens synthesized several 
complexes using CpRu(CO)2Cl as a precursor and AlCl3 as the halogen abstractor, as illustrated 
by Equation 3 [82]. Other syntheses by Jungbauer are illustrated in Equations 4 and 5 
 
CpRu(CO)2Cl + n AlCl3 + L {[CpRu(CO)2]nL}(AlCl4)n
25 oC - 80 oC
C6H6




Reaction of the complexes with NH4PF6 or NaBF4 gave the corresponding complex salts, 
{[CpRu(CO)2]nL}(PF6)n or {[CpRu(CO)2]nL}(PF6)n respectively. 
 






CpRu(CO)2Cl + L [CpRu(CO)2-nL]Cl + nCO Equation 5
60 - 70 oC
C6H6
n = 0: L = PEt; n = 1: L = Ph2PCH2CH2PPh2
 
 
It is worth noting that very few CpRu(CO)2 complexes with simple nitrogen containing ligands 
have been reported. In the nitrogen-containing ruthenium complexes, [CpRu(CO)2NH3]+ [82], 
[CpRu(CO)2CH3CN]PF6 [82,83] and [CpRu(CO)2(NCO) [84], the ligand is coordinated to the 
metal through the nitrogen atom, whereas in [CpRu(CO)2(CONHNH2)] [84] and the quaternary 
ammonium salt, {CpRu(CO)2[CH2CH2(NH3)+]}PF6 [85], the ligand is not coordinated through 
the nitrogen atom. The η5-cyclopentadienyldicarbonylruthenium(II) complexes in which 
primary amines are coordinated to the ruthenium centre via the nitrogen atom were reported by 
us for the first time [86]. 
 
The η5-cyclopentadienyldicarbonylruthenium(II) complexes of various primary amines 
synthesized in this study are soluble in water and were used as catalysts in the oxidative 
cleavage of styrene. Their antimicrobial activity against selected Gram-positive and Gram-
negative bacteria was also tested. In the next sections, a brief review of the use of ruthenium 
complexes in both catalysis and medicine is given. The importance of water solubility of 
organometallic complexes is discussed.  
 
1.3 Water soluble organometallic complexes 
 
Water is the most desirable solvent in catalysis because it is cheap, abundant, non-flammable, 
and nontoxic. There has been great interest in water-soluble organometallic complexes due to 
their usefulness in aqueous biphasic catalysis [87,88]. The use of biphasic catalysis allows for 
utilization of water as a co-solvent, hence, it is important in designing green chemical processes. 
Since the amine group is hydrophilic, including them in the complex may make the 
organometallic species water soluble. Water is also very important in biological systems, since 
it is the main solvent. Solubility of organometallic compounds in water is a major prerequisite 
for innovations in biomedicine [89], bioorganometallic chemistry and organometallic 
radiopharmaceuticals. Aqueous solubility is one of the important properties required for early 
stages of effective drug delivery, hence the need to explore the possibility of synthesizing water 
soluble complexes. Furthermore, due to the growing interest in green chemistry, the desire to 
use aqueous phase catalysis has made the development of water soluble organometallic 
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compounds vital in both the laboratory and industry. The synthesis of a series of 1-aminoalkane 
and α,ω-diaminoalkane complexes of η5-cyclopentadienyldicarbonyliron(II) was recently 
reported [68]. The amino group on the hydrocarbon chain renders these complexes soluble in 
water by virtue of hydrogen-bonding. The 1-aminoalkane complexes were shown to react with 
sodium salts such as NaBPh4 and NaI in aqueous media to give the respective BPh4- and I- salts 
[70]. 
 
1.4 Ruthenium complexes in catalysis 
 
A catalyst is a substance that is able to accelerate a chemical reaction by providing an 
alternative reaction pathway with significantly lower activation energy as compared to the non-
catalyzed process [90]. Activation energy for a reaction in organometallic catalysis decreases 
through coordination of the substrates to the transition metal centre, thus promoting the reaction 
[91-94]. Catalysis is significant in the chemical industry because it contributes both to its 
economical success and environmental sustainability. Catalysis can be categorized as 
homogeneous or heterogeneous, depending on their relationship to the phase of the reaction in 
which they are involved. If a catalyst is in the same phase as the components of the reaction it 
catalyses, it is homogenous, whereas one in a different phase from the components of the 
reaction it is catalyzing is heterogeneous. Homogeneously catalyzed reactions have improved 
activity due to their monomolecular nature, high selectivity (i.e. regioselectivity, enantiomeric 
excesses), and their ability to avoid mass transfer limitations, thus favouring lower temperature 
conditions. The main disadvantage of homogeneous catalysis is the difficult and costly catalyst 
separation and recovery due to homogeneous nature of the solution. Contamination of the 
product by residual catalyst or metal species is also a challenge. Biphasic solvent systems have 
been developed in an effort to improve recovery and recyclability of selective homogeneous 
catalysts, as well as minimize industrial waste streams [95-97]. An aqueous biphasic system is a 
typical example where catalyst recovery can be achieved by maintaining an aqueous catalyst-
rich phase separate from the substrate containing non-polar organic phase. The two phases can 
be separated by decantation, resulting in no loss of catalyst. The aqueous layer can be recycled 
many times yielding high catalytic turnover with little metallic contamination of the product.  
This aspect has made the water-soluble organometallic complexes more attractive due to their 
utility in aqueous biphasic catalysis.  
 
Organometallic complexes are mainly homogeneous catalysts and enhance conversion as well 
as product selectivity by accelerating just one of the competing reaction sequences when 
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alternative routes exist [98-100]. Ruthenium complexes have been reported as catalysts in 
reactions such as oxidation, isomerisation, carbon–carbon bond formation, racemisation of 
alcohols and amines, polymerization, olefin metathesis and nucleophilic addition to multiple 
bonds [101-105].  
 
1.4.1 Homogenous catalysis and water soluble complexes 
 
Application of water-soluble organometallic complexes in catalysis has continued to attract 
interest because the process is environmentally friendly, product separation is simple and 
selectivity in aqueous media is pH dependent [88]. The recycling of aqueous organometallic 
catalysts represents a fundamental application of the core principle of green chemistry and 
sustainable technology through the reduction of waste streams and remediation and the 
combination of atom economical catalytic chemistry with water. The solubility of 
organometallic complexes in water is usually achieved by introduction of polar substituents in 
their structures [106]. The most commonly used polar substituents are hydroxyl and amino 
functionalities, as well as ionic groups such as sulfonate, carboxylate and ammonium.  Nitrogen 
coordinated water soluble organometallic complexes have also been shown to be active aqueous 
biphasic catalyst. For instance, the cationic ruthenium complexes 11 and 12 are effective 
catalysts for enantioselective transfer hydrogenation of aryl ketones [107], while complexes 13 
and 14 have been shown to be effective catalysts in transfer hydrogenation of acetophenone 
(Fig. 6) [108]. Biphasic catalysts can be pH dependent [109,110] and counter anions such as PF6 


























R = H (13); R = Me (14)  





1.4.2 Catalytic oxidation of organic syntheses 
 
Oxidation catalysis represents the core of a variety of chemical processes for producing bulk 
and fine chemicals. Oxidation catalysis based on ruthenium, a powerful and useful synthetic 
tool, selectively affords oxygenate products both in homogeneous and heterogeneous processes 
[111,112]. Ruthenium complexes have been shown to selectively catalyse a large variety of 
oxidative conversions, including the generation of molecular oxygen from water [113-115], the 
dihydroxylation of olefins [50,116], oxidative cleavage of olefinic double bonds [117,118], the 
oxidative dehydrogenation of alcohols to carbonyls [117,118] and the asymmetric epoxidation 
of alkenes [119,120]. The ability of ruthenium complexes to catalyze a great variety of 
oxidation processes is based on ruthenium’s wide range of oxidation states, choice of suitable 
co-ligands, and a generally favourable balance of kinetic lability and stability. Co-ligands used 
can lead to changes in the redox characteristics of the ruthenium centre and, hence, adjust the 
oxidation properties of the ruthenium complexes as catalysts. Some substituted η5-
cyclopentadienyldicarbonyl ruthenium complexes used in the catalytic oxidation of amines are 

































Figure 7: η5-Cyclopentadienyldicarbonyl ruthenium complexes used in catalytic oxidation of amines 
 
Typical examples of ruthenium complexes that have demonstrated good catalytic activity in 
oxidation processes are summarized in Table 1.  
 
1.4.2.1 Olefin oxidation 
 
Metal catalyzed oxidation of terminal olefins gives rise to a variety of products as illustrated in 




The oxidative cleavage of a C—C double bond involves splitting of the double bond and 
insertion of oxygen into the two fragments (Scheme 1). The initial oxidation products of 
terminal alkenes are two aldehydes, while tertiary alkenes yield both an aldehyde and ketone. 
Aldehydes can be over-oxidized to carboxylic acids, while ketones are not oxidized. Oxidative 
cleavage, therefore, provides access to intermediates suitable for sequential reactions, or directly 












































Scheme 1: Products of metal-catalyzed oxidation of terminal alkenes
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Table 1: Oxidation reactions catalyzed by Ru complexes 
Catalyst  Co-oxidant Oxidation reaction catalysed Conditions  Ref. 
[RuIII(bda)(mmi)(OH2]CF3SO3  





water oxidation  [113,115] 
[RuIII(amp)(bipy)(H2O)]+  
(H2amp = N-(2-hydroxyphenyl)salicyldimine;  
bipy =  2,2`-bipyridyl) 
 
t-BuOOH benzene to phenol CH2Cl2; RT [122] 
[RuII(amp)(bipy)Cl] t-BuOOH cyclohexene to cyclohexene-1-
ol, cyclohexane to cyclohexanol 
and cyclohexanone, stilbene to 
stilbene epoxide and 
benzaldehyde 
CH2Cl2; RT 
Phase transfer catalyst 
(benzyltributylammoniumchloride) 
[123] 
RuL(CO)2Cl2, [RuL(CO)2L’2]2+ and [RuL(CO)2ClL’]+  
(L = bipyridine (bpy), phenanthroline (phen), biquinoline 
(biq) and L’ = pyridines, 4-chloropyridine, 4 – 
methoxypyridine) 
 
PhIO epoxidation of olefins (CH3)2CO/H2O; 25 °C [124] 
trans-RuVI(tmp)(O)2]  
(tmp =  5, 10, 15, 20 – tetramesitylporphyrin) 
 
Air  dehydrogenation of primary and 
secondary amines 
 [125] 
Ruthenium(II) porphyrin complexes 
 
NMO or O2/air alkenes to aldehydes (scheme 1)  [126] 
RuL2  
(L = 1, 10-phenanthroline, 8-hydroxyquinoline and 2, 2`-
bipyridine) 
 
PhIO benzylic and aliphatic alcohols 
to corresponding aldehydes and 
ketone 
MeCN; RT [127] 
Figure 7 
 
Air  oxidation of amines to nitriles 
and imines  
Toluene; 110 °C [128] 
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Oxidative cleavage pathways discussed in literature can be summarized into two main 
categories: (i) dihydroxylation followed by cleavage with NaIO4 or other oxidants [80] or (ii) 
ozonolysis which involves direct cleavage of the olefin into a variety of functionalized products 
depending on the workup conditions [102-104]. The direct oxidative cleavage of olefinic double 
bonds is conventionally performed at industrial level by ozonolysis to convert alkenes into 
aldehydes or carboxylic acids [129] upon oxidative or reductive workups respectively. The 
problem with ozonolysis is the dangerous and unstable nature of ozone, the oxidant, which 
necessitates use of high-technology equipment, which increases the overall cost [114,130]. The 
oxidative cleavage can also be achieved by several stoichiometric oxidants, such as m-
chloroperbenzoic acid (mcpba) used for cleavage of diarylethylene derivative to ketones [64] 
and PhIO/HBF4 (1:1 equiv) which affords aldehydes selectively [131].  
 
Several transition metal-containing compounds have been used as stoichiometric oxidants in the 
oxidative cleavage of olefinic double bonds but there are drawbacks to their usage.  
Stoichiometric amounts of KMnO4, for instance, oxidises olefins to aldehydes [132] or 
carboxylic acids [133-135], but the organic substrates formed are often poorly soluble in the 
aqueous reaction medium. It is also worth noting that KMnO4 cannot be used in catalytic 
amounts due to the irreversible precipitation of MnO2 after oxidation of the substrate. On the 
other hand, chromyl chloride, CrO2Cl2, [136] oxidises styrene into benzaldehyde and 
phenylacetaldehyde [137], but since such chromium salts are known to be very toxic, their use 
is discouraged.  
 
The challenges encountered in using ozone and stoichiometric amounts of the transition metal 
compounds inspired research into the use of simple ruthenium salts and complexes as catalysts 
for the oxidative cleavage of olefinic double bonds. RuO4 has been used as a selective 
stoichiometric oxidant for the conversion of alkenes to aldehydes [3,138]. Simple ruthenium 
salts, RuO4 and RuCl3. nH2O, have been widely used as catalysts in the oxidative cleavage of 
the olefinic double bond [139-141]. The oxidation of cyclohexene to adipic acid, by stirring a 
solution of cyclohexene in CH2Cl2 with an aqueous solution of RuCl3.nH2O and NaOCl, was 
reported [139]. Carlsen and co-workers reported the use of RuCl3/NaIO4 for the oxidative 
cleavage of alkenes to carboxylic acid with the CCl4-MeCN-H2O solvent system [140]. RuCl3, 
1.5 equiv. oxone and 4.7 equiv. NaHCO3 in the MeCN/H2O solvent system selectively cleave 
styrene and derivatives to aldehydes instead of carboxylic acid [141]. RuO2, formed as an 
intermediate product when RuCl3 is used as the catalyst, unlike MnO2, is soluble in solvents 
such as CCl4 or MeCN and can be re-oxidized to RuO4 by NaIO4 [142] or NaOCl [140]. 
15 
 
Catalytic amounts of RuO2.2H2O and 2-6 equiv. NaIO4 in CCl4/H2O were used to cleave 
electron poor cyclic enolic C=C bonds on the β-position to aldehydes in 35-95% yield [143].  
 
The use of catalytic amounts of ruthenium complexes in the oxidative cleavage of olefins is 
more advantageous than the use of salts, because it reduces the levels of toxicity of the metal 
and improves selectivity towards the cleavage products, while preventing side reactions such as 
epoxidation, dihydroxylation or allylic oxidation. The co-ligand coordinated to the metal plays a 
major role in improving the catalytic activity as well as selectivity of the catalyst. Several 
ruthenium complexes, as catalysts, have demonstrated good selectivity to C—C bond cleavage 
oxidative products in oxidation reactions. The complex cis-[RuCl2(bipy)2].2H2O, has been used 
in catalytic oxidative cleavage of alkenes to acids with IO(OH)5 as co-oxidant as well as chemo-
selective degradation of aromatic rings to acids with NaIO4 as a co-oxidant, in the CCl4-MeCN-
H2O biphasic solvent system [117]. [Cis-Ru(II)(dmp)2(H2O)2]2+ (dmp = 2, 9 – 
dimethylphenanthroline) was used as a catalyst in the oxidative cleavage of terminal alkenes to 
aldehydes using H2O2 as the oxidant in acetonitrile at 55 °C [118].  It is worth noting that 
research into the possible use of ruthenium complexes as catalysts in the oxidative cleavage of 
C—C double bonds has not been extensively done, despite the fact that they show excellent 
activity and selectivity.  
 
1.4.2.2 Mechanism for oxidative cleavage of olefinic double bond 
 
Simple ruthenium compounds, such as RuCl3.nH2O and RuO2, have been shown to catalyse 
oxidative cleavage of olefinic double bonds through the formation of RuO4 as the main oxidant. 
RuO4 catalyzed oxidation has been proposed to proceed through the formation of a 
ruthenium(VI) diether (Scheme 2) which is oxidatively cleaved to give an aldehyde 
[115,144,145]. After coordination of the alkene, a metal-dioxyethane moiety, a metaldiether, is 
formed via a 3 + 2 pericyclic reaction (Scheme 2). A sufficient lifetime of the diether is crucial, 
as its rearrangement yields the desired aldehydes, while hydrolysis causes the formation of 
diols. RuO4, therefore, shows high selectivity towards cleavage products because the reaction 























Scheme 2: Mechanism for oxidative cleavage of olefin carbon-carbon double bond 
 
Most ruthenium complexes have also been demonstrated to catalyze oxidation processes 
through formation of an oxo-ruthenium species intermediate as the oxidant [122,146,147]. For 
instance, the high valent ruthenium oxo-species, [RuV(amp)(bipy)O]+ (H2amp = N-(2-
hydroxyphenyl)salicyldimine; bipy =  2,2`-bipyridyl) is formed during the oxidation process 
catalyzed by [RuIII(amp)(bipy)(H2O)]+ and [RuIII(amp)(bipy)Cl] [123]. 
 
1.5 Ruthenium complexes in medicine 
 
The stability of different oxidation states of ruthenium and, thus, its redox properties are 
influenced by the coordination environment [148,149]. The activity of ruthenium compounds as 
drugs depend on the oxidation state, the ligand, as well as their stability in highly acidic and 
alkaline environments. The toxicity of ruthenium containing drugs are low because, ruthenium 
is able to mimic iron in the mechanism exploited by the body for non-toxic transportation of 
iron, i.e. by binding to biomolecules [150]. The ability of the body to catalyse reduction and 
oxidation reactions in different physiological environment is dependent on the redox potential 
between the different oxidation states of ruthenium, RuII, RuIII and RuIV, accessible under the 
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physiological conditions [150]. Furthermore, the physiological environment altered by the 
biochemical changes that accompany disease facilitates the selective activation of ruthenium 
compounds in the diseased tissues [150]. Ruthenium complexes have been used as 
immunosuppresants, antimicrobials [16, 71,125,151,152], antibiotics, nitric oxide scavangers 
[150] and anticancer drugs [112,113,131]. They have also demonstrated DNA binding 
[153,154], and chemiluminescence [155]. 
 
1.5.1 Ruthenium complexes as chemotherapeutic agents 
 
For a long time, platinum-based compounds have been used as chemotherapeutic agents in to 
treat solid tumors, such as ovarian and testicular carcinomas [156]. However, the renal, 
neurologic, gastroenterologic, and marrow toxicity, as well as cancer cells resistance to the 
platinum-based drugs has triggered the search for new metal-based antitumor drugs, which are 
more effective and with less side effects [150,157]. Ruthenium, gold and osmium compounds 
have received great attention as alternatives to platinum compounds [158]. Ruthenium 
complexes have received greater attention and are extensively studied where two of them, 


































NAMI-A, ImH[Ru(Im)(dmso)Cl4] (Im=imidazole), is a chemotherapeutic agent that 
demonstrates low toxicity, high selectivity and efficacy for solid tumour metastasis at 
pharmacologically active doses [159-161]. It does not affect primary tumor growth [162]. 
Contrary to earlier reports that NAMI-A does not exhibit cytotoxicity against tumour cells in 
vitro [163], recent studies have shown that it induces potent and selective cytotoxic effects on a 
few leukaemia cell lines [164]. The ruthenium complex, trans-[tetrachlorobis(1H-
indazole)ruthenate(III)] KP1019, is also a hopeful chemotherapeutic agent that has 
demonstrated ability to reduce the size of tumours in rats [165], triggers apoptosis in vitro [166], 
is non-toxic at any dose administered with about 80% of the patients improving or stabilizing 
[165] and is also effective against cancer cell lines that are highly resistant to other 
chemotherapeutic agents [167]. Ruthenium complexes, therefore, are a promising alternative to 
platinum-based antitumor drugs [168-170].  
 
The cyclopentadienyl and p-cymene ruthenium(II) complexes have been shown to exhibit anti-
tumour activity [171-173]. The piano-stool complexes, such as, RAPTA-C [Ru(η6-p-
cymene)Cl2(PTA)](PTA=1,3,5-triaza-7-phosphatricyclo-[3.3.1.1]decanephosphine) [174], best 
represent this class of compounds. They have properties, similar to those of NAMI-A, that 
inhibit metastasis process at low in vitro anticancer activity [175]. New research findings have 
revealed that a new ruthenium compound, [(η6-1,3,5-triisopropylbenzene)RuCl(4-methoxy-N-
(2-quinolinyl-methylene)aniline)]Cl has anticancer activity against ovarian cancer, breast 
cancer, and colorectal cancer cell lines [170]. 
 
1.5.2 Antimicrobial and antimycobacterial agents 
 
Bacteria are capable of rapidly developing resistance to known antimicrobial drugs as well as to 
new drugs based upon analogues of known scaffolds. Noteworthy, bacterial resistance to 
antimicrobial drugs is a threat to humans worldwide [176] and, therefore, requires urgent 
intervention. The increased rate of bacterial resistance and need to eradicate the bacteria has 
triggered increased interest in the development of new classes of antimicrobial agents [177] that 
can evade the bacterial mechanisms of resistance developed against the antimicrobial agents in 
clinical use. The Infectious Diseases Society of America (IDSA) 2009 update [176] indicated 
that “drug resistance by the ‘ESKAPE’ pathogens; Enterococcus faecium, Staphylococcus 
aureus (S. aureus), Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa 
(P. aeruginosa) and Enterobacter species is of global concern”. Methicillin-resistant S. aureus 
(MRSA), fluoroquinolone-resistant P. aeruginosa and vancomycin-resistant Enterococcus 
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(VRE) show increasing rates of infection [178]. There is, therefore, a need to develop new 
classes of antibacterial agents that may evade the mechanisms of resistance developed by the 
bacteria against the antimicrobial agents currently in clinical use. 
 
The mycobacterium tuberculosis (MTB), which causes the infectious tuberculosis (TB) disease, 
is another bacterial strain that is a major threat to human life. The rapid spread of the MTB 
strain that is resistant to at least isoniazid and rifampicin, known as multidrug resistant TB 
(MDR-TB), has been a challenge in recent years. In 2011, there were up to 400,000 estimated 
cases of multidrug-resistant TB (MDR-TB) among notified TB patients with close to 10% of all 
MDR cases being extensively drug-resistant (XDR-TB), meaning they are also resistant to two 
of the key drugs used as a part of second-line regimens [179]. Thus, there is a great need to 
develop new antimycobacterial agents that can act fast while providing more effective treatment 
against multidrug resistant (MDR), extensive drug resistant (XDR) and latent tuberculosis 
infections [180]. Currently, two approaches are used in the development of anti-TB drug [181]. 
Analogues of existing drugs can be synthesized with the aim of reducing the drug 
administration period and improve TB treatment, or, search for new structures that MTB has 
never encountered [182]. These approaches are also applicable to the development of other 
antimicrobial agents. 
 
Transition metal complexes have been successfully used as anticancer agents [183-185], and 
this has triggered immense interest in metal complexes as antimicrobial agents [12,13,186,187]. 
Dwyer and co-workers were the first researchers to show that the ruthenium and iron 
complexes, polypyridyl mononuclear tris(bidentate)-ruthenium(II) and -iron(II) complexes, e.g. 
[Ru(Me4phen)3]2+ (Me4phen = 3,4,7,8-tetramethyl-1,10-phenanthroline), have potential 
antibacterial activity [151,188]. Their findings have inspired immense interest and research in 
the possible use of ruthenium complexes as antimicrobial agents. Based on Dwyer’s findings, 
research on ruthenium complexes as potential antimicrobial agents has been mainly focused 
around polypyridyl ligands [12,13,189]. Li and co-workers synthesized and demonstrated that 
the inert flexibly-linked dinuclear ruthenium(II) complexes, [{Ru(phen)2}2{µ-bbn}]4+ {Rubbn; 
phen = 1,10-phenanthrolin and bb = bis[4(4´-methyl-bipyridyl)]-1, n = alkane (n = 2, 5, 7, 10, 
12, 16)}, are potential antimicrobial agents against an array of Gram-positive and Gram-
negative bacteria [152,190]. Pandrala and co-workers synthesized a series of polypyridyl-
ruthenium(II) complexes, [{Ru(tpy)Cl}2{µ-bbn}]2/4+ {Cl-Mbbn; tpy = 2,2´:6´,2´´-terpyridine; 
and bbn = bis[4(4´-methyl-2,2´-bipyridyl)]-1,n-alkane (n = 7, 12 or 16)} and demonstrated that 
ClRubb12 is active and bactericidal against the Gram-positive and Gram-negative bacteria 
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tested. Another ruthenium pyridyl complex with a labile chlorido ligand was reported to be 
active against bacteria [16]. Lam et al. synthesized ruthenium(II) bis(2,2′-bipyridyl) complexes 
containing N-phenyl-substituted diazafluorenes and demonstrated their potential antimicrobial 
activity against the Methicillin-Resistant S. aureus [191]. The binuclear ruthenium(II) carbonyl 
complexes, [{RuX(CO)(EPh3)2}2L] (where X=H or Cl; E = P or As and L = dibasic tetradentate 
diacetyl resorcinol (H2-DAR)) were shown  [192] to be better  inhibitors of the growth of the 
Gram positive S. aureus, and the Gram-negative E. coli and K. pneumoniae than the free ligand. 
The Ruthenium(II) complexes, [Ru(dmb)2IIP]2+, {dmb is 4,4′-dimethyl-2,2′-bipyridine and IIP 
is 2-(1H-indol-3-yl)-1H-imidazo[4,5-f][1,10-phenanthroline}, have also demonstrated potential 
antibacterial activities against E. coli and S. aureus by Tweedy’s chelation theory [193]. 
 
Non-pyridine containing ruthenium complexes have also been shown to be active against a 
number of bacteria. For example, thiosemicarbazone ruthenium complexes have been shown to 
exhibit antimicrobial activity against S. aureus, B. Cereus, E. faecalis, S. typhimurium, Proteus 
vulgaris  and Vibrio cholera [194]. Pavan and co-workers synthesized a series of ruthenium(II) 
phosphine, diimine/picolate complexes [195] and demonstrated their activity against 
mycobacterium tuberculosis (MTB) [196,197]. They also showed that the ruthenium complexes 
were more active against MTB than the free ligand [198]. 
 
1.6 Iron complexes  
 
1.6.1 A survey of η5-cyclopentadienyldicarbonyl iron (II) complexes 
 
Compounds containing the iron fragment CpFe(CO)2 (Cp = η5-C5H5) have been extensively 
studied [199-201] since the discovery of [CpFe(CO)2]2 [202]. Some of the most recent 
contributions towards the understanding of the chemistry of iron complexes containing the 
CpFe(CO)2 fragment were made by M'thiruaine et al. [68-72].  They reported the synthesis of 
the etheral complex [CpFe(CO)2O(CH2CH3)]BF4 and its application as a precursor in the 
synthesis of the iron amine complexes of the type [CpFe(CO)2L]BF4, (L = n-alkylamine, α,ω-
diaminoalkanes, N-heterocyclic ligands and aromatic amines). It is worth noting that the 





1.6.2 Iron complexes in catalysis 
 
The ease with which the oxidation states of iron catalysts are interchangeable and their unique 
Lewis acid character enables them to catalyse a variety of  synthetic transformations; 
rearrangements, hydrogenations, substitutions, cycloadditions, coupling reactions, reductions, 
polymerizations, oxidations, isomerizations, and additions. Low-valent α-diimine iron 
complexes have been demonstrated as good catalysts in the hydrogenation of various C—C 
double and triple bonds [203-206]. In addition to hydrogenation of the olefinic double bond, 
Casey and Guan reported the first efficient iron complex (Fig. 9) catalysed H2-hydrogenation of 
ketones, imines aldehydes and diketones [207]. The catalyst has some structural features similar 










Figure 9: Iron complex catalyst for the hydrogenation of ketones, aldehydes and ketones 
 
Catalytic oxidation of cycloalkanes and alkylarenes with catalytic amounts of iron salts was 
reported by Bolm and co-workers [208,209]. Selective C H oxidation of ethyl benzene to 
acetophenone and traces of phenylethanol occurred in the presence of ligand-free iron(II) 
chloride salts and mild reaction conditions. Epoxidation of olefins by hydrogen peroxide have 
also been achieved in the presence of iron(II) chloride, pyridine-2,6-dicarboxylic acid 
(H2pydic), and a chiral diamine as a three-component catalyst [210]. 1,2-disubstituted aromatic 
olefins were epoxidized with enantiomeric excesses of up to 97% ee. Bis(imino)pyridine iron 
pre-catalysts have been shown to catalyze the hydroxylation of aldehydes and ketones [211]. 
Furthermore, iron-based catalysts have been shown to be highly active and selective in the 
oligomerization of ethylene to linear α-olefins [212,213].  
 
In this study, therefore, the antimicrobial and catalytic activity tests on some of the Cp´ iron 
complexes, [Cp´Fe(CO)2L]+, have been done alongside the η5-cyclopentadienyldicarbonyl-





Ruthenium complexes have been reported as ideal catalysts for many organic syntheses. Amines 
have been reported to be effective catalysts and have antimicrobial activities as well. 
Furthermore, the medicinal properties of various drugs have been shown to improve when 
coordinated to a ruthenium centre.  This work, thus, hypothesizes that cyclopentadienyl 
dicarbonyl ruthenium(II) amine complexes can be effective catalysts for the oxidation of olefins 
and active as antimicrobial agents. 
 
1.8 Aim and objectives 
 
The main aim of this study was to find a procedure for the synthesis various ruthenium(II) 
cationic complexes, characterize them and test their catalytic and antimicrobial activities. The 
findings may improve the understanding of the nature of bonding and structure of the 
complexes and, hence, provide an insight into the possible development of homogenous 
oxidation catalysts based on similar or the same complexes. Furthermore, the findings from this 
study may ultimately inspire more research directed towards the development of similar 
complexes for use as antimicrobial agents against the documented drug-resistant bacteria. Thus, 
the following specific objectives of the study were outlined: 
a) To develop a procedure for the synthesis of amine complexes of η5-
cyclopentadienyldicarbonylruthenium(II) and η5-
pentamethylcyclopentadienyldicarbonylruthenium(II) 
b) To synthesize and characterize amine complexes of η5-
cyclopentadienyldicarbonylruthenium(II) and η5-
pentamethylcyclopentadienyldicarbonylruthenium(II). 
c) To study the bonding and structures of nitrogen containing ruthenium complexes, compare 
them with the reported analogous iron complexes and provide possible explanation for any 
observed difference in behavior.  
d) To determine the antimicrobial activities of the η5-cyclopentadienyldicarbonylruthenium(II) 
amine. 
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The reaction of RpI (Rp = (η5-C5H5)Ru(CO)2) and AgBF4 in two different solvents, 
tetrahydrofuran and dichloromethane afforded two polymorphs of the iodo-bridged cationic 
complex [Rp2I]BF4. Polymorph I precipitated out of solution as yellow broad-shaped blocks 
while polymorph II crystallized out as thin-shaped blocks. While I crystallized in the 
monoclinic P2/c space group with a = 12.0982(5) Å, b = 9.7923(4) Å, c = 15.5321(6) Å, β = 
102.9880(10)°, polymorph (II) crystallized in  the monoclinic P21/c with a = 7.00560(10) Å, b = 
14.1446(3) Å, c = 18.2226(3) Å, β = 96.2390(10)°. The IR spectra of the compound showed the 
presence of terminal carbonyl groups but the absence of bridging carbonyl groups. Thermal 
studies of the two polymorphs reveal very close melting points, 432.2 and 435.2 K for I and II 
respectively. The enthalpies associated with their melting are +15.1 kJ mol-1 and +21.9 kJ mol-1 
for polymorphs I and II respectively. ESI-mass spectroscopy showed the presence of a number 
of statistically possible combinations of the cationic species. The two polymorphs have also 
been characterized using DSC, IR and NMR. 
 
 Key words: cyclopentadienylruthenium carbonyl, iodo-bridged, cationic complex, diruthenium 






1. Introduction  
 
Synthesis of the halogen bridged derivatives [{(CpFe(CO)2}2X]Y (X = Cl, Br or I; Cp = η5-
C5H5 and Y = BF4 or PF6) was first reported in the mid 1960s by Fischer and Moser [1]. This 
was achieved by treatment of the neutral iron complex [CpFe(CO)2X] with strong Lewis acids 
such as AlBr3 and BF3.OEt2. Studies of halogenation of [CpM(CO)2]2 (M = Fe or Ru) [2-4] and 
halide abstraction in CpM(CO)2X by AgBF4 [5] have shown that the halogen-bridged species 
[{CpM(CO)2X}2]BF4 (M = Fe or Ru; X = Cl or I) are formed as intermediate products that can 
be isolated under appropriate experimental conditions. Haines and co-workers [4] established 
that halogenation of CpRu(CO)2]2 in benzene or toluene forms the cation, [{CpM(CO)2}2X]+ in 
the presence of large counter ions such as PF6-. In the halide abstraction from CpFe(CO)2X with 
AgBF4 [5], a silver adduct CpFe(CO)2IAg is initially formed but decomposes to yield 
[CpFe(CO)2]+ and AgI. In the presence of excess CpFe(CO)2I, the iodine-bridged 
[{CpFe(CO)2}2I]BF4 species is formed. Similarly, a number of structures of  iodine-bridged 
ruthenium complexes have been reported [6,7], examples of these that are similar to the 
structures reported here being, [(η-C4Ph4C = O)Ru(CO)2]2I, [6] and the cationic complex salt, 
[Cp*Ru(CO)2]2I]+[B{Ph(CF6)2}4]- (Cp* = η5-C5Me5) [7]. We hereby report the synthesis and 
structural characterization of two polymorphs of [Rp2I]BF4, both crystallizing in the monoclinic 
system in P2/c (I) and P21/c (II) space groups. The two polymorphs have also been 
characterized thermally by DSC and also by NMR, IR and mass spectrometry. 
 




All reactions were carried out under inert atmosphere using standard Schlenk line techniques. 
Nitrogen gas (Afrox) was dried over phosphorus(V) oxide. Reagent grade THF (Merck) and 
Et2O (Merck) were distilled from sodium/benzophenone and stored over molecular sieves; 
CH2Cl2 (Merck) was distilled from phosphorous(V) oxide. Silver tetrafluoroborate (Alfa Aesar), 
Ruthenium trichloride hydrate (DLD), dicyclopentadiene (Aldrich), carbon monoxide (Afrox) 
and iodine (Unilab) were used as supplied. Melting points were recorded on an Ernst Leitz 
Wetzlar hot-stage microscope and are uncorrected. Elemental analyses were performed on a 
LECO CHNS-932 elemental analyzer. Infrared spectra were recorded using an FTIR 
PerkinElmer Spectrum 100 spectrophotometer between 4000 and 400 cm–1, in dichloromethane. 
Mass spectra were recorded on an Agilent 1100 series LC/MSD trap with electrospray 




operated in the positive mode. Acetonitrile (100%) was used as mobile phase and 10 μL of the 
sample injected at 0.3 ml/min flow rate. NMR spectra were recorded on Bruker topspin 400 and 
600 MHz spectrometers. The deuterated solvents CDCl3 (Aldrich, 99.8%) and acetone-d6 
(Aldrich, 99.5%), were used as purchased. Solutions for NMR spectroscopy were prepared 
under nitrogen using nitrogen-saturated solvents. DSC curve was recorded on a SDT Q600 
V20.9 Build 20 instrument using nitrogen at a flow rate of 10/min. The precursors Ru3(CO)12 
[8], [CpRu(CO)2]2 [9], CpRu(CO)2I [4], and [Cp(CO)2Ru]BF4  [10] were prepared by the 
literature methods.  
 
2.2  Preparation of polymorph I of [Rp2I]BF4 
 
A mixture of RpI (0.58 mmol) and a slight excess of silver tetrafluroborate were added into an 
aluminium foil-wrapped, dry Schlenk tube and dried under reduced pressure for 1hr to remove 
any water absorbed by AgBF4 during transfer. Dry, deoxygenated THF (30 mL) was added and 
the mixture stirred at 0 °C for 3 h. The solvent was evaporated at reduced pressure leaving a 
dark-gray solid. The residue was extracted with two 10 mL portions of CH2Cl2. The mixture 
was filtered by use of a canula. An orange coloured filtrate was obtained. The filtrate was 
concentrated and dry diethyl ether was slowly added to the concentrated filtrate to precipitate 
out the product. The mixture was kept at  20 °C for 30 min and a pale yellow solid was 
formed. It was washed with diethyl ether and dried under reduced pressure. The solid was 
characterized by NMR spectroscopy and found to be a mixture of products. Analysis: 1H NMR 
(600 MHz, C3D6O):  δ 6.39 (s, 5H, Cp), δ 6.00 (s, Cp), δ 5.90 (s, 5H, Cp) and δ 5.73 (s, 5H, Cp). 
13C NMR (600 MHz, C3D6O): δ 92.49 (Cp), δ 89.75 (Cp), δ 88.9 (Cp), δ 88.42 (Cp), δ 196.55 
(CO) and δ 189.60 (CO). The product was then dissolved in 2 mL of CH2Cl2 in a vial. Dry, 
deoxygenated diethyether (4 mL) was slowly added to form a layer on the solution. The vial 
was wrapped with an aluminium foil and left for 24 h. Yellow needle shaped crystals were 
formed. Analysis: Calc. For C14H10IO4BF4: C, 25.55%; H, 1.53% and found for C14H10IO4BF4: 
C, 24.72%; H, 1.84%. 1H NMR (400 MHz, CDCl3): δ 5.72 (s, 5H, Cp). 13C NMR (400 MHz, 
CDCl3): δ 88.40 (Cp), 194.70 (CO). FTIR in CH2Cl2 one broad ν(CO) stretch split at tip (2068 
and 2058) and 2017 cm–1; one ν(Cp) peak split at the tip to give  3056 and 3052 cm–1 . Melting 
point is 432.2 K. Es-ms (positive mode) m/z: 572.8 { 15.50% [(η5-C5H5)2Ru2(CO)4I]+}, exact 
mass calc. for  [(η5-C5H5)2Ru2(CO)4I]+ 572.8; 543.8 {13.37% [(η5-C5H5)2Ru2(CO)3I]+exact mass 
calc. for  [(η5-C5H5)2Ru2(CO)3I]+ 543.8; 515.8 {35.37% [(η5-C5H5)2Ru2(CO)2I]+}, exact mass 
calc. for  [(η5-C5H5)2Ru2(CO)2I]+ 515.8; 488.8 {35.76%  [(η5-C5H5)2Ru2(CO)I]+, exact mass 




2.3 Preparation of polymorph II of [Rp2I]BF4 
 
Polymorph II of [Rp2I]BF4 was obtained when a mixture of RpI (0.454 g; 1.299 mmol) and an 
equimolar amount of silver tetrafluroborate (0.253 g; 1.299 mmol) were added into an 
aluminium foil-wrapped, dry Schlenk tube and dried under reduced pressure for 1 h to remove 
any water absorbed by AgBF4 during transfer.  Dry, deoxygenated (30 mL) CH2Cl2 was added 
and the mixture stirred for 2 h after which it was filtered by canula and excess solvent removed 
under reduced pressure. A dark green coloured filtrate was obtained. The filtrate was 
concentrated under reduced pressure.  Dry diethyl ether was slowly added to the filtrate. An 
orange precipitate was formed, leaving a dark-green mother liquor. The orange precipitate was 
washed with diethyl ether and characterized. It was found to melt at 435.2 K. Elemental 
analysis, IR spectroscopy, NMR spectroscopy and mass spectrometry results for polymorph II 
are similar to those observed and recorded for polymorph I.  
 
2.4 X-ray crystal structure determination of [{(Cp(CO)2Ru)2}I]BF4 
 
Crystals of [{(Cp(CO)2Ru)2}I]BF4 suitable for single crystal X-ray diffraction studies were 
grown by the liquid diffusion method. Solutions of the compounds in dry CH2Cl2 were layered 
with a fourfold of excess diethyl ether and allowed to stand undisturbed in the dark at room 
temperature for 24 h. Crystals of the two polymorphs were selected and glued onto the tip of 
glass fibres. The crystals were then mounted in a stream of cold nitrogen at 100(1) K and 
centred in the X-ray beam by using a video camera.  
The crystal evaluation and data collection were performed on a Bruker Smart APEXII 
diffractometer with Mo Kα radiation (λ = 0.71073 Å). The diffractometer to crystal distance 
was set at 4.00 cm. The initial cell matrix was obtained from three series of scans at different 
starting angles. Each series consisted of 12 frames collected at intervals of 0.5° in a 6° range 
about with the exposure time of 10 s per frame. The reflections were successfully indexed by an 
automated indexing routine built in the APEXII program suite [11]. The final cell constants 
were calculated from a set of 6460 strong reflections from the actual data collection. Data 
collection method involved ω scans of width 0.5°. Data reduction was carried using the program 
SAINT+ [11]. The structure was solved by direct methods using SHELXS [12] and refined [11]. 
All structures were checked for solvent-accessible cavities using PLATON [13] and the 
graphics were performed with the DIAMOND [14] visual crystal structure information system 




full-matrix least-squares calculations based on F2 using SHELXS.  All H atoms were positioned 
geometrically and allowed to ride on their respective parent atoms. The carboxyl H atoms were 
located from the difference map and allowed to ride on their parent atoms. All H atoms were 
refined isotropically. The absorption correction was based on fitting a function to the empirical 
transmission surface as sampled by multiple equivalent measurements [11]. Crystal data and 
structure refinement information for polymorph I and II are summarized in Table 1. 
 
Table 1: Crystal data and structure refinement for polymorphs I and II 
 Polymorph I Polymorph II 
Empirical formula  C14 H10 B F4 I O4 Ru2 C14 H10 B F4 I O4 Ru2 
Formula weight  658.07 658.07 
Temperature  173(2) K 173(2) K 
Wavelength  0.71073 Å 0.71073 Å 
Crystal system  Monoclinic Monoclinic 
Space group  P2/c P21/c 
Unit cell dimensions (Å / °) a = 12.0982(5)    a = 7.00560(10) 
b = 9.7923(4)    β= 102.9880(10) b = 14.1446(3)   β= 96.2390(10) 
c = 15.5321(6)  c = 18.2226(3)  
Volume 1793.00(13) Å3 1795.01(5) Å3 
Z 4 4 
Density (calculated) 2.438 Mg/m3 2.435 Mg/m3 
Absorption coefficient 3.462 mm-1 3.458 mm-1 
F(000) 1232 1232 
Crystal size 0.43 x 0.34 x 0.16 mm3 0.42 x 0.16 x 0.11 mm3 
Theta range for data 
collection 
1.73 to 28.45°. 1.83 to 28.32°. 
Index ranges -16 h 15, -13 k 11,  
-20 l 20 
-8 h 9, -18 k 18,  
-24 l 22 
Reflections collected 46542 42242 
Independent reflections 4492 [R(int) = 0.0247] 4471 [R(int) = 0.0244] 
Completeness to theta = 
28.45° 
99.2 %  99.8 %  
Absorption correction Semi-empirical from equivalents Semi-empirical from equivalents 
Max. and min. transmission 0.6858 and 0.4069 0.7022 and 0.3245 
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2 
Data / restraints / parameters 4492 / 0 / 236 4471 / 28 / 235 
Goodness-of-fit on F2 1.201 1.111 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0141, wR2 = 0.0378 R1 = 0.0127, wR2 = 0.0322 
R indices (all data) R1 = 0.0149, wR2 = 0.0385 R1 = 0.0135, wR2 = 0.0326 









The reaction between RpI and AgBF4 in THF yields the iodide-bridged complex salt, [Rp2I]BF4 
(I) as a major product and the expected THF salt, [Rp(THF)]BF4, as a minor product. Similar 
reactions on the Fe analogue, CpFe(CO)2I and AgBF4 in THF preferentially result in 
[(CpFe(CO)2(THF)]BF4 [10] types of complexes. On carrying out the same reaction of RpI and 
AgBF4 in dichloromethane as the solvent, a different polymorph of [Rp2I]BF4 (II) is formed. 
The NMR spectra of the two polymorphs are the same, but their melting points differ slightly, 
432.2 and 435.2 K for I and II respectively. Polymorph I crystallize as yellow broad blocks, 
while II crystallizes also as yellow but thinner blocks.  
 
3.2 IR and NMR spectroscopic studies  
 
Polymorphs I and II have similar IR spectral properties. The IR spectra of the two polymorphs 
recorded in dichloromethane gave two characteristic v(CO) absorption bands, at 2069 and 2014 
cm–1, suggesting terminally bound CO ligands. These IR signals are in agreement with the 
literature values for [Rp2I]BF4 [4]. A band corresponding to the cyclopentadienyl anion 
stretching was also observed at 3122 cm–1.  In the IR spectrum of a crude sample of polymorph 
I in dichloromethane, additional weak bands at 2945 cm–1 and 2874 cm–1  associated with C H 
stretching in THF were observed, an indication of the minor product, [Rp(THF)]BF4, from the 
reaction. The crystals gave strong νCO stretching frequencies at 2068 cm–1, and 2016 cm–1. The 
NMR spectrum of the crude product I in acetone-d at 25 °C also confirmed the formation of the 
minor product, as extra resonance peaks associated with the Cp ring protons of the major and 
minor products, were observed at 6.37, 6.00, 5.90 and 5.73 ppm. These peaks may be associated 
with protons of η5-C5H5 of [Rp{OC(CH3)2}]BF4, [Rp2I]BF4, [Rp{H2O}]BF4, and RpI 
respectively. The 13C NMR spectrum also gave four signals associated with cyclopentadienyl 
rings at 92.49 ppm, 89.75 ppm, 88.90 ppm and 88.42 ppm. 1H NMR spectra were obtained in 
acetone–d for authentic samples of [Rp2I]BF4 (6.00 ppm) and RpI (5.72 ppm) prepared 
according to literature methods.  
 





The aqua complex, [CpFe(CO)2(H2O)]BF4, is readily formed when even adventitious water is 
available around the THF complex [CpFe(CO)2(THF)]BF4 [1]. It is therefore assumed, based on 
the extra resonance peaks in the 1H and 13C NMR spectra, that a  similar reaction may have 
taken place in the NMR tube, hence the presence of [Rp(H2O)]BF4 due to the presence of 
adventitious water in the wet deuterated acetone as shown in Eq. (1). 
 
[Rp(THF)]BF4 + (CH3)2CO [RpOC(CH3)2]BF4 + THF (2)
 
Similarly, the acetone complex, [Rp{OC(CH3)2}]BF4 is probably formed by rapid displacement 
of THF by deuterated acetone molecules (Eq. (2)). It has been reported that at high temperatures 
the acetone complex forms [10] and since the NMR samples were not freshly made, there is a 
chance that it forms. The reaction between AgBF4 and an equimolar quantity or a slight excess 
of RpI gives a product [(Rp)2I]BF4 and not the expected final product [Rp]BF4. The same 
happens for the formation of [{(η5-C5H5)Fe(CO)2}2I]+ from the halide abstraction reaction of 
CpFe(CO)2I by AgBF4 [5] as one of the intermediates. The main product when 2 equivalents of 
CpFe(CO)2I are reacted with 1 equivalent of AgBF4 is  [{CpFe(CO)2}2I]BF4.  The complex 
[(Rp)2I]BF4  is formed according to equations 3 and 4 [15]. 
 
RpI + AgBF4 [Rp]BF4 + AgI (3)
[Rp]BF4 + RpI [Rp2I]BF4 (4)
 
In the 13C NMR spectrum in acetone-d, two CO signals are observed at 196.55 ppm and 189.60 
ppm. The signal at 189.60 ppm is assignable to the carbon on the CO group of I. The 1H and 13C 
NMR spectra of II were obtained using CDCl3 and the resonance signals observed at 5.73 ppm, 
5.60 ppm and 5.53 ppm correspond with the same observed for the cyclopentadienyl ring in 
[Rp(H2O)]+ (5.62 ppm), {[(Rp)2]I}+ (5.74 ppm) and RpI (5.45 ppm). The proton resonance 
signal observed in the experiment done in acetone-d which was assigned to the acetone 
compound was absent when CDCl3 is used as the solvent. The 13C NMR spectrum gave 3 
carbon resonance signals for the Cp carbons at 88.37 ppm, 86.65 ppm and 86.59 ppm. A 






3.3 Electro spray mass spectrometry 
 
The identification of the cationic nature of various species was done by analysis of the isotopic 
abundance for ruthenium (96Ru 5.5%, 98Ru 1.9%, 99Ru 12.8%, 100Ru 12.6%, 101Ru 17.1%, 102Ru 
31.6% and 104Ru 18.6%) and for their statistical  combinations (96Ru and 98Ru, 98Ru and 99Ru, 
99Ru and 100Ru, 100Ru and 101Ru, 101Ru and 102Ru, and 102Ru and 104Ru) in the cationic species, 
[(η5-C5H5)2Ru2(CO)4I]+ (see Fig 1). The electro spray mass spectrum shows that the most 
abundant fragments are [(η5-C5H5)2Ru2(CO)2I]+ and [(η5-C5H5)2Ru2(CO) I]+  with greatest peaks 
intensities at 3.65   106 (m/e = 515.8) and 3.69   106 (m/e = 488.8), whereas the least abundant 
fragment is [(η5-C5H5)2Ru2(CO)3I]+ with its greatest peak intensity at 1.38   106 (m/e = 543.8). 
Table 2 shows molecular masses of some of the cationic complex fragments detected by the 
mass spectrometer.  
 
 
Figure 1: Electro spray mass spectrum of the iodo-bridged complex 
 
Table 2: Molecular masses of the cationic complex [CpRu2(CO)4] I+ and subsequent cationic fragments 
containing different ruthenium isotopes 
Ru isotopes in 
molecule 
Molecular cationic masses 
[Cp2Ru2(CO)4]+ [Cp2Ru2(CO)3]+ [Cp2Ru2(CO)2]+ [Cp2Ru2(CO)]+ 
96Ru    2 560.8 532.8 504.8 476.8 
96Ru and 98Ru 562.8 534.8 506.8 478.8 
98Ru     2 564.8 536.8 508.8 480.8 
98Ru and 99Ru 565.8 537.8 509.8 481.8 
99Ru    2 566.8 538.8 510.8 482.8 








































Ru isotopes in 
molecule 
Molecular cationic masses 
[Cp2Ru2(CO)4]+ [Cp2Ru2(CO)3]+ [Cp2Ru2(CO)2]+ [Cp2Ru2(CO)]+ 
100Ru   2 568.8 540.8 512.8 484.8 
101Ru and 100Ru 569.8 541.8 513.8 485.5 
101Ru   2 570.8 542.8 514.8 486.8 
101Ru and 102Ru 571.8 543.8 515.8 487.8 
102Ru   2 572.8 544.8 516.8 488.8 
102Ru and 104Ru 574.8 546.8 518.8 490.8 
104Ru   2 576.8 548.8 520.8 492.8 
 
Species with the different isotopes of ruthenium all readily release the counter anion BF4- 
leaving the cationic complex, [(Rp)2I]+, whose molecular ions m/e range from 560.6 to 576.8, 
with the most abundant complex  peak at 569.7. The peak at 569.7 corresponds to the mass of 
the cationic complex molecule consisting of 100Ru and 101Ru isotopes whose atomic masses are 
99.91 and 100.91 respectively.  Subsequent fragments, [Cp2Ru2(CO)3I]+,  [Cp2Ru2(CO)2I]+ and  
[Cp2Ru2(CO)I]+, whose molecular ions m/e range from 538.7 to 548.8, 508.8 to 520.8, and 
480.7 to 492.8 respectively, show the sequential loss of carbonyl groups. This is clear proof that 
the yellow crystals are of the iodide-bridged complex [Cp2Ru2(CO)4I]+BF4–. The Cp anion 
remained coordinated to the ruthenium metal in all the fragments. This shows that the carbonyl 
groups are more weakly coordinated than the Cp anion and hence more readily lost to give the 
various cationic fragments. The presence of two ruthenium atoms and an iodine atom in all the 
fragments shows that the Ru I bond was also not affected in the fragmentation process.   
 
3.4 Thermal analysis 
[Rp2I]+BF4- has two polymorphic forms, with similar crystal shapes both being blocks but with 
slightly different shades of orange. Figure 2 shows DSC traces of the two polymorphs during 
the first heating cycle. The DSC experiments were done between the temperatures of 298 K and 
1173.15 K. In the traces, data has been reported for the range between 360 and 610 K as nothing 
meaningful was observed outside of this range. The traces showed endotherms at 432.2 and 
435.2 K for polymorphs I and II respectively, corresponding to their respective melting points. 
Two other endotherms are observed at 562.83 and 600.71 K corresponding to their respective 
decomposition temperatures. The area under the curve at the melting point of polymorph I was 
determined and found to be 26.42J/g. The enthalpies associated with the melting point 








Figure 2: An overlay of the DSC traces for (a), polymorph (I) and (b), polymorph (II) 
 
3.5 Molecular and crystal structure analysis 
 
The two polymorphs of Ruthenium(I)tetracarbonylbis(η5-cyclopentadienyl)-µ-iodido 
tetrafluoroborate have different molecular geometries but crystallize to form dinuclear 
ruthenium cationic complex salts of tetrafluoroborate (Figures 3 and 4). Both polymorphs 
crystallized into yellow (I) and pale yellow (II) blocks in a monoclinic crystal system, but with 
different space groups; P2/c and P21/c.  
 
The combined electron count is 35 with a mean oxidation state of +2 on each ruthenium in each 
polymorph. In both polymorphs, the Ru atom is coordinated in a pseudo-octahedral three-legged 
piano-stool fashion; with the η5-coordinated cyclopentadienyl ligand occupying apical positions 
while the two carbonyl groups and the bridging iodide anion occupying the basal positions. 
Both polymorphs have one molecule of the dinuclear ruthenium cation in the asymmetric unit. 
Whereas the tetrafluoroborate anion is split into two halves in polymorph I, specially positioned 
at ( 
 
   
 
 









unit. Only one iodide bridged ruthenium compound similar to polymorphs I and II can be found 
in literature [10] and that was found to be a neutral compound. 
 
 
Figure 3: The molecular structure of polymorph I showing the atomic numbering scheme. Displacement 
ellipsoids are drawn at the 50% probability level and H atoms are not shown 
 
However, polymorph I has similar cell parameters as µ-iodo-bis(η5-cyclopentadienyl-
dicarbonyl-iron)tetrafluoroborate [4] whose glide is along the crystallographic a axis (P2a) as 
opposed to the c axis in I. In both polymorphs, the CpRu(CO)2 are staggered, the degree of 
staggering being larger in I with the dihedral angle Cg Ru Ru Cg  of 148.88(7)° and only 
46.90(9) in II. In I, the Ru I Ru bond angle is 106.91 (5)° while in II the same angle is 
111.98(5)°, that of II being closer to the Fe-I-Fe in µ-iodo-bis(η5-cyclopentadienyl-dicarbonyl-
iron)tetrafluoroborate [4] (110.8(1)°). These are comparable to values obtained for the related 
complex {[Cp*Ru(CO)2]2I}+ where the angle is 113o [7]. The orientations of the two Cp rings in 
both polymorphs are different and in I the torsional angles (Table 3) Cg Ru I Ru are closer to 




131.17(6)°]. These torsion angles are closer in II to those of µ-iodo-bis(η5-cyclopentadienyl-
dicarbonyl-iron)tetrafluoroborate [4]. However, the Cg Ru I bond angles are comparable in 




Figure 4: The molecular structure of polymorph II showing the atomic numbering scheme. Displacement 





Table 3: Selected bond distances (Å) and angles ( °) 
 I II Ref 4b 
Ru I  2.68658(18) 2.69093(15) 2.666  
Ru I  2.69787(18) 2.68768(15) 2.685  
    
Ru I Ru  106.91(5) 111.98(5) 113.0 
Cg Ru I  119.7(2) 121.18(3) 122.1 
Cg Ru I  123.34(3) 122.15(3) 124.5 
Cg Ru Ru Cg 148.88(7) 46.90(9) 50.71 
Cg Ru I Ru  94.36(8) 76.35(8) 118.8 
Cg Ru I Ru  98.59(8) 131.17(8) 159.9 
Cg is the centroid for C1-C5 of the Cp ring 
  
The Ru I bond lengths are 2.68658(18) Å and 2.69707(18) Å respectively for polymorph I and 
2.69093(15) Å and 2.68768(15) Å for polymorph II (Table 3). These bonds are comparable to 
those observed for the related compound, [{(η5-C5Me5)Ru(CO)2}2I]+ [7] (Ru I1 = 2.666(3) Å; 
Ru2 I1 = 2.685(3) Å). The same bond distances are slightly longer in [{(η5-
OC5Ph4)Ru(CO)2}2I] (Ru1 I = 2.727(1) Å ; I Ru2 = 2.714(1) Å) [6].  
 
 




Figure 5 shows the root mean square deviation overlay of the two cations. The root mean square 
deviation for the two cations is 1.6169. This value is large due to the difference in the 
orientation of the Cp Ru moieties. The densities of the two polymorphs are very similar. 
Polymorph I is only denser than polymorph II by 0.003 mg/m3, a probable indication that the 
stabilities of the two polymorphs are similar. Furthermore the packing indices as calculated by 
platon [13] for both polymorphs reveal no voids in the structures and are 73.4% and 73.5% for I 
and II respectively, even though the packing patterns are vastly different (see Figs. 6 and 7). 
 
 




Figure 7: Packing diagram for polymorph II viewed along the b-axis 
  
In the crystal structures of the two polymorphs, π π (I) and C H F intermolecular 
interactions (I and II) play a role in the packing (Table 4). In polymorph I, the cationic 




a Cg Cg distance of 3.8520(12) Å [symmetry code;  , 1 + y, z] resulting in chains that run 
along the crystallographic b axis (Fig. 6). In between the chains are the tetrafluoroborate anions 
which, through two C H F intermolecular interactions, link up the chains to form sheets along 
the diagonal of the ac face (Fig. 8). In the crystal of polymorph II the anion is involved in three 
C H F intermolecular interactions through three of its fluorine atoms. F3 and F4 link two 
cations related by a c-glide through C1 H1 F4 and C10 H10 F3 intermolecular 
interactions. These interactions are further stabilized by C4-H4…F3 intermolecular interactions 
and a C5 H5 F1 intramolecular interaction (Fig. 9). 
 
Table 4: C-H…F intermolecular interactions in polymorphs I and II (Å / °) 
C H X D H H A D A D H A Symmetry codes 
Polymorph I      
C1 H1 F2 0.98 2.31 3.286(2) 171 Intramolecular 
C2 H2 F2 0.98 2.23 3.167(2) 160 -x, 1-y, 1-z 
C8 H8 F4 0.98 2.51 3.319(2) 175 X, -y, ½+z  
Polymorph II      
C1 H1 F4 0.98 2.37 3.3388(19) 168 1+x, y, z 
C4 H4 F3 0.98  2.34 3.2711(18) 159 -x, -½+y, ½-z 
C5 H5 F1 0.98 2.38 3.2989(18) 155 Intramolecular 








Figure 8: Hydrogen bonding diagram for polymorph I. π…π interactions are shown in bold blue 
dashed lines while C-H…F interactions are shown in thin red dashed lines as viewed down the 
crystallographic b axis. Symmetry operator: i = -x, -y, 2-z 
 
 
Figure 9: A perspective of polymorph II showing C-H…F intermolecular interactions in red dashed 





4. Conclusion  
 
The [(η5-C5H5)2Ru2(CO)4I]+ cation consists of an iodide bridge, Rp I Rp, and exists in two 
polymorphic forms with similar spectral properties. The crystal structures of the polymorphs 
also confirm that the CO groups are terminal and not bridging. They have different crystal 
packing leading to different melting points and hence enthalpies of fusion. The formation of the 
polymorphs seems to be dependent on the solvent used during preparation. The complex consist 
of [(η5-C5H5)2Ru2(CO)4I]+ cationic molecules. The CO groups in the cation are readily lost as 
shown by the fragmentation patterns in the mass spectra. This suggests that the CO groups are 
not as strongly bonded to the metal cations as are the Cp and I anions. 
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New water-soluble 1-alkanaminedicarbonyl(η5-cyclopentadienyl)ruthenium(II) tetrafluoroborate  
complex salts, [CpRu(CO)2NH2R]+BF4- (Cp = η5-C5H5 (R = CH3 1, C2H5 2, C3H7 3, C4H9 4, 
C5H11 5 and C6H13 6), were  synthesized by the reaction of the organometallic Lewis acid,  
[CpRu(CO)2]+BF4, with slight excesses of 1-alkanamines, RNH2, in dry methylene chloride at 
room temperature and pressure. These compounds are reported for the first time and have been 
fully characterized by IR, electrospray ionization mass spectrometry, 1H and 13C NMR 
spectroscopy, and elemental analysis. Spectral data show that the n-alkanamines are σ-bonded 
to the metal centre via the nitrogen atom. Complexes 2 to 5 were characterized by single crystal 
X-ray diffraction and all four cationic species feature a “pseudo-octahedral three-legged piano 
stool” structure in which the ruthenium centre is coordinated through a sigma bond to the amine 
N atom and two carbonyl ligands at the base of the stool and the cyclopentadienyl ring in the 
apex of the stool. IR studies showed that peaks of the νCO stretching vibrations shifted slightly 
to lower frequency as the carbon chain length increased.  The melting point and percentage 
yields were observed to generally decrease with increase in n-value.  
 
Keywords: Ruthenium alkanamine complexes; Crystal structure; Ruthenium carbonyl; 







1. Introduction  
 
Synthesis, characterization and reactions of organometallic complexes having metal-nitrogen 
bonds have not been widely reported [1] due to the general belief that the bond between the 
nitrogen ligand and late transition metals is relatively weak [2] and that complexes with 
nitrogen donors containing N-H bonds are generally unsuitable for organometallic reactions, as 
H atom(s) on the coordinating nitrogen are sufficiently acidic to react with nucleophiles [3]. 
Despite these beliefs, neutral aliphatic amine dicarbonyl cyclopentadienyl manganese(I) 
complexes are relatively well studied compared to other metals; and CpMn(CO)2(pip) (Cp = η5-
C5H5, pip = piperazine) [4];  CpMn(CO)2NH2(CH2)2CH3  [5]; CpMn(CO)2(m-NH2C6H4CH3) 
[6]; and CpMn(CO)2(pyrrolidine) are known [7]. Neutral 1-propanamine complexes of 
manganese and rhenium were prepared from an ethereal complex by the substitution of the 
labile ligand by n-propanamine [8]. Very few such compounds for group 8 transition metals had 
been reported [9-11]. Recently, amine dicarbonyl cyclopentadienyliron complexes [12,13] were 
prepared, but none for ruthenium have been reported.   
 
The chemistry of water-soluble transition metal compounds has gained considerable 
prominence in recent years, not only because water is an environmentally and biologically 
benign solvent, but also because of their use in biphasic catalysis [14] and biomedicine [15]. 
Biologically, transition metals have been shown to exert therapeutic and diagnostic influence on 
certain diseases increasing impetus in the development of new water-soluble and in vivo-stable 
transition metal compounds [15,16]. As such, the compatibility of organometallic compounds 
with water is important for the development of biomedicines [17], bioorganometallic chemistry 
and organometallic radiopharmaceuticals.  
 
Most compounds that are pharmacologically important have been nitrogen-containing 
organometallics such as, diaminoalkanes [18,19], ferrocenyl diamines [20] and ferrocenyl 
diaminoalcohols [21], which have shown high activity biologically. These compounds may also 
have exciting catalytic applications [22]. For this reason, we have decided to investigate the 
interaction of iron and ruthenium carbonyl complexes with nitrogen-containing species to 
develop the chemistry and also study the physiology and pharmacology of the resulting 
complexes. We recently reported iron complexes of the form [CpFe(CO)2NH2R]BF4 (R = CH3 
1, C2H5 2, C3H7 3, C4H9 4 and C5H11 5), synthesised from the ethereal complex salt, 
[CpFe(CO)2(CH3CH2)2O]BF4 [12]. In this paper we report the synthesis and characterization of 





of complexes 2 – 5 are reported. To the best of our knowledge, 1-alkanamine complexes of the 
cyclopentadienyl dicarbonyl ruthenium(II) have not been previously reported. Furthermore, 
these new 1-alkanaminedicarbonyl(η5-cyclopentadienyl)ruthenium(II) complex salts are soluble 
and stable in water.  
 
2. Experimental  
 
2.1 General methods and materials 
 
Standard Schlenk techniques were employed for all reactions. Nitrogen gas (AFROX) was dried 
over phosphorus(V) oxide. Chemical reagents and solvents were obtained from the suppliers 
shown in parentheses:  reagent grade Et2O (Merck) was distilled from sodium/benzophenone 
and stored over molecular sieves; methylene chloride (Merck) was distilled from 
phosphorous(V) oxide. Silver tetrafluoroborate (Alfa Aesar), ruthenium trichloride hydrate 
(DLD-Aldrich), dicyclopentadiene (Aldrich), n-propylamine, n-pentylamine, n-hexylamine 
(Merck), n-pentylamine (BDH), n-ethylamine, n-methylamine (Aldrich), carbon monoxide 
(AFROX) and iodine (Unilab) were used as supplied. Melting points were recorded on an Ernst 
Leitz Wetzlar hot-stage microscope and are uncorrected. Elemental analyses were performed on 
a Thermo-Scientific Flash 2000 CHNS/O analyser. Solid state infrared spectra were recorded 
using an FTIR Perkin Elmer Spectrum 100 spectrophotometer between 4000 and 400 cm–1. 
Mass spectra were recorded on an Agilent 1100 series LC/MSD trap with electrospray 
ionization (ESI) source and quadrupole ion trap mass analyzer by direct infusion and ESI 
operated in the positive mode. Acetonitrile (100%) was used as mobile phase and 10 μL of the 
sample injected at 0.3 ml/min flow rate. NMR spectra were recorded on Bruker Topspin 400 
and 600 MHz spectrometers. The deuterated solvents CDCl3 (Aldrich, 99.8%), and D2O 
(Aldrich) were used as purchased. Solutions for NMR spectroscopy were prepared under 
nitrogen using nitrogen-saturated solvents. The precursors Ru3(CO)12 [23], [CpRu(CO)2]2 [24], 







2.2 Synthesis of the 1-alkanaminedicarbonyl(η5-cyclopentadienyl)ruthenium(II) 




Figure 1: General structure of 1-alkanaminedicarbonyl(η5-cyclopentadienyl)ruthenium(II) complex 
cation with carbon atoms on the alkyl chain labelled 
 
2.2.1 Methanamine complex salt (1), [η5-C5H5Ru(CO)2NH2CH3]BF4  
 
RpI (0.1263 g; 0.3618 mmol) (Rp = η5-C5H5Ru(CO)2) and a magnetic stirrer bar were placed in 
a clean, dry Schlenk tube wrapped in aluminium foil and purged with dry, oxygen-free nitrogen 
gas. AgBF4 (0.0872 g; 0.4479 mmol) was added and the tube evacuated at reduced pressure for 
4 h to remove any moisture. It was filled with dry nitrogen gas, dry deoxygenated methylene 
chloride, 20 mL, was added and the mixture stirred for 1 ½ h. The resulting mixture was canula 
filtered under dry, oxygen-free nitrogen gas to give a white residue and an orange filtrate.  
A slight excess of methylamine (0.400 mmol; 50 µL of 33 weight % methylamine in absolute 
ethanol) was added to the filtrate and stirred for 3 h. The colour of the solution changed from 
orange to yellow. The solution was allowed to remain undisturbed for 30 min. A black residue 
settled at the bottom of the Schlenk tube. The pale-yellow mother liquor was canula filtered into 
a clean, dry pre-weighed Schlenk tube. The filtrate was concentrated under reduced pressure. A 
four-fold volume of dry, oxygen-free diethyl ether was added to the pale yellow solution (2 mL) 
and a greyish-white precipitate was formed on shaking the mixture. The precipitate was allowed 
to settle and the mother liquor removed by canula filtration. The residue was re-dissolved in 
methylene chloride, allowed to stand for a few minutes and then canula filtered to remove a 





gave a white solid which was washed twice with 10 mL portions of dry diethyl ether. The solid 
was dried under reduced pressure for 4 h to give 0.0998 g (82 %) of white powder. The solid 
decomposes after 178 °C. Anal. Found (calculated) for C8H10NO2RuBF4; C, 28.08 (28.26)%; H, 
2.30 (2.96)%; N, 4.17 (4.12)%. NMR:  (400 MHz; CDCl3): 1H NMR δ 5.59 (s, 5H, Cp); δ 3.91 
(s, 2H, NH2); δ 2.63 (m, 3H, CH3). 13C NMR δ 195.18 (CO); δ 87.81 Cp); δ 41.42 (CH3). NMR:  
(400 MHz; D2O): 1H NMR δ 5.68 (s, 5H, Cp); δ 4.41 (s, 2H, NH2); δ 2.51 (m, 3H, CH3). 13C 
NMR δ 195.99 (CO); δ 87.65 Cp); δ 40.28 (CH3). IR (solid state): ν(CO) 2036, 1978 cm–1,  
ν(CH3) 2953, 2917cm–1; ν(NH2) 3321, 3276 cm-1 
 
2.2.2  1-Ethanamine complex salt (2), [η5-C5H5Ru(CO)2 NH2CH2CH3 BF4  
 
RpI (0.1760 g; 0.4956 mmol) and a slight excess of AgBF4 (0.1276 g; 0.6554 mmol) was placed 
in a clean, dry Schlenk tube wrapped with aluminium foil and treated as described for the 
methylamine complex salt preparation. n-Ethanamine (0.6208 mmol of 2M n-ethylamine in 
THF) were added to the resulting orange solution and the mixture treated as described in 
Section 2.2.1 above. The product (0.1592 g) was formed in 89% yield. The melting range of the 
solid is 87-88 °C.  Anal: Found (calculated) for C9H12NO2RuBF4; C, 30.49 (30.53)%; H, 3.14 
(3.42)%; N, 4.01 (3.94)%. NMR:  (400 MHz; CDCl3): 1H NMR δ 5.59 (s, 5H, Cp); δ 3.88 (w, 
2H, NH2); δ 2.73 (m, 2H, CH2); δ 1.20 (m, 3H, CH3). 13C NMR δ 195.32 (CO); δ 87.83 Cp); 
50.04 (CH2); δ 17.49 (CH3). NMR: (400 MHz; D2O): 1H NMR δ 5.67 (s, 5H, Cp); δ 4.46 (w, 
2H, NH2); δ 2.73 (m, 2H, CH2); δ 1.13 (m, 3H, CH3). 13C NMR δ 196.08 (CO); δ 87.61 (Cp); 
49.07 (CH2); δ 17.01 (CH3). IR (solid state): ν(CO) 2058, 1995 cm–1,  ν(C5H5) 3126 cm–1; 
ν(CH3) 2997 cm–1, 2952 cm–1; ν(NH2) 3325, 3286 cm–1. 
 
2.2.3 1-Propanamine complex salt (3), [η5-C5H5Ru(CO)2NH2(CH2)2CH3]BF4  
 
RpI (0.26 g; 0.7448 mmol) and a magnetic stirrer bar were put in a clean, dry Schlenk tube and 
evacuated at reduced pressure for 2 h, then filled with dry nitrogen gas. Dry methylene chloride 
(15 mL) was added and the mixture stirred. At the same time, AgBF4 (0.1864 g; 0.9575 mmol) 
and a magnetic stirrer bar were placed in a separate clean, dry Schlenk tube wrapped with 
aluminium foil and evacuated for 2 h, then filled with dry nitrogen gas. Methylene chloride (15 
mL) was added to this and the mixture stirred.  The RpI solution in methylene chloride was 
added to the stirring solution of AgBF4. The mixture was stirred for 1½ h, a slight excess of n-





of the solution changed from orange to yellow. The mixture was cannula filtered to give a 
yellow filtrate and a white precipitate. The solvent was evaporated under reduced pressure to 
give a greenish yellow solid.  Methylene chloride (10 mL) was added to the solid and stirred to 
give a pale yellow solution and a grey precipitate. The solution was filtered into a clean, dry, 
pre-weighed Schlenk tube and the filtrate evaporated under reduced pressure to give a white 
solid. The solid was recrystallized from methylene chloride (5 mL) and excess diethylether 
added. White needle-shaped crystals (0.2055 g) were obtained in 75% yield. The melting point 
ranged from 109.2-109.6 °C.  
 
Anal: Found (calculated) for C10H14NO2RuBF4; C, 31.98 (32.63)%; H, 3.98 (3.83)%; N, 3.42 
(3.81)%. NMR:  (400 MHz; CDCl3): 1H NMR δ 5.59 (s, 5H, Cp); δ 3.89 (s, 2H, NH2); δ 2.62 
(m, 2H, αCH2); δ 1.60 (m, 2H, βCH2); δ 0.89 (t, 3H, CH3). 13C NMR δ 195.41 (CO); δ 87.89 
Cp); 57.25 (αCH2); δ25.65 (βCH2) δ 10.74 (CH3). (600 MHz; D2O): 1H NMR δ 5.64 (s, 5H, 
Cp); δ 4.42 (s, 2H, NH2); δ 2.64 (m, 2H, αCH2); δ 1.50 (m, 2H, βCH2); δ 0.87 (t, 3H, CH3).  13C 
NMR δ 196.15 (CO); δ 87.71 Cp); 56.44 (αCH2); δ25.38 (βCH2) δ 10.08 (CH3). IR (solid state): 
ν(CO) 2061, 2009 cm–1, ν(C5H5) 3118 cm–1; ν(CH3) 2967 cm–1, 2876 cm–1; ν(NH2) 3314, 3272 
cm–1. 
 
2.2.4 1-Butanamine complex salt (4), [η5-C5H5Ru(CO)2NH2(CH2)3CH3 BF4  
 
RpI (0.2194 g; 0.6285 mmol), excess AgBF4 (0.7936 mmol) and a magnetic stirrer bar were 
placed in a clean, dry Schlenk tube wrapped with aluminium foil. The tube was evacuated for 3 
h under reduced pressure to remove any moisture then filled with dry nitrogen gas. Methylene 
chloride (25 mL) was added, followed by a slight excess of 1-butanamine (0.9223 mmol) and 
the mixture stirred for 3 h. The resulting mixture was treated as described for the 1-propanamine 
complex in Section 2.2.3.  The product was obtained in 72% yield (0.158 g).  The melting point 
is 54-55 °C. 
Analysis: Found (calculated) for C11H16NO2RuBF4; C, 33.98 (34.57)%; H, 3.98 (4.22)%; N, 
3.42 (3.67)%. NMR:  (400 MHz; CDCl3): 1H NMR δ 5.59 (s, 5H, Cp); δ 3.85 (s, 2H, NH2); δ 
2.64 (m, 2H, αCH2); δ 1.55 (m, 2H, βCH2); δ 1.30 (m, 2H, γCH2); δ 0.87 (t, 3H, CH3). 13C NMR 
δ 195.41 (CO); δ 87.85 Cp); 55.23 (αCH2); δ34.30 (βCH2); δ19.52 (γCH2); δ 13.59 (CH3). 
NMR:  (400 MHz; D2O): 1H NMR δ 5.67 (s, 5H, Cp); δ 4.43 (s, 2H, NH2); δ 2.68 (m, 2H, 
αCH2); δ 1.49 (m, 2H, βCH2); δ 1.33 (m, 2H, γCH2); δ 0.90 (t, 3H, CH3). 13C NMR δ 196.09 





state): ν(CO) 2062, 1994 cm–1, ν(C5H5) 3110 cm–1; ν(CH3) 2967 cm–1, 2937 cm–1; ν(NH2) 3322, 
3280 cm–1 
 
2.2.5 1-Pentanamine complex salt (5), [η5-C5H5Ru(CO)2NH2(CH2)4CH3]BF4  
 
RpI (0.1544 g; 0.4423 mmol), excess AgBF4 (0.1080 g; 0.5548 mmol) and a magnetic stirrer bar 
were placed in a clean, dry Schlenk tube wrapped in aluminium foil and treated as described for 
the n-butylamine complex. To the orange solution obtained after filtration, a slight excess of 1-
pentanamine (0.0472 g; 0.5415 mmol) was added and the mixture stirred for 3 h. The colour 
changed from orange to greenish yellow. The resulting mixture was treated as described for the 
1-butanamine complex and a white solid was obtained (0.1141 g; 65%). The solid melts at 81.6 
°C.  
 
Anal: Found (calculated) for C12H18NO2RuBF4; C, 35.98 (36.38)%; H, 4.02 (4.58)%; N, 3.42 
(3.54)%. NMR:  (600 MHz; CDCl3): 1H NMR δ 5.60 (s, 5H, Cp); δ 3.89 (s, 2H, NH2); δ 2.65 
(m, 2H, αCH2); δ 1.60 (m, 2H, βCH2); δ 1.28 (m, 4H, γ and δCH2); δ 0.87 (t, 3H, CH3). 13C 
NMR δ 195.43 (CO); δ 87.86 Cp); 57.51 (αCH2); δ32.04 (βCH2); δ28.43 (γCH2); δ22.21 
(δCH2); δ 13.85 (CH3). NMR:  (400 MHz; D2O): 1H NMR δ 5.66 (s, 5H, Cp); δ 4.46 (s, 2H, 
NH2); δ 2.68 (m, 2H, αCH2); δ 1.52 (m, 2H, βCH2); δ 1.29 (m, 4H, γ and δCH2); δ 0.89 (t, 3H, 
CH3).  IR (solid state): ν(CO) 2053, 1997 cm–1, ν(C5H5) 3127 cm–1; ν(CH3) 2942 cm–1, 2866 cm–
1; ν(NH2) 3321, 3280 cm–1.  
 
2.2.6 1-Hexanamine complex salt (6), [η5-C5H5Ru(CO)2NH2(CH2)5CH3]BF4  
 
RpI (0.4535 g; 1.30 mmol), AgBF4 (0.2993 g; 1.54 mmol) and a magnetic stirrer bar were put in 
a clean, dry Schlenk tube wrapped with aluminium foil. The mixture was dried under reduced 
pressure for 3 h, and then the tube was filled with dry nitrogen gas. Dry methylene chloride (30 
mL) was added and the mixture stirred for 1½ h. A white precipitate and an orange filtrate were 
obtained. The mixture was filtered into a clean dry Schlenk tube. A slight excess of 1-
hexanamine (0.1850 g; 1.83 mmol) was added to the orange filtrate and stirred for 3 h. The 
solution changed colour from orange to greenish yellow. The mixture was left undisturbed for 1 
hr and then cannula filtered into a pre-weighed, clean, dry Schlenk tube. A black residue was 
left, while the filtrate obtained was pale yellow. The volume of the solution was reduced under 





was formed. The mixture was filtered; the precipitate re-dissolved in dry methylene chloride and 
re-crystallized using dry hexane. The precipitate was washed twice with dry hexane and dried 
under vacuum for 4 h. The product was obtained in 62% yield (0.3329 g). The solid melted in a 
temperature range of 73-74 °C. 
Anal: Found (calculated) for C13H20NO2RuBF4; C, 37.72 (38.07)%; H, 5.12 (4.91)%; N, 3.62 
(3.41)%. NMR:  (400 MHz; CDCl3): 1H NMR δ 5.59 (s, 5H, Cp); δ 3.85 (s, 2H, NH2); δ 2.64 
(m, 2H, αCH2); δ 1.29 (m, 8H, β, γ, δ and εCH2); δ 0.87 (t, 3H, CH3). 13C NMR δ 195.40 (CO); 
δ 87.87 Cp); δ 55.58 (αCH2); δ32.34 (βCH2); δ 31.31(γCH2); δ 26.06 (δCH2); δ22.46 (εCH2); δ 
13.93 (CH3). (400 MHz; D2O): 1H NMR δ 5.66 (s, 5H, Cp); δ 4.43 (s, 2H, NH2); δ 2.68 (m, 2H, 
αCH2); δ 1.50 (m, 8H, β, γ and δCH2); δ 1.31 (m, 2H, εCH2); δ 0.89 (t, 3H, CH3). 13C NMR δ 
196.08 (CO); δ 87.63 Cp); δ 54.52 (αCH2); δ 31.89 (βCH2); δ 30.62 (γCH2); δ 23.30(δCH2); δ 
21.81(εCH2); δ 13.22 (CH3). IR (solid state): ν(CO) 2057, 1999 cm–1, ν(C5H5) 3126 cm–1; 
ν(CH3) 2958, 2928, 2856 cm–1, ν(NH2) 3315, 3276 cm–1 
 
2.3 X-ray crystal structure determination of [CpRu(CO)2NH2(CH2)nCH3]BF4 (n=1-4) 
 
Crystals of [CpRu(CO)2NH2(CH2)nCH3]BF4 suitable for single crystal X-ray diffraction studies 
were grown by the liquid diffusion method. Solutions of the compounds in dry dimethyl 
chloride were layered with a fourfold volume excess of diethyl ether and allowed to stand 
undisturbed in the dark at room temperature for 24 hours. Crystals of the complex salts 2 - 5 
were selected and glued on to the tip of glass fibres. The crystals were then mounted in a stream 
of cold nitrogen at 100(1) K and centred in the X-ray beam by using a video camera.  
 
The crystal evaluation and data collection were performed on a Bruker Smart APEXII 
diffractometer with Mo Kα radiation (λ = 0.71073 Å) and a diffractometer to crystal distance of 
4.00 cm. The initial cell matrix was obtained from three series of scans at different starting 
angles. Each series consisted of 12 frames collected at intervals of 0.5° in a 6° range with the 
exposure time of about 10 seconds per frame. The reflections were successfully indexed by an 
automated indexing routine built in the APEXII program suite [27]. The final cell constants 
were calculated from a set of 6460 strong reflections from the actual data collection. Data 
collection method involved ω scans of width 0.5°. Data reduction was carried using the program 
SAINT+ [27]. The structure was solved by direct methods using SHELXS [28] and refined by 
SHELXL [27]. All structures were checked for solvent-accessible cavities using PLATON [29] 
and the graphics were performed with the DIAMOND [30] visual crystal structure information 





refinement with full-matrix least-squares calculations based on F2 using SHELXS [29].  All H 
atoms were positioned geometrically and allowed to ride on their respective parent atoms. The 
carboxyl H atoms were located from the difference map and allowed to ride on their parent 
atoms. All H atoms were refined isotropically. The absorption correction was based on fitting a 
function to the empirical transmission surface as sampled by multiple equivalent measurements 
[27]. Crystal data and structure refinement information for compounds 2 – 5 are summarized in 
Table 1. 
 
Table 1:  Crystal data and structure refinement for compounds 2, 3, 4 and 5 
 2 3 4 5 
Empirical 
formula  
C9H12BF4NO2Ru C10H14BF4NO2Ru C11H16BF4NO2Ru C12H18BF4NO2Ru 
Formula weight  354.08 368.10 382.13 396.15 
Temperature  173(2) K 173(2) K 173(2) K 173(2) K 
Wavelength  0.71073 Å 0.71073 Å 0.71073 Å 0.71073 Å 
Crystal system  Orthorhombic Monoclinic Monoclinic Monoclinic 
Space group  Pbca P21/c P21/c P21/c 
Unit cell 
dimensions (Å / °) 
a = 14.6686(5) Å,  a = 10.4412(2) Å,  a = 9.1329(5)  a = 14.4432(3) Å,  
b = 11.3131(4) Å,  b = 7.69910(10) Å, 
β= 97.7450(10)°. 
b = 8.4964(4) Å, β 
= 112.154(2)°. 
b = 14.1166(3) Å, β 
= 115.978(2)°. 
c = 14.9801(6) Å,  c = 16.8002(3) Å,  c = 19.3325(9) Å,  c = 17.0859(4) Å,  
Volume 2485.91(16) Å3 1338.21(4) Å3 1389.39(12) Å3 3131.65(12) Å3 
Z 8 4 4 8 
Density 
(calculated) 
1.892 Mg/m3 1.827 Mg/m3 1.827 Mg/m3 1.680 Mg/m3 
Absorption 
coefficient 
1.303 mm-1 1.214 mm-1 1.173 mm-1 1.044 mm-1 
F(000) 1392 728 760 1584 
Crystal size 0.23 x 0.15 x 0.13 
mm3 
0.47 x 0.26 x 0.15 
mm3 
0.36 x 0.25 x 0.21 
mm3 
0.13 x 0.23 x 0.50 
mm3 
Theta range for 
data collection 
2.65 to 28.40°. 1.97 to 28.34°. 2.41 to 25.00°. 1.96 to 28.42°. 
Index ranges -19 h 19, 
 -15 k 14,  
-19 l 19 
-13 h 13,  
-10 k 10,  
-22 l 21 
-10 h 10, 
 -10 k 10,  
-22 l 19 
-19 h 19,  
-18 k 18,  
-22 l 22 









3103 [R(int) = 
0.0190] 
3325 [R(int) = 
0.0203] 
2417 [R(int) = 
0.0377] 
7542 [R(int) = 
0.0329] 
Completeness to 
theta = 28.45° 
99.6 %  99.7 %  98.9 %  95.9 %  
Absorption 
correction 
Multi-scan Multi-scan Multi-scan Multi-scan 
Max. and min. 
transmission 




squares on F2 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Data / restraints / 
parameters 
3103 / 0 / 164 3325 / 0 / 173 2417 / 0 / 182 7542 / 0 / 381 
Goodness-of-fit on 
F2 
1.076 1.156 1.301 1.131 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0148, wR2 
= 0.0390 
R1 = 0.0161, wR2 
= 0.0442 
R1 = 0.0262, wR2 
= 0.0630 
R1 = 0.0257, wR2 = 
0.0648 
R indices (all 
data) 
R1 = 0.0164, wR2 
= 0.0409 
R1 = 0.0172, wR2 
= 0.0456 
R1 = 0.0275, wR2 
= 0.0637 
R1 = 0.0372, wR2 = 
0.0728 
Largest diff. peak 
and hole 
0.438 and -0.409 
e.Å-3 
0.363 and -0.699 
e.Å-3 
0.740 and -0.430 
e.Å-3 
0.552 and -0.822 
e.Å-3 
 
3. Results and discussion 
 
3.1 Synthesis and characterization of [CpRu(CO)2NH2R]BF4  
 







The reaction of the organometallic Lewis acid, [CpRu(CO)2]+ (Cp = η5-C5H5), with  1-
alkanamines in dry methylene chloride at room temperature gives the  new water-soluble 1-
alkanamine complex salts of tetrafluoroborate, [CpRu(CO)2L]BF4 (L = NH2(CH2)nCH3). The 
complexes, [CpRu(CO)2L]BF4, form white, needle-shaped crystals that are air-stable and non-
hygroscopic. The 1-alkanamine complexes are soluble in polar solvents such as methylene 
chloride, methanol, acetone, water and chloroform, but are insoluble in non-polar solvents such 
as hexane and diethyl ether. The yield of the complexes depends on the reaction duration and 
the length of the alkyl chain. The longer the chain, the longer the reaction time required to give 
a high yield. This could be due to increase in flexibility of the alkyl chain as the length increase. 
As the percentage yield decreases with increase in chain length, the iodine-bridged complex, 
{[CpRu(CO)2]2I}BF4 [31], is simultaneously formed, from the competitive reaction between 
CpRu(CO)2I and [CpRu(CO)2]BF4. Similar observations were made in the synthesis of 
[CpFe(CO)2L]BF4 (L = NH2(CH2)nCH3) [12] where {[CpFe(CO)2]2I}BF4 was simultaneously 
formed.  
 
The melting points of the complexes were also found to decrease with increase in the n-
alkylamine chain length probably due to decrease in the strength of the intermolecular 
interactions as the chain length increases. The complex salts with an even number of carbon 
atoms in the alkyl chain had relatively lower melting points compared to those with an odd 
number of carbon atoms. The odd numbered alkyl chained complexes have a higher packing 
efficiency in the solid phase, hence require more energy to weaken intermolecular interactions. 
This is in contrast to the classical observations reported for the melting point trends in the 
alkane series where, the even numbered alkanes have a higher melting point compared to the 
odd numbered ones [32].  
 
The 1H NMR data for the complexes 1 to 6 were obtained in CDCl3 as well as D2O and peak 
assignments were done using 2D NMR. The 1H NMR spectra in CDCl3 showed a sharp singlet 
peak at ca. 5.59 ppm, assignable to the five equivalent cyclopentadienyl protons. A proton 
resonance singlet peak, observed at ca. 3.80 ppm, was assigned to the two amine protons. The 
amine proton peak was observed to be more down-field compared to those of the corresponding 
iron complexes, [CpFe(CO)2NH2(CH2)nCH3]BF4 [12]. These amine proton peaks were observed 
more down-field, a difference of about ca. 1.50 ppm from that of free 1-alkanamines (2.30 
ppm), likely due to the de-shielding by the metal centre. This was a further indication of 





possibility of hydrogen bonding between the amine group protons and the fluoride atoms of the 
tetrafluoroborate counter anion which can potentially contribute to the downfield shift of the 
amine protons in the 1H NMR. The amine proton peak was observed to be more down-field in 
D2O (4.45 ppm) than in CDCl3 likely due to hydrogen bond interaction between the amine 
protons and deuterium in D2O. A multiplet at ca. 2.65 ppm was assigned to the protons on the α-
carbon (Fig. 1) of the coordinated n-alkylamines. The α-carbon protons follow the same trend as 
the coordinated amine protons.  
 
The 13C NMR spectra for the complexes were recorded in CDCl3 and peaks assigned by 
comparison with data reported for the cationic complexes [CpFe(CO)2NH2(CH2)nCH3]+ [12] and 
[CpM(CO)2(η2-CH2 = CHR)]+ [33] as well as HSQC experiments. There is a notably shift up-
field in the methyl group carbon resonance signals as the chain length increases from n = 0 to n 
= 1 and then to n = 2, from 41.4 ppm to 17.5 and then to 10.9 ppm respectively (Table 2).  This 
is probably because of a decrease in interaction with the amine group as the 1-alkanamine chain 
length increases. The methyl group carbon resonance signal for the 1-alkanamine complex salt 
does not change as the 1-alkanamine chain length increases from n = 3 onwards and occurs at 
ca.13.9 ppm,  likely due to no further interaction of the methyl group with the amine. The 
methylene carbon resonance signals generally shift downfield due also to the deshielding effect 
caused by charge transfer by the alkyl group to the amine group [12]. The chain length does not 
affect the carbonyl and Cp carbon resonance signals, generally observed at ca. 195.4 ppm and 
ca. 87.9 ppm respectively. It is worth noting that the carbonyl carbon resonance signal for the 
ruthenium complexes, [CpRu(CO)2NH2(CH2)nCH3]+, is more upfield than in 
[CpFe(CO)2NH2(CH2)nCH3]+ (210.6 ppm). This is probably due to the higher electron density in 
the ruthenium nucleus, which in turn leads to greater charge transfer to the carbonyl group.  
 
Table 2: 13C NMR signals (ppm) for [CpRu(CO)2NH2(CH2)nCH3]BF4 (CDCl3) 
 n 0 1 2 3 4 5 
αCH2 - 50.0 53.3 55.3 55.5 55.6 
βCH2 - - 25.6 34.3 32.0 32.3 
γCH2 - - - 19.5 28.4 31.3 
δCH2 - - - - 22.2 26.5 
εCH2 - - - - - 22.5 






The IR spectra of the 1-alkanamine complexes 1 to 6 show two strong absorption bands in the 
νCO region between 2061 and 2036 cm–1 assignable to the asymmetric CO stretching vibrations 
and between 2009 and1974 cm–1 assignable to the symmetric CO stretching vibrations. It was 
observed that both sets of peaks of the νCO stretching vibrations shifted slightly to lower 
frequency as the carbon chain length increased. This could be attributed to steric and electronic 
effects of the alkyl chains towards the coordinated amine group. There is an increased electron 
back-donation to the carbonyl groups with increasing chain length leading to the shift to lower 
frequency [34]. Also noted were two weak bands in the ν(N–H ) region  assignable to the N–H  
stretching modes between 3325 and 3311 cm–1 for the asymmetric stretching and between 3280 
and 3272 cm–1 for the symmetric stretching modes. These bands showed a significant shift to 
lower wavenumbers when compared to the stretching frequencies of the unreacted starting 1-
alkanamine further proving coordination to the Ru(II) centre. The observed shift could be 
attributed to charge transfer towards the metal centre through the coordinated nitrogen of the n-
alkylamine. Back-donation of electrons by the metal centre to the coordinated carbonyl ligands 
leaves the methylene group electron deficient, hence the shift to lower wave numbers. A single 
absorption peak assignable to the N-H bending vibration is observed in the region 1596–1615 
cm–1.  
 
Electrospray mass spectra of complexes 3, 4 and 6 (Fig. 3) show the same fragmentation 
patterns. They lose the counter anion BF4- to give the base peak of the 1-alkanamine complex 
cation [CpRu(CO)2NH2(CH2)nCH3]+, followed by successive loss of the carbonyl groups leaving 
the most stable fragment [CpRuNH2(CH2)nCH3]+. No peaks associated with the fragment 
[CpRu(CO)2]+ were observed. These observations suggest that the n-alkylamine is strongly 
coordinated to the metal centre, while the CO groups are readily lost. The multiple peaks 
associated with the seven stable isotopes of ruthenium are clearly observed in each fragment 







Figure 2: ES-MS spectrum showing the fragmentation pattern of [CpRu(CO)2NH2(CH2)2CH3]BF4 
 
3.2 Crystal and molecular structures  
 
The structures of complexes 2–5 were determined using single crystal X-ray diffraction. All 
four compounds crystallize as white needle-like crystals. The molecular diagrams of the 
complexes are provided in Figs. 3–6, while Table 3 gives a comparison of important bond 
distances and angles.  
 
 
Figure 3: The structure of compound 2 showing the atom-numbering scheme. Displacement ellipsoids 































Figure 4: The structure of compound 3 showing the atom-numbering scheme. Displacement ellipsoids 
are drawn at 50% probability level and H atoms have been omitted for clarity 
 
Complexes 2–4  each crystallize with one molecule of the cation [(η5-C5H5)(CO)2Ru(NH2)L)]+ 
and a counter anion BF4–  in their asymmetric units, while complex 5 crystallizes with two 
molecules of the cation [(η5-C5H5)(CO)2Ru(NH2(CH2)4CH3)]+ and two BF4–  counter anions in 
the unit cell. All of the four cationic species of the complexes feature the known “pseudo-
octahedral three-legged piano stool” structures very similar to those of previously reported iron 
analogues [CpFe(CO)2NH2(CH2)2CH3]+BF4– and [CpFe(CO)2NH2(CH2)3CH3]+BF4– [12]. In this 
arrangement, the ruthenium center is coordinated through a sigma bond to the amine N atom 
and two carbonyl ligands at the base of the stool and by the cyclopentadienyl ring in the apex of 
the stool. The 1-alkanamine moiety seems to have a generally planar conformation with the 
exception of molecule 1 of compound 5, which has a kink at the end of 1-pentanamine moiety 
(Fig. 6 and Table 3). This molecule has a reduced C9–C10–C11 torsional angle of 64.2(3) 
compared to analogous alkyl chain ends in the second molecule of compound 5, as well as 
compounds 2–4 which range between 171.5 and 179.5° [35].  
 
The Ru–N bond distances show only a slight increase from 2.139(1) to 2.148(2) Å as the amine 
chain length increases from n = 1 to n = 4. The bond distance is, however, comparable to Ru–N 
bonds of similar compounds, but significantly longer than those of analogous iron based 







Figure 5: The structure of compound 4 showing the atom-numbering scheme. Displacement ellipsoids 




Figure 6: The structures of the two sets of molecules of compound 5 in the asymmetric unit showing the 
atom-numbering scheme. Displacement ellipsoids are drawn at 50% probability level and H atoms have 






In the crystal, molecules of 2, 3, 4 and 5 generally adopt the energetically favoured gauche type 
conformation in which the α-carbon of the 1-alknamine lies between a CO ligand and the 
cyclopentadienyl ring as shown in Fig. 7.  










                         
Figure 7: Gauche type conformation in compounds 2 and 4 
 
Table 3: Selected bond distances (Å) and angles ( °) for compounds 2, 3, 4 and 5 
 2 3 4 5a 5b 
*Cg Ru 1.8767(6) 1.8804(7) 1.8747(17) 1.8737(12) 1.8698(13) 
Ru1 N1 2.139(1) 2.1406(12) 2.143(3) 2.145(2) 2.148(2) 
C8 C9 1.485 1.483 1.491 1.487 1.489 
C6 Ru1 1.896(1) 1.895(1) 1.896(3) 1.897(2) 1.897(2) 
C7 Ru1 1.907(1) 1.896(1) 1.896(4) 1.902(2) 1.902(2) 
      
*Cg Ru1 N1 123.48(4) 122.92(4) 124.08(9) 123.99(7) 124.07(7) 
Ru1 N1 C8 118.53(8) 115.06(8) 117.5(2) 116.4(8) 116.4(8) 
N1 C8 C9 111.6(1) 113.9 111.7 113.2(2) 113.2(2) 
OC Ru CO  90.89 89.56 92.76 91.51 91.33 
      
*Cg Ru1 N1 C8 78.68 85.52 –44.19 –78.85 –78.85 
      
Ru1 N1 C8 C9 171.40(8) 174.58 173.0(2) 173.9(1) 172.2(1) 
N1 C8 C9 C10 – 179.2(1) 171.4(3) 178.6(2) 170.5(2) 
C8 C9 C10 C11 – – 175.8(3) 176.7(2) 177.8(2) 
C9 C10 C11 C12 – – – 64.23 173.7 
 






All four compounds feature fairly strong N H F and C H F intermolecular interactions 
(Table 4).  In the crystal structure of compound 2, there is an additional π π intermolecular 
interaction (Cg Cg = 3.9760(9) Å, symmetry code = 1-x, 1-y, 1-z) that connects pairs of 
molecules that are related through an inversion centre. The cationic species are connected to the 
anionic species through three N H F and one C H F intermolecular interaction. Molecules 
in the crystal lattice of compound 3 are held together through one N H F, three C H F and 
a C H O intermolecular interaction. The crystal lattices of compounds 4 and 5 are dominated 
by N H F and C H F intermolecular interactions. 
 
Table 4: Important intermolecular interactions and symmetry codes of the complex salts’ crystal 
structures 
C-H…X D–H H…A D…A D–H…A Symmetry codes 
2      
N2 H2a F1 0.92 2.33 3.1170(15) 143 3/2-x, -½+y, z 
N2 H2a F3 0.92 2.27 3.1442(15) 158 3/2-x, -½+y, z 
N2 H2b F4 0.92 2.00 2.8928(13) 164 x, y, z  
C1 H1 F1 1.00 2.47 3.3305(16) 143 3/2-x, -½+y, z 
3      
N1 H1b F4 0.99 2.07 2.9456(13) 147 x, y, z 
C2 H2 F2 1.00  2.54 3.4765(19) 155 x, y, z 
C3 H3 F2 1.00 2.42 3.4265(17) 154 -1+x,- ½-y, -½+z 
C5 H5 F3 1.00 2.42 3.2631(19) 142 1-x, ½+y, ½-z 
C8 H8b O1 0.99 2.60 3.4764(17) 148 2-x, -½+y, 3/2-z 
4      
N1 H1a F1 0.92 2.34 3.106(3) 141 1-x, 1-y, 2-z  
N1 H1b F1 0.92 2.35 3.175(3) 149 x, y, z 
N1 H1b F3 0.92 2.20 3.976(3) 141 x, y, z 
C1 H1 F2 1.00 2.31 3.295(4) 169 2-x, 1-y, 2-z 
C3 H3 F4 1.00 2.48 3.357(4) 147 1-x, ½+y, 3/2-z 
C8 H8b F4 0.99 2.53 3.387(4) 144 x, 1+y, z 
5      
N1 H1a F1 0.90 2.09 2.940(3) 158 x, ½-y, -½+z  
N1 H1b F7 0.90 2.39 3.258(3) 162 -1+x, ½-y, -½+z  





C-H…X D–H H…A D…A D–H…A Symmetry codes 
N2 H2b F4 0.90 2.13 2.920(3) 146 x, ½-y, -½+z  
C3 H3 F4 0.98 2.27 3.230(3) 166 x, ½-y, -½+z  
C4 H4 F1 0.98 2.34 3.208(3) 147 1-x, -½+y, ½-z 
C13 H13 F7 0.98 2.54 3.448(3) 154 x, y, z 
C14 H14 F6 0.98 2.30 3.224(3) 157 x, ½-y, -½+z 
C15 H15 F5 0.98 2.35 3.188(3) 144 x, -½-y, ½-z 
 
4. Conclusion  
 
The stable and water soluble 1-alkanaminedicarbonyl(η5-cyclopentadienyl)ruthenium(II)  
complex salts, [CpRu(CO)2NH2(CH2)nCH3]+BF4- (Cp= η5-C5H5, n=0-5) have been successfully 
synthesized. Their IR data has shown that the carbonyl peak shifts to lower frequency as the 
alkyl chain increases. The 1H and 13C NMR data has shown that the 1-alkanamine is σ-bonded 
to the metal centre via nitrogen as the donor atom. This is further confirmed by the X-ray crystal 
structure, which also reveals gauche conformation responsible for stability of the cationic 
complex. The molecules are held together by N–H…F and C–H…F bonds, which enhance their 
stability and solubility in water. There is a general decrease in melting point of the 1-alkanamine 
complex salts as the alkyl chain increases. 
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Five new 1-alkanaminedicarbonyl(η5-pentamethylcyclopentadienyl)ruthenium(II) tetrafluoro-
borate complex salts, [Cp*Ru(CO)2NH2(CH2)nCH3]BF4 (Cp* = η5-C5(CH3)5; n = 0 (1), 1 (2), 2 
(3), 3 (4) and 4 (5)) have been synthesized by the reaction of the Lewis acid [Cp*Ru(CO)2]BF4 
with a slight excess of the 1-alkylamines in dry methylene chloride. The water-soluble 
complexes are reported for the first time and have been characterized by IR, NMR and high 
resolution mass spectrometry. The 1-alkylamines are linked to the ruthenium centre by a sigma 
bond via the nitrogen atom of NH2. The crystal structure of the complex 
[Cp*Ru(CO)2NH2CH2CH3]BF4 (2) was obtained by single crystal X-ray diffraction. It 
crystallizes in the triclinic crystal system, space group P-1.  
 





η5-Pentamethylcyclopentadienyl ruthenium complexes have been known for more than four 
decades and have been shown to be potential catalysts in various organic transformations. The 
complex [Cp*Ru(NCCH3)3]PF6 (Cp* = η5-C5(CH3)5), for example, was shown to catalyze the 





substituted allyl terminal [1]. The complex [Cp*Ru(bpy)Cl] effectively catalyzed the formal 
[3,3] rearrangement of allyl β-ketoesters [2], while the Cp* ruthenium dicarbonyl complex, 
{[Cp*Ru(CO)2]2(µ-H)}+Otf– (Otf = OSO3CF3) was shown to selectively catalyze the 
deoxygenation of diols to alcohols, e.g. 1,2-propanediol to n-propanol [3,4].  
 
The synthesis of ruthenium complexes of the [Cp*Ru(CO)2] moiety with a variety of ligands 
have been reported. For example, the Cp* ruthenium dicarbonyl complex K[Cp*Ru(CO)2] was 
synthesized by the reduction of [Cp*Ru(CO)2]2 with potassium dispersed in sodium [5]. The 
reaction of this complex, K[Cp*Ru(CO)2], with HCl, MeI, MeOCH2Cl, HSiCl3 and t-BuPCl2 to 
form the corresponding complexes [Cp*Ru(CO)2H], [Cp*Ru(CO)2CH3], 
[Cp*Ru(CO)2CH2OCH3], [Cp*Ru(CO)2HSiCl2] and [Cp*Ru(CO)2t-BuPCl] was reported [5].  
The Cp* ruthenium(II) dicarbonyl complexes, [Cp*Ru(CO)3]BF4, [Cp*Ru(CO)2CH2OCH3], 
[Cp*Ru(CO)2H] and [Cp*Ru(CO)2CH2OH] are also known [6]. The complex 
[Cp*Ru(CO)2(=CHOCH3)]PF6 was obtained by α-hydride abstraction from 
[Cp*Ru(CO)2CH2OCH3] by PH3CPF6 [7,8].  
 
The Cp* ruthenium carbonyl complexes can, therefore, exist as neutral complex molecules or 
complex salts with weakly coordination counter anions such as BF4-, PF6-, SO3CF3-, BPh4- and 
SbF6- or as [Cp*Ru(CO)2]- anionic salts of monovalent metals such as Li, Na or K.  
 
Complexes of the type [Cp*Ru(CO)2L] (L = nitrogen containing ligands), where the ligand is 
coordinated to the metal through the nitrogen atom are, however, not known. As part of the 
ongoing study on the coordination of amine ligands to the metal centre of [CpM(CO)2] (Cp = 
η5-C5H5) (M = Fe or Ru) and [Cp*Fe(CO)2] moieties, our group recently reported on the 
synthesis, characterization and crystal structures of [CpFe(CO)2(amines)]BF4, 
[Cp*Fe(CO)2(amines)]BF4 [9-11] and CpRu(CO)21-alkanamines]BF4 [12,13] complexes. We 
herein now report the synthesis and characterization of the five new, water-soluble complexes, 
[Cp*Ru(CO)2NH2(CH2)nCH3]BF4 (n = 0 (1), 1 (2), 2 (3), 3 (4) and 4 (5)), and the crystal 
structure of [Cp*Ru(CO)2NH2CH2CH3]BF4 (2). To the best of our knowledge η5-
pentamethylcyclopentadienyldicarbonylruthenium(II) complexes of 1-alkylamines have not 
been reported before. The solubility of these complexes in water makes them suitable candidates 







2. Experimental  
 
2.1 General  
 
All manipulations were done under dry and oxygen-free conditions, unless otherwise stated. 
Reagent grade Et2O, methylene chloride, n-propylamine and n-pentylamine were obtained from 
Merck; silver tetrafluoroborate, ruthenium trichloride hydrate, pentamethylcyclopentadiene, n-
ethylamine (2 M in THF) and n-methylamine (33 weight% in absolute ethanol) were obtained 
from Aldrich; nitrogen and carbon monoxide gases were obtained from AFROX. Nitrogen was 
dried over phosphorus(V) oxide, Et2O was distilled from sodium/benzophenone and stored over 
molecular sieves, while  methylene chloride was distilled from phosphorous(V) oxide. All other 
chemicals were used as supplied. Melting points were recorded on a Stuart Scientific melting 
point apparatus SMP3 and are uncorrected. Solid state infrared spectra were recorded using an 
ATR Perkin Elmer Spectrum 100 spectrophotometer between 4000 and 400 cm-1. NMR spectra 
were recorded on Bruker Topspin 400 and 600 MHz spectrometers. The deuterated solvent 
CDCl3 (Aldrich, 99.8%) was used as purchased. Solutions for NMR spectroscopy were prepared 
under nitrogen using nitrogen-saturated solvents. The high resolution mass spectra for the 
complexes were recorded on a Waters Synapt G2 instrument by injecting via the ESI probe into 
a stream of methanol. [Cp*Ru(CO)2]2 was prepared by a modified literature method [14]. Best 
results were obtained when excess C5Me5H is refluxed over Ru3(CO)12 in n-decane at 160 °C 
for 6 h. Orange crystals of  [Cp*Ru(CO)2]2 (0.2 g; 3.4 mmol) were dissolved in CH2Cl2 (20 mL) 
and an equimolar amount of iodine in CH2Cl2 (10 mL) added. Evaporation of the solvent under 
reduced pressure gave an orange solid of Cp*Ru(CO)2I [15].  
 
2.2 Synthesis of complexes [Cp*Ru(CO)2NH2(CH2)nCH3]BF4]BF4 (1 - 5) 
 
The synthesis of all the η5-pentamethylcyclopentadienyldicarbonylruthenium(II) complexes, 
[Cp*Ru(CO)2NH2(CH2)nCH3]BF4]BF4, was achieved by a common procedure illustrated by the 
generic method for the synthesis of [Cp*Ru(CO)2NH2CH3]BF4.  
 
2.2.1 [Cp*Ru(CO)2NH2CH3]BF4 (1) 
 
Cp*Ru(CO)2I (0.0525 g; 0.1270 mmol) and AgBF4 (0.0296 g; 0.1520 mmol) were placed in an 
aluminium foil-wrapped Schlenk tube and evacuated under reduced pressure for 4 h to remove 





mixture stirred for 1½ h. The mixture was canula filtered and excess (1.0 mmol; 125 µL) n-
methylamine (33% weight in absolute ethanol) was added to the filtrate and the mixture stirred 
for 4 h. The colour of the mixture changed from orange to pale yellow. The solution was 
allowed to remain undisturbed for 30 min. The mother liquor was then transferred into a 
Schlenk tube by canula filtration. The pale yellow solution was concentrated under reduced 
pressure and a five-fold quantity of diethyl ether added.  A pale-yellow gelatinous precipitate 
formed on shaking the mixture and this was then allowed to settle to the bottom of the Schlenk 
tube and the mother liquor removed by canula filtration. The residue was re-dissolved in CH2Cl2 
(2 mL) and filtered to remove any solid impurities. Addition of excess diethyl ether gave a 
white precipitate, which was washed with diethyl ether (2 x 10 mL). The white precipitate was 
dried under reduced pressure for 4 h. The white solid (0.0370 g) was obtained in 72% yield. The 
solid turns black at 165 °C and then melts at 167.3 °C. Anal: Found (calculated) for 
C13H20NO2RuBF4; C, 37.68 (38.07)%; H, 5.23 (4.91)%; N, 3.91 (3.41)%. HRMS: Found 
(calculated) for (C13H20NO2Ru)+, M+ 100%; 324.0528 (324.0538), 59%; 326.0545 (326.0548), 
54.1%; 323.0545 (323.0550). IR (solid state): νmax/cm–1 2034, 1976 (CO); 2953, 2914 (CH3); 
3321, 3276, 1593 (NH2). δH (400 MHz; CDCl3): 3.36 (s, 2H, NH2), 2.62 (t, 3H, CH3), 1.95 (s, 
15H, C(CH3)5. δC (400 MHz; CDCl3): 197.88 (CO), 100.24 C(CH3)5, 40.73 (CH3), 10.45 
C(CH3)5. 
 
2.2.2  [Cp*Ru(CO)2NH2CH2CH3]BF4 (2) 
 
The solid turns black at 158 °C and then melts 162 °C. Yield: (0.0416 g; 67%). Anal: Found 
(calculated) for C14H22NO2RuBF4; C, 36.68 (36.64)%; H, 5.20 (5.23)%; N, 3.27 (3.30)%. 
HRMS: Found (calculated) for (C14H22NO2Ru)+, M+ 100%; 338.0686 (338.0694), 59%; 
340.0703 (340.0705), 54.1%; 337.0702 (337.0706). IR (solid state): νmax/cm–1 2034, 1980 (CO), 
2978 cm-1, 2934 (CH3), 3312, 3282, 1607 (NH2). δH (400 MHz; CDCl3): 3.30 (s, 2H, NH2), 2.73 
(m, 2H, αCH2), 1.22 (t, 3H, CH3), 1.95 (s, 15H, C(CH3)5. δC (400 MHz; CDCl3): 198.00 (CO), 
100.26 C(CH3)5, δ 49.12 (CH2), δ 17.42 (CH3), δ 9.61 C(CH3)5. 
 
2.2.3 [Cp*Ru(CO)2NH2(CH2)2CH3]BF4 (3) 
 
The solid turns black at 148 °C and then melts at 150 °C. Yield: (0.0293 g; 40%). Anal: Found 
(calculated) for [C15H24NO2RuBF4; C, 41.21 (41.11)%; H, 5.48 (5.52)%; N, 3.28 (3.20)%. 





354.0857 (354.0861), 54.1%; 351.0862 (351.0863). IR (solid state): νmax/cm–1 2032, 1974 (CO); 
2966, 2940(sh), 2882(sh) (CH3); 3318, 3275, 1604 (NH2). δH (400 MHz; CDCl3): 3.30 (s, 2H, 
NH2), 2.59 (m, 2H, αCH2), 1.62 (m, 2H, βCH2), 0.88 (t, 3H, CH3), 1.95 (s, 15H, C(CH3)5. δC 
(400 MHz; CDCl3): 197.94 (CO), 100.24 C(CH3)5, 56.26 (αCH2), 25.43 (βCH2), 10.88 (CH3), 
9.61 C(CH3)5. 
 
2.2.4 [Cp*Ru(CO)2NH2(CH2)3CH3]BF4 (4) 
 
The solid turns black at 138 °C and then melts at 140 °C. Yield: (0.0241 g; 37%). Anal: Found 
(calculated) for C16H26NO2RuBF4; C, 42.68 (42.49)%; H, 5.82 (5.79)%; N, 3.13 (3.10)%.  IR 
(solid state): νmax/cm–1 2029, 1975 (CO), 2964, 2935, 2875 (CH3), 3309, 3271, 1600 (NH2). δH 
(400 MHz; CDCl3) 3.24 (s, 2H, NH2), 2.63 (m, 2H, αCH2), 1.58 (m, 2H, βCH2), 1.28 (m, 2H, 
γCH2), 0.89 (t, 3H, CH3), 1.95 (s, 15H, C(CH3)5. δC (400 MHz; CDCl3): 197.87 (CO), 100.26 
C(CH3)5, 54.18 (αCH2), 34.08 (βCH2), 19.69 (γCH2), 13.60 (CH3), 9.64 C(CH3)5. 
 
2.2.5 [Cp*Ru(CO)2NH2(CH2)4CH3]BF4 (5) 
 
The solid turns black at 152 °C and melts at 154 °C. Yield: (0.0348 g; 27%). Anal: Found 
(calculated) for C17H28 NO2RuBF4; C, 43.70 (43.79)%; H, 5.98 (6.05)%; N, 3.13 (3.00)%. IR 
(solid state): νmax/cm–1 2030, 1980 (CO), 2948, 2873(CH3), 3309, 3271 (NH2) 1601 (NH2). δH 
(400 MHz; CDCl3): 3.31 (s, 2H, NH2), 2.61 (m, 2H, αCH2), 1.61 (m, 4H, β,γCH2), 1.26 (m, 2H, 
εCH2), 0.86 (t, 3H, CH3), 1.95 (s, 15H, C(CH3)5. δC (400 MHz; CDCl3): 197.92 (CO), 100.27 
C(CH3)5, 54.45 (αCH2), 31.86 (βCH2), 28.66 (γCH2), 22.23 (εCH2), 13.90 (CH3), 9.71 C(CH3)5. 
 
2.3 X-ray crystal structure determination of [CpRu(CO)2NH2(CH2)CH3]BF4  
 
Crystals of the complex [Cp*Ru(CO)2NH2(CH2)CH3]BF4 (2) suitable for single crystal X-ray 
diffraction studies were grown by the liquid diffusion method. Solutions of the compounds in 
dry methylene chloride were layered with a fourfold volume of diethyl ether and allowed to 
stand undisturbed in the dark at 22 °C for 24 h. Crystals of the complex salt 2 was selected and 
glued on to the tip of glass fibres. The crystals were then mounted in a stream of cold nitrogen 
at 100(1) K and centred in the X-ray beam by using a video camera. The crystal evaluation and 
data collection were performed on a Bruker Smart APEXII diffractometer with Mo Kα radiation 





obtained from three series of scans at different starting angles. Each series consisted of 12 
frames collected at intervals of 0.5° in a 6° range with the exposure time of about 10 seconds 
per frame. The reflections were successfully indexed by an automated indexing routine built in 
the APEXII program suite [16]. The final cell constants were calculated from a set of 6460 
strong reflections from the actual data collection. Data collection method involved ω scans of 
width 0.5°. Data reduction was carried using the program SAINT+ [16]. The structure was 
solved by direct methods using SHELXS [17] and refined by SHELXL [16]. All structures were 
checked for solvent-accessible cavities using PLATON [18] and the graphics were performed 
with the DIAMOND [19] visual crystal structure information system software. Non-H atoms 
were first refined isotropically and then by anisotropic refinement with full-matrix least-squares 
calculations based on F2 using SHELXS [18].  All H atoms were positioned geometrically and 
allowed to ride on their respective parent atoms. The carboxyl H atoms were located from the 
difference map and allowed to ride on their parent atoms. All H atoms were refined 
isotropically. The absorption correction was based on fitting a function to the empirical 
transmission surface as sampled by multiple equivalent measurements [16]. Crystal data and 
structure refinement information for the compound 2 are summarized in Table 1. 
 
Table 1: Crystal data and structure refinement for [Cp*Ru(CO)2NH2(CH2)CH3]BF4 (2) 
[Cp*Ru(CO)2NH2(CH2)CH3]BF4 (Compound 2) 
Empirical formula  C14H22BF4NO2Ru 
Formula weight  424.21 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions  a = 10.5561(2) Å, α= 106.1380(10)°. 
b = 11.3098(3) Å, β= 99.5730(10)°. 
c = 16.0927(4) Å, γ = 105.3010(10)°. 
Volume 1719.56(7) Å3 
Z 4 
Density (calculated) 1.639 Mg/m3 
Absorption coefficient 0.957 mm-1 
F(000) 856 
Crystal size 0.46 x 0.24 x 0.12 mm3 





[Cp*Ru(CO)2NH2(CH2)CH3]BF4 (Compound 2) 
Index ranges -14 h 14, -14 k 15, -21 l 21 
Reflections collected 44322 
Independent reflections 8618 [R(int) = 0.0206] 
Completeness to theta = 28.42° 99.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. Transmission 0.8939 and 0.6674 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8618 / 7 / 427 
Goodness-of-fit on F2 1.025 
Final R indices [I>2sigma(I)] R1 = 0.0165, wR2 = 0.0415 
R indices (all data) R1 = 0.0193, wR2 = 0.0437 
Largest diff. peak and hole 0.469 and -0.487 e.Å-3 
 
 
3. Results and discussion 
 
3.1 Synthesis and characterization of the [Cp*Ru(CO)2NH2(CH2)nCH3]BF4 (1 – 5) 
 
The reaction of the complex Cp*Ru(CO)2I with AgBF4 in methylene chloride affords the 
solvated Lewis acid,  [Cp*Ru(CO)2]BF4, which reacts, in situ, with 1-alkylamines in methylene 
chloride at room temperature to give a pale yellow solution, from which the 1-alkylamine 
complex salts, [Cp*Ru(CO)2NH2(CH2)nCH3]BF4 (1 – 5), were obtained. The isolated yield of 
the complexes decreased with increase in chain length for complexes 1 – 5. The complexes are 
fairly stable in the solid state when kept at room temperature, but gradually decompose on 
exposure to light to give a black solid.  
 
The complexes are soluble in chlorinated solvents and polar solvents, but are insoluble in 
hexane and diethyl ether. They were, therefore, easily precipitated from methylene 
chloride/diethyl ether mixtures. The complexes were soluble in water but their stability in water 
lasted for 1 h. This was established when a 1H NMR of the complexes in oxygen-free D2O was 
obtained but a clean 13C NMR could not be obtained after 1 h of dissolving the solid. The high 
solubility in water can be attributed to the polarity of the amine group and the ionic nature of the 






The melting point of the complexes generally decreases with increase in 1-alkylamine 
hydrocarbon chain length. This can be attributed to decrease in the strengths of intermolecular 
forces, particularly, the ionic bonds in the crystal lattice. The melting point of the complex salts 
with odd numbers of carbon atoms in the 1-alkanamine chain have relatively higher melting 
points compared to those with an even number, a trend also observed for the analogous η5-
cyclopentdienyldicarbonylruthenium(II) 1-alkylamine complexes [12]. This is probably because 
the complexes with the odd numbered alkanes pack better than the even numbered ones. The 
melting points of the complexes are higher than for their analogous Cp ruthenium complexes 
[12], mainly because the Cp* ligand imparts electronic and steric effects that probably increases 
the strength of the intermolecular interaction. 
 
The complex salts were characterized by IR and NMR spectroscopy. The IR spectra of the 
complex salts 1 – 5 showed two strong absorption bands in the regions 2034 – 2029 cm–1 and 
1980 – 1994 cm–1 assignable to νCO anti-symmetric and symmetric stretching modes, 
respectively. The carbonyl absorption bands for the complex salts are at lower wavenumbers 
than those for the analogous Cp ruthenium complexes [12]. The ruthenium centres in the Cp* 
complexes have higher electron density leading to increased back-bonding to the carbonyl 
carbon and hence weakening of C   O bond. Noteworthy, the νCO absorption bands are at 
higher wavenumbers in the Cp* ruthenium complex salts than the corresponding iron analogues 
[10]. This may be due to greater back-donation from the iron centre to the carbonyl group, than 
there is from the ruthenium centre to the carbonyl, thus weakening the CO bond in the iron 
complex. Medium absorption bands were also observed in the regions 3324 – 3309 cm–1 and 
3282 – 3271 cm–1 assignable to ν(N–H) anti-symmetric and symmetric stretching modes 
respectively and a peak, observed at ca. 1600 cm–1, is assignable to ν(N–H) bending modes. The 
ν(N–H) stretching bands for the complex salts are at lower wavenumbers compared to the 
uncoordinated ligands, due to charge transfer towards the metal centre from the coordinated 
nitrogen of the 1-alkylamine. This clearly indicates that the 1-alkylamine ligands are 
coordinated to the ruthenium centre through the nitrogen. 
 
The 1H NMR data for the complexes were obtained in CDCl3 and D2O. Peak assignments were 
done with the help of 1H HSQC, as well as by comparison with data reported for analogous Cp 
ruthenium complexes [12]. Each of the complexes exhibited a sharp peak at ca 1.95 ppm 
assignable to the 15 CH3 protons on the Cp* moiety.  A triplet was observed at ca. 2.63, 1.22 
and 0.87 ppm in the 1H NMR spectra of complexes, 1, 2 and 3–5 respectively, assignable to the 





3.30 ppm, an up-field shift of about 0.55 ppm relative to the analogous Cp ruthenium complexes 
[12], and a downfield shift of 1.1 ppm relative to the analogous Cp* iron complexes [10]. The 
up-field shift in the NH2 proton resonance peaks in the Cp* ruthenium complexes relative to the 
analogous Cp ruthenium complexes is probably due to increased electron density on the 
ruthenium centre leading to reduced electrophilicity and hence shielding of the NH2 protons. 
Furthermore, the downfield shift in the proton resonance peaks observed for the Cp* ruthenium 
complexes relative to the analogous Cp* iron complexes could be due to the greater ability of 
the ruthenium centre to accept electrons than the iron centre, thus, the NH2 protons are more 
deshielded in Cp* ruthenium complexes [10]. Noteworthy, the NH2 proton resonance peaks 
were observed more downfield (ca. 1.1 ppm) than those for the free 1-alkylamine ligands, a 
result of deshielding by the metal centre, further confirming the coordination of the 1-
alkanamine ligand to the metal centre via the nitrogen atom of the NH2 functionality. Peaks 
assignable to the CO, Cp* ring carbon atoms and CH3 carbons of the Cp* in all the complexes 
were observed at ca. 198, 100 and 10 ppm in the 13C NMR spectra, respectively. The CO peak 
for the Cp* ruthenium complexes is more up-field than for iron, while the peaks for the Cp* 
ring carbons and CH3 carbons of the Cp* in the ruthenium complex are more downfield than in 
the analogous Cp* iron complexes. The 13C NMR peaks for the methylene groups showed a 
significant downfield shift trend from αCH2 to ωCH2, a result of probable charge transfer by the 
methyl group towards the amine group and more so on coordination to the ruthenium metal 
centre.  
 
3.2 Structural elucidation of complex [Cp*Ru(CO)2NH2CH2CH3]BF4 
 
Single crystal X-ray diffraction was used to determine the molecular structure of the complex 2. 
The compound crystallized as white needle-like crystals in a triclinic crystal system, space 
group P-1, with two molecules, A and B, of the cation [Cp*Ru(CO)2NH2CH2CH3]+ and two 
counter anions BF4– in the unit cell. This observation is contrary to that made for the analogous 
Cp ruthenium complex, [CpRu(CO)2NH2CH2CH3], which crystallized in an orthorhombic 
crystal system with one cationic molecule and one counter anion in the asymmetric unit cell 
[12]. Fig. 1 provides the molecular diagram of the complex 2, while Table 2 gives a comparison 
of important bond distances and angles.  
 
The coordination in the cationic species of the complex 2 is in such a way that the ruthenium 
centre is coordinated to the 1-alkylamine ligand through a sigma bond to the amine N atom and 





pseudo-octahedral “three-legged piano stool” geometry (Fig. 1). The complex 2 adopts the 
energetically favoured gauche conformation, similar to that observed in other metal complexes 
with the Cp* ligand [10,20-22], in which the α-carbon of the 1-alkylamine lies in conformation 
between the cyclopentadienyl ring and the two carbonyl ligands. This confirms that the 
symmetric and anti-symmetric stretches, as observed in the IR data for the complex at 1980 and  
2034 cm–1, respectively, are indeed of the two nominally cis-CO ligands.  
 
 
Figure 1: The molecular structure of compound 2 showing the atom-numbering scheme. Displacement 






The Ru N bond length in molecule A (2.152(10) Å) is slightly shorter than that in molecule B 
(2.161(10) Å), but both are longer than that reported for the analogous Cp ruthenium complex 
(2.139(1) Å) and Cp* iron complexes (2.022(15) Å). The slightly longer Ru N bond observed 
in Cp* ruthenium complex compared to the Cp ruthenium complex can be attributed to 
increased electron density around the Ru metal centre leading to reduced electrophilicity and 
hence, weaker Ru N bond. The C N bond lengths for molecules A and B of the complex 2 are 
within the same range as that reported for the analogous Cp ruthenium complex, implying that 
the change from Cp to Cp* has no effect on the Ru N bond length, contrary to the observation 
made in the iron complexes [10]. Noteworthy, the C O bond length for the complex 2 is greater 
than that reported for the analogous Cp ruthenium complex (1.134 Å), mainly because the Cp* 
ring increases electron density on the metal centre, which in turn increases back-donation to the 
carbonyl carbon thus weakening the C O bond as discussed earlier for the IR spectra. The bond 
angles in the structure of complex 2 are essentially similar to those of the analogous Cp 
ruthenium complexes, except for the Ru N C angle which is slightly greater than that reported 
for the analogous Cp ruthenium complex (90.35°). This difference is likely due to the steric bulk 
of the Cp* ring.  
 
The coordinated 1-ethylamine has a planar conformation in the two cationic molecules in the 
unit cell, but the two cations are oriented in opposite directions with  torsion angles for C(14)-
C(13)-N(1)-Ru(1) and C(28)-C(27)-N(2)-Ru(2) being –162.48(9)° and 173.18(10)° 
respectively. The angles of torsion (Table 2) of the two cationic molecules imply opposite 
orientation in space. The crystal packing in the structure of complex 2 is such that the cationic 
molecules are arranged in diagonal layers with Cp* rings or alkyl chain tails of neighbouring 
cationic molecules, within the same layer, facing each other ( Fig. 2).  
 
The crystal structure of the complex 2 features fairly strong N H F and C H F hydrogen 
bonds (Table 3). Other weak intermolecular interactions exist between C O C O, O C F, 
C=O O and C H O as illustrated in Figure 3.  
 
Table 2: Selected bond distances (Å) and angles (°) for complex 2 
 Molecule A Molecule B 
*Cg - Ru  1.873  1.875 
C(11) O(1)    1.1388(16) 1.1389(15) 





 Molecule A Molecule B 
C(13) N(1)    1.4893(16) 1.4769(17) 
C(13) C(14)    1.5148(18) 1.5051(19) 
Ru(1) N(1)    2.1520(10) 2.1612(10) 
   
*Cg Ru N  124.66  124.84 
N(1) C(13) C(14)   111.99(11) 113.28(12) 
C(12) Ru(1) C(11)  92.89(6) 91.93(5) 
C(12) Ru(1) N(1)  90.35(5)  91.72(4) 
C(11) Ru(1) N(1)  91.57(5)  91.40(5 
C(13) N(1) Ru(1)   117.75(7) 118.62(8) 
   
*Cg Ru N C13 76.11 -65.67 
O(2) C(12) Ru(1) N(1) -150.2(10) -173.6(11) 
O(1) C(11) Ru(1) N(1) 162.5(14) 156.6(9) 
C(14) C(13) N(1) Ru(1) -162.48(9) 173.18(10) 
C(12) Ru(1) N(1) C(13) -152.90(9) 162.84(11) 
C(11) Ru(1) N(1) C(13) -60.00(9) 70.87(11) 








Figure 2: Packing diagram for [Cp*(CO)2Ru{NH2CH2CH3}]BF4 2 viewed along the a-axis with 
hydrogen atoms omitted for clarity 
 
Table 3: Important intermolecular interactions and symmetry codes of the crystal structure of complex 2 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
N(1) H(1A) F(6) 0.92 2.13  2.9638(15)  150  1-x,1-y,-z 
N(1) H(1B) F(8) 0.92 2.11 3.0196(15) 170 -1+x,y,z 
N(2) H(2A) F(3) 0.92 2.24 3.1521(15) 169 1+x,y,z  
N(2) H(2B) F(2) 0.92 2.16  2.9801(16) 148 1-x,-y,1-z 
C(21) H(21A) F(4) 0.98 2.55 3.4191(19) 148 1-x,1-y,1-z 







Figure 3: The intermolecular interactions in the molecular structure of complex 2 are indicated by the 
blue dotted lines 
 
4. Conclusion  
 
The reaction of the Lewis acid [η5-C5(CH3)5M(CO)2]+ with 1-alkyl amines readily gave the 
water-soluble ruthenium complexes [η5-C5(CH3)5M(CO)2NH2(CH2)nCH3]BF4 (n = 0 – 4) at 
room temperature. Spectral data analysis has shown that the amines coordinate to the metal 
centre by utilizing the lone pair of electrons on the nitrogen atom. The crystal structure 
elucidation has shown that the stability of the complex salts can be attributed to the existence of 
strong intermolecular attractions, N H F and C H F, and the gauche conformation 
exhibited by the complex cations in the crystal. The Cp* complexes are more thermally stable 
than their analogous Cp molecules. 
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Bacterial resistance to antimicrobial drugs is a significant threat to humans and requires urgent 
intervention. There is, therefore, a clear need for the development of new types of antibacterial 
agents. We have thus synthesized the α,αʹ-diaminoalkane-bridged diruthenium complex salts 
[Rp2NH2(CH2)nNH2]Y2 (Rp = CpRu(CO)2 where Cp = η5-C5H5; n = 2, 3, 4 and 6; Y = BF4 (1) 
or SO3CF3(2)) by the reaction of [RpNCCH3]Y  and NH2(CH2)nNH2 (n = 2 (DAE) (3); n = 3 
(DAP) (4); n = 4 (DAB) (5) and n = 6 (DAH) (6 (BF)4, 7(SO3CF3)) at ambient temperature and 
pressure. These compounds are reported for the first time and have been fully characterized by 
infrared spectroscopy, 1H and 13C NMR spectroscopy, elemental analyses and melting points.  
The crystal structures of compounds 1 and 3 were obtained by single crystal X-ray 
crystallography. The two compounds crystallized in the monoclinic crystal system in the P21/n 
space group. Antimicrobial susceptibility tests were done for the new dinuclear complexes 3 – 7 
as well as for mononuclear ruthenium complexes, [RpBA]BF4 (8),  [RpMBA]BF4 (9), 
[RpMeOBA]BF4 (10) and [RpAMBN]BF4 (11) (BA = NH2CH2C6H5, MBA = 
NH2CH(CH3)C6H5,  MeOBA = NH2CH2C6H4OCH3 and  AMBN = NH2CH2C6H5) against 
selected drug-resistant and drug-susceptible Gram-positive and Gram-negative bacteria. Some 
of the dinuclear and mononuclear ruthenium complexes demonstrated good potential 
antimicrobial activities against the bacteria tested with some showing better activity than well 
known antibiotics such as ampicillin (AMP 10). The ruthenium moiety CpRu(CO)2 triggered or 
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The increased rate of bacterial resistance and the need for their eradication has triggered 
increased interest in the development of new classes of antimicrobial agents [1], that may not be 
as susceptible to the bacterial mechanisms of resistance developed against the current range of 
drugs. Interest in the chemistry of ruthenium complexes is growing fast, due to their application 
in biomedicine as well as in catalysis. Ruthenium complexes containing the cyclopentadienyl 
group have been the subject of investigation by many research groups during the past decades 
because of their widespread applications in transition metal-catalyzed organic syntheses [2-10] 
and as anticancer agents [11-15]. The ruthenium complexes ImH[Ru(Im)(dmso)Cl4] 
(Im=imidazole) (NAMI-A) and trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) 
successfully entered clinical trials as a chemotherapeutic agents, with NAMI-A showing low 
host toxicity at pharmacologically active doses [16-18], and KP1019 exhibiting no dose-limiting 
toxicity [19] and effectiveness against cancer cell lines that are highly resistant to other 
chemotherapeutic agents [20]. The successful use of transition metal complexes as anticancer 
agents [21-23] has triggered great interest in the use of metal complexes as antimicrobial agents 
[24-27]. Currently, a lot of research is being done on the possible application of platinum group 
metal complexes in medicine and more so as antibacterial agents. Palladium(II) and platinum(II) 
complexes have been demonstrated as potential antibacterial agents against selected bacterial 
strains and are more active than the free, uncoordinated ligands [28,29]. The interest in 
developing platinum group metal complexes as antimicrobial agents is also motivated by the 
fact that bacteria are rapidly developing resistance to new drugs based upon analogues of known 
scaffolds. Particularly, ruthenium complexes have been shown to exhibit antimicrobial activity 
against drug-resistant pathogenic microorganisms [30].  
 
Dwyer and co-workers’ findings, more than five decades ago, that polypyridyl mononuclear 
tris(bidentate)-ruthenium(II) and -iron(II) complexes, e.g. [Ru(Me4phen)3]2+ (Me4phen = 
3,4,7,8-tetramethyl-1,10-phenanthroline), have potential antibacterial activity [31,32] inspired 
research into the possible use of ruthenium complexes as antimicrobial agents [33]. The activity 
of many organic antimicrobial and antibiotic agents has been shown to increase when directly 
coordinated to the ruthenium centre [34-36]. Recent studies by Li and co-workers demonstrated 





1,10-phenanthroline and bbn = bis[4(4ʹ-methyl-2,2ʹ-bipyridyl)]-1, n-alkane} have potential 
antimicrobial activity against both Gram-positive Staphylococcus aureus and methicillin-
resistant Staphylococcus aureus (MRSA), and Gram-negative Escherichia coli and 
Pseudomonas aeruginosa [37].   
 
A majority of drugs contain at least a nitrogen atom in their structure. The η5-
cyclopentadienyldicarbonylruthenium(II) complexes reported herein are dinuclear with the 
ruthenium metal centers linked by α,α`-diaminoalkanes. The amine functionality-containing 
compounds form a very important class of therapeutic agents. A good example is 1,2-
ethylenediamine, a pharmacophore of ethambutol, a front-line drug used to treat tuberculosis 
(TB) [38,39]. α,ω-Diaminoalkanes and bis-glycosylated diamino alcohols have been shown to 
exhibit good antibacterial activity against Mycobacterium tuberculosis [40,41]. 
Diethylcarbamazine (DEC) (N,N-diethyl-4-piperazine-1-carboxamide), a synthetic derivative of 
piperazine, and secondary amines such as N-hexylcyclohexylamine exhibited activity against 
filariasis causing parasites [42].  
 
Additionally, metal carbonyls are potential CO-releasing molecules (CO-RMs); carbon 
monoxide delivered through organometallic CO-RMs has been shown to cause rapid death of 
pathogenic bacteria such as Escherichia coli and Staphylococcus aureus [43,44]. Coordinating 
the carbonyl ligand to the ruthenium in the complexes synthesized in this work is assumed to 
lead to the formation of ruthenium complexes that are active against pathogenic bacteria. 
Coordinating nitrogen containing ligands, such as α,α`-diaminalkanes, to a ruthenium center, 
such as in η5-cyclopentadienyldicarbonylruthenium(II) moieties, thus may afford compounds 
with improved activity against pathogenic agents.  
 
In our ongoing studies on the coordination of cyclopentadienyl carbonyl metal groups to various 
ligands [45-48], α,αʹ-diaminoalkane-bridged iron complexes, [CpFe(CO)2]2NH2(CH2)nNH2 
[49], as well as η5-pentamethycyclopentadienyldicarbonyliron(II) complexes, 
[Fp*2NH2(CH2)nNH2]2+ (Fp* = Cp*Fe(CO)2 and Cp* = C5(CH3)5) [50], in which there are no 
metal-metal bonds, were reported. Our success in the synthesis and characterization of the air- 
and water-soluble 1-alkanamine complexes of [CpRu(CO)2]+ [51] inspired us to explore the 
possible synthesis of α,αʹ-diaminoalkane complexes and study their antimicrobial activities. To 
the best of our knowledge, the α,αʹ-diaminoalkane-bridged cyclopentadienyl dicarbonyl 





synthesis and characterization of these ruthenium complexes and their antimicrobial activities 




2.1 General methods and materials 
 
Standard Schlenk techniques were employed for all reactions using dry, distilled and nitrogen 
saturated solvents in all manipulations. Nitrogen gas (AFROX) was dried over phosphorus(V) 
oxide. Chemical reagents and solvents were obtained from the suppliers shown in parentheses: 
reagent grade diethyl ether (Merck) was distilled from sodium/benzophenone and stored over 
molecular sieves; methylene chloride (Merck) was distilled from phosphorous(V) oxide; 
analytical grade acetonitrile (Merck) was dried over phosphorous(V) oxide. Silver 
tetrafluoroborate (Merk), ruthenium trichloride hydrate (DLD, Aldrich), dicyclopentadiene 
(Aldrich); 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane and 1,6-diaminohexane 
(Aldrich), carbon monoxide (AFROX) and iodine (Unilab) were used as supplied. Melting 
points were recorded on an Ernst Leitz Wetzlar hot-stage microscope and are uncorrected. 
Elemental analyses were performed on a Thermo-Scientific Flash 2000 CHNS/O analyser. Solid 
state infrared spectra were recorded using an FTIR Perkin Elmer Spectrum 100 
spectrophotometer between 4000 and 400 cm–1. NMR spectra were recorded on Bruker Topspin 
400 and 600 MHz spectrometers. The deuterated solvents CDCl3 (Aldrich, 99.8%), CD3CN 
(Merck) and D2O (Aldrich) were used as purchased. Solutions for NMR spectroscopy were 
prepared under nitrogen using nitrogen-saturated solvents. DSC curves were recorded on a SDT 
Q600 V20.9 Build 20 instrument using nitrogen at a flow rate of 10 min–1 and a temperature 
ramp of 5 °C min–1. The high resolution mass spectrum for compound 10 was recorded on a 
Waters Synapt G2 instrument by injecting via the ESI probe into a stream of methanol. The 
precursors Ru3(CO)12 [52], Rp2 (Rp = CpRu(CO)2) [53], RpI [54], [Rp]BF4  [55,56], as well as 
compounds [RpBA]BF4 (8),  [RpMBA]BF4 (9), [RpMeOBA]BF4 (10) and [RpAMBN]BF4 (11) 
(BA = NH2CH2C6H5, MBA = NH2CH(CH3)C6H5,  MeOBA = NH2CH2C6H4OCH3 and  AMBN 







2.2 Preparation of [RpNCCH3]BF4 , 1 
 
RpI (0.3168 g) and a magnetic stirrer bar were placed in a dry Schlenk tube wrapped in 
aluminium foil. Silver tetrafluorborate (0.26 g) was added to the Schlenk tube and the mixture 
evacuated at reduced pressure for 3 h to remove any traces of moisture. Methylene chloride (20 
mL) was added and the mixture stirred for 1½ h. A white precipitate and orange mother liquor 
were formed. The mixture was canula-filtered. Acetonitrile (5 mL) was added to the filtrate 
while stirring and the mother liquor immediately turned yellow. The mixture was stirred for 12 
h at room temperature. The volume of the reaction mixture was reduced to 5 mL under reduced 
pressure. To the resulting saturated solution, excess diethyl ether (20 mL) was added, the 
mixture shaken and left to stand for 2 h. A greyish-yellow solid was deposited on the sides of 
the Schlenk tube. The mixture was canula-filtered and the residue dried under reduced pressure. 
Acetonitrile (10 mL) was added to the residue and the mixture stirred for 1 h to extract 1. The 
Schlenk tube was left undisturbed for 20 min after which a white precipitate settled at the 
bottom. The mixture was canula-filtered into a Schlenk tube and the volume of the filtrate 
reduced to 5 mL to give a saturated solution. Diethyl ether (20 mL) was added and a greyish 
white precipitate appeared. The solid was purified by repeated dissolution in dry methylene 
chloride, canula-filtering under reduced pressure to remove any silver iodide residue and 
addition of dry diethyl ether until a white precipitate finally formed, which was dried under 
reduced pressure for 6 h. Yield: 0.2543 g, 89%; Melts at 111.8 – 112.6 °C. Anal. Calc. For 
C9H8BF4NO2Ru: C, 30.88; H, 2.30; N, 4.00%. Found: C, 30.16; H, 2.43; N, 4.18%. 1H NMR 
(600 MHz, CDCl3): δ 5.73 (s, 5H, Cp), 2.88 (s, 3H, CH3). 13C NMR (600 MHz, CDCl3): δ 
194.74 (CO), 131.37 (CN), 88.78 (Cp), 4.92 (CH2). IR (solid state): ν(CO) 2079, 2032 cm–1; 
ν(CN) 2332 cm–1. 
 
2.3 Preparation of [RpNCCH3]SO3CF3, 2 
 
The procedure described in Section 1.2 was repeated for the synthesis of compound 2 using 
15% excess of silver trifluoromethane sulphonate. Compound 2 was obtained in 90% yield. IR 
and NMR data obtained was very similar to those of 1. Anal. Calc. For C10H8F3NO5RuS: C, 







2.4 Preparation of [Rp2DAE](BF4)2, 3 
 
Compound 1 (0.3145 g, 0.8961 mmol) was dissolved in methylene chloride (20 mL) at room 
temperature in a Schlenk tube.  A solution of 1, 2-diaminoethane, DAE, (0.0269 g; 0.4481 
mmol) in methylene chloride was added drop-wise to the stirring solution of 1. A white 
precipitate appeared after 10 min. After 2 h of stirring, the mixture was left standing for 1 h and 
then filtered into a Schlenk tube. The residue was washed three times with 3 × 10 mL portions 
of methylene chloride, dissolved in acetonitrile and then left undisturbed for 30 min. It was 
filtered into a clean, dry, pre-weighed Schlenk tube and the volume of the solution reduced to 3 
mL. Diethyl ether (10 mL) was added to the saturated solution and a white microcrystalline 
solid formed. The mixture was allowed to stand for 30 min and then canula-filtered. The residue 
was rinsed with 2 × 5 mL portions of dry diethyl ether and dried under reduced pressure for at 
least 6 h. Yield: 0.3534 g, 58%; Anal. Calc. for C16H18B2F8N2O4Ru2: C, 29.50; H, 2.68; N, 
4.13%. Found: C, 29.06; H, 2.34; N, 4.08%. 1H NMR (400 MHz, CD3CN): δ 5.61 (s, 10H, Cp), 
3.72 (s, 4H, NH2), 2.68 (s, 4H, CH2). 1H NMR (400 MHz, D2O): δ 5.63 (s, 10H, Cp), 2.78 (s, 
4H, CH2). 13C NMR (400 MHz, CD3CN): δ 195.43 (CO), 87.78 (Cp), 55.20 (CH2). 13C NMR 
(400 MHz, D2O): δ 195.72 (CO), 87.63 (Cp), 54.72 (CH2). IR (solid state): ν(CO) 2058, 1996 
cm–1; ν(NH) 3319, 3278 cm–1. Melts at 150 ˚C and then immediately decomposes. 
 
2.5 Preparation of [Rp2DAP](BF4)2, 4 
 
To a solution of 1 (0.2150 g, 0.6126 mmol) in methylene chloride (20 mL), 1,3-
diaminopropane, DAP, (0.0227 mg, 0.3063 mmol) was added drop-wise at room temperature 
and stirred for 24 h. The mixture was filtered; the residue washed with 2 × 10 mL portions of 
methylene chloride to give a white solid. The white solid was extracted with 10 ml of 
acetonitrile and diethyl ether was added to the extract until a white precipitate formed. 
Filtration, followed by drying of the residue under reduced pressure, gave a white 
microcrystalline solid. Yield: 0.1700 g, 40%; Anal. Calc. for C17H20B2F8N2O4Ru2: C, 29.50; H, 
2.68; N, 4.13. Found: C, 29.06; H, 2.34; N, 4.08%. 1H NMR (400 MHz, CD3CN): δ 5.61 (s, 
10H, Cp), 3.65 (s, 4H, NH2), 2.57 (m, JHH = 7.12 Hz, 4H, αCH2), 1.65 (t, JHH = 7.20 Hz, 2H, 
βCH2). 1H NMR (400 MHz, D2O): δ 5.68 (s, 10H, Cp), 2.68 (m, JHH = 7.12 Hz, 4H, αCH2), 
1.74 (t, JHH = 7.20 Hz, 2H, βCH2). 13C NMR (400 MHz, CD3CN): δ 195.64 (CO), 87.76 (Cp), 
51.40 (α C), 35.01 (β C). 13C NMR (400 MHz, D2O): δ 195.93 (CO), 87.62 (Cp), 51.15 (α C), 
35.12 (β C). IR (solid state): ν(CO) 2056, 1994 cm–1; ν(NH) 3318, 3283 cm–1. The compound 





2.6 Preparation of [Rp2DAB](BF4)2, 5 
 
To a solution of 1 (0.2831 g, 0.8066 mmol) in methylene chloride (15 mL), 1,4-diaminobutane, 
DAB, (0.0357 g, 0.4033 mmol) was added drop-wise at room temperature while stirring. The 
mixture was stirred for 12 h and then allowed to stand at room temperature overnight. The rest 
of the procedure was performed as described in Section 2.4 to give a white microcrystalline 
solid. Yield: 0.2741 g, 48%; Anal. Calc. for C18H22B2F8N2O4Ru2: C, 30.62; H, 3.14; N, 3.97. 
Found: C, 30.49; H, 2.80; N, 4.04%. 1H NMR (400 MHz, CD3CN): δ 5.60 (s, 10H, Cp), 3.66 (s, 
4H, NH2), 2.56 (m, 4H, αCH2), 1.44 (m, 4H, βCH2). 1H NMR (400 MHz, D2O): δ 5.67 (s, 10H, 
Cp), 4.49 (s, 4H, NH2), 2.69 (m, 4H, αCH2), 1.50 (m, 4H, βCH2). 13C NMR (400 MHz, 
CD3CN): δ 195.72 (CO), 87.76 (Cp), 54.01 (α C), 28.73 (β C). 13C NMR (400 MHz, D2O): δ 
196.02 (d, CO), 87.63 (Cp), 53.91 (α C), 29.01 (β C). IR (solid state): ν(CO) 2060, 1994 cm–1; 
ν(NH) 3307, 3281 cm–1. Decomposes (turns into a black liquid) at temperature >179 °C. 
 
2.7 Preparation of [Rp2DAH](BF4)2, 6 
 
To a solution of 1 (0.2463 g, 0.7018 mmol) in 15 mL of methylene chloride, 1,6-
diaminohexane, DAH, (0.0408 g, 0.4033 mmol) was added drop-wise at room temperature 
while stirring. The mixture was stirred for 18 h and then allowed to stand at room temperature 
overnight. The rest of the procedure was performed as described in Section 2.4 to give white 
microcrystalline solid. Yield: 0.1319 g, 43% yield. Anal. Calc. for C20H26B2F8N2O4Ru2: C, 
32.72; H, 3.57; N, 3.82. Found: C, 32.86; H, 3.12; N, 3.92%. 1H NMR (600 MHz, CD3CN): δ 
5.59 (s, 10H, Cp), 3.64 (s, 4H, NH2), 2.57 (m, 4H, αCH2), 1.45 (m, 4H, βCH2) 1.25 (m, 4H, 
γCH2). 1H NMR (600 MHz, D2O): δ 5.84 (s, 10H, Cp), 4.55 (s, 4H, NH2), 2.85 (m, 4H, αCH2), 
1.68 (m, 4H, βCH2) 1.48 (m, 4H, γCH2).  13C NMR (600 MHz, CD3CN): δ 196.11 (CO), 88.09 
(Cp), 54.76 (α C), 32.06 (β C), 25.50 (γ C). 13C NMR (400 MHz, D2O): δ 196.07 (CO), 87.63 
(Cp), 54.32 (α C), 31.80 (β C), 26.47 (γ C). IR (solid state): ν(CO) 2055, 2003 cm–1; ν(NH) 
3331, 3284 cm–1. Decomposes at temperatures > 220 °C. 
 
2.8 Preparation of [Rp2DAH](SO3CF3)2, 7 
 
To a solution of 2 (0.2463 g, 0.5974 mmol) in methylene chloride (15 mL), 1,6-diaminohexane, 
DAH, (0.0347 g, 0.2987 mmol) was added drop-wise at room temperature while stirring. The 





Anal. Calc. for C22H26F6N2O10Ru2S2: C, 30.77; H, 3.05; N, 3.26. Found: C, 30.91; H, 3.18; N, 
3.37%. IR and NMR data obtained was very similar to that of 5a. Decomposes at temperatures 
> 220 °C 
 
2.9 X-ray crystal structure determination of compounds 1 and 3 
 
Crystals of compounds 1 and 3 suitable for single crystal X-ray diffraction studies were grown 
by the liquid diffusion method. A solution of the compound 3 in acetonitrile was layered with a 
fourfold volume excess of diethyl ether and allowed to stand undisturbed in the dark at 
approximately 22 °C for 24 h to give white crystals. White crystals of compound 1 were 
obtained by treating its solution in methylene chloride as described for compound 3. Crystals of 
the two compounds were each selected and glued onto the tip of glass fibers separately. The 
crystals were then mounted in a stream of cold nitrogen at 100(1) K and centered in the X-ray 
beam by using a video camera. Crystal evaluation and data collection were performed on a 
Bruker Smart APEXII diffractometer with Mo Kα radiation (λ = 0.71073 Å) and a 
diffractometer to crystal distance of 4.00 cm. The initial cell matrix was obtained from three 
series of scans at different starting angles. Each series consisted of 12 frames collected at 
intervals of 0.5° in a 6° range with the exposure time of about 10 seconds per frame. The 
reflections were successfully indexed by an automated indexing routine built in the APEXII 
program suite [58]. Data collection method involved ω scans of width 0.5°. Data reduction was 
carried using the program SAINT+ [58]. The structure was solved by direct methods using 
SHELXS [59] and refined by SHELXL [58]. Non-H atoms were first refined isotropically and 
then by anisotropic refinement with full-matrix least-squares calculations based on F2 using 
SHELXS [60]. All H atoms were positioned geometrically and allowed to ride on their 
respective parent atoms. All H atoms were refined isotropically. Crystal data and structure 
refinement information for compounds 1 and 3 are summarized in Table 1. 
 
Table 1: Crystal data and structure refinement for compound 1 and 3 
 1 3 
Empirical formula  C9H8BF4NO2Ru C16H18B2F8N2O4Ru2 
Formula weight  350.04 678.08 
Temperature  173(2) K 173(2) K 
Wavelength  0.71073 Å 0.71073 Å 





 1 3 
Space group  P21/c P21/n 
Unit cell dimensions (Å, °) a = 6.8540(2)  a = 12.5336(5)  
b = 15.1790(5)  b = 12.9444(5)  
c = 11.5373(4)  
β = 94.9170(10) 
c = 13.7516(5)  
β = 93.562(2) 
Volume (Å3) 1195.89(7)  2226.75(15)  
Z 4 4 
Densitycalc(Mg/m3) 1.944  2.023  
Absorption coefficient (mm-1) 1.353  1.450  
F(000) 680 1320 
Crystal size (mm3) 0.35 x 0.16 x 0.15  0.37 x 0.19 x 0.14  
Theta range for data collection 2.22 to 27.99° 2.13 to 25.00° 
Index ranges -7 h 9, -19 k 19, -15 l 14 -14 h 14, -15 k 14, -
16 l 16 
Reflections collected 18373 28701 
Independent reflections 2798 [R(int) = 0.0336] 3915 [R(int) = 0.0321]  
Completeness to theta = 25.00° 97.5 %  99.7 %  
Absorption correction Semi-empirical from equivalents Semi-empirical from 
equivalents 
Max. and min. transmission 0.8228 and 0.6488 0.8228 and 0.6161 
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2 
Data / restraints / parameters 2798 / 0 / 164 3915 / 0 / 307 
Goodness-of-fit on F2 1.119 1.026 
Final R indices [I>2sigma(I)] R1 = 0.0264, wR2 = 0.0693 R1 = 0.0238, wR2 = 0.0572 
R indices (all data) R1 = 0.0290, wR2 = 0.0719 R1 = 0.0268, wR2 = 0.0595 
Largest diff. peak and hole 1.585 and -0.642 e.Å-3 1.051 and -0.540 e.Å-3 
 
2.10 Evaluation of antimicrobial activity by disc diffusion assay 
 
The antimicrobial susceptibility to the complexes was determined using the disc diffusion 
method [61]. Stock solutions of the ruthenium and iron complexes (20 mg) were prepared in 
DMSO (1 mL). Sterile blank discs (6 mm; MAST, UK) were impregnated with 10 µL (0.2 mg) 
and 40 µL (0.8 mg), respectively, and allowed to dry for 1 h. Five Gram-negative (Escherichia 





aeruginosa ATCC 27853 and P. aeruginosa ATCC 35032) and six Gram-positive (Bacillus 
subtilis ATCC 6633, Enterococcus faecalis ATCC 51299, Mycobacterium smegmatis mc2155, 
Staphylococcus aureus ATCC 29213, S. aureus ATCC 43300, and S. saprophyticus ATCC 
35552) bacterial strains, grown overnight on TSA agar plates, were re-suspended in sterile 
distilled water and the turbidity of cell suspensions adjusted equivalent to that of a 0.5 
McFarland standard. These were used to inoculate Mueller-Hinton (MH) agar plates by 
streaking swabs over the entire agar surface followed by the application of the respective 
complexes discs [61]. Plates were then incubated for 18 h at 37 °C. M. smegmatis mc2155 plates 
were incubated for 48 h at 37 °C. Testing was done in duplicate and tetracycline (TE30) and 
ampicillin (AMP10) discs (Oxoid, UK) were used as standard antimicrobial agent controls, 
while DMSO-impregnated discs were used as negative controls. Zone diameters were 
determined and averaged. The following zone diameter criteria were used to assign 
susceptibility or resistance to compounds tested: Susceptible (S) ≥ 15 mm, Intermediate (I) = 11 
– 14 mm, and Resistant (R) ≤ 10 mm. The criteria for assigning susceptibility or resistance to 
AMP10 was as follows: (S) ≥ 17 mm, (I) = 14 – 16 mm, (R) ≤ 13 mm, while those for TE30 
were: (S) ≥ 19 mm, (I) 15 – 18 mm, (R) ≤ 14 mm [61]. The test results are summarized in Table 
3. 
 
3. Results and Discussion 
 
3.1 Synthesis and characterization of the complexes [RpNCCH3]Y (1) and 
[Rp2NH2(CH2)nNH2](Y)2 (3–6 ) 
 
The reaction of RpI (Rp = η5-C5H5Ru(CO)2) with a slight excess of AgBF4 or AgCF3SO3 in a 
mixture of methylene chloride and acetonitrile took place smoothly at approximately 22 °C 
forming compound 1 or 2 in good yield, respectively. Although the complexes [RpNCCH3]BF4 
and [RpNCCH3]SO3CF3 are not new in the first coordination sphere [62,63], their preparation 
methods are new and as salts of the counter ions BF4- and SO3CF3-, they are reported for the first 
time.  Compound 1 melted in a temperature range of 111.8 – 112.6 °C, compared to 140 °C 
reported for  [RpNCCH3]PF6 [62]. 
 
The reaction of α,αʹ-diaminoalkanes with two equivalents of [RpNCCH3]Y gave the new 
asymmetric bridged bimetallic complexes 3 – 6 in fairly good yields. The acetonitrile ligand in 






It is worth noting that attempts were made to synthesize the complexes 3 – 5 from the reaction 
of the organometallic Lewis acid RpBF4 with excess α, α`-diaminoalkanes, as described for the 
syntheses of 1-alkanaminedicarbonyl(η5-cyclopentadienyl)ruthenium(II) tetrafluoroborate 
complex salts [51], but instead of the expected dinuclear complexes, a dark-brown semi-solid 




















n = 2, 3 n = 3, 4
n = 4, 5 n = 6, 6 and 7
Y2
Y = BF4 or CF3SO3
 
Scheme 1: Reaction of [RpNCCH3]Y with half equivalent of α,ω-diaminoalkanes 
 
The complexes 3 – 6 were obtained as white microcrystalline, air-stable solids. They decompose 
in a temperature range of 180 °C to 225 °C. DSC-TGA curves were obtained for the compounds 
2, 5 and 6 in a temperature range of 25 °C to 500 °C. Compound 3 melts at 150 °C and begins to 
decompose at 180 °C, while compounds 5 and 6 do not melt but decomposes at 180 °C and 225 
°C, respectively. The greatest weight change for the complexes is noted at 250 °C for all the 
complexes, with 3 showing the highest rate of 2.25 weight %/°C and 5 showing the lowest rate 
of 1.75 weight %/°C. The decomposition temperature increases with increase in the value of n. 
The complexes readily dissolve in water, acetonitrile, dimethyl sulphoxide and methanol, but 
are insoluble in non-polar solvents such as hexane, diethylether and chlorinated solvents. They 
also dissolve in acetone, but their stability in acetone is short-lived. The yield of the complexes 
decreased with increase in the value of n.   
 
Characterization by IR, 1H NMR, 13C NMR and elemental analysis clearly indicated that the 
diamino-bridged ruthenium complexes were formed (Fig. 1). In the IR spectra, the ν(CO) 
absorption bands were observed as two strong peaks in the region  2060 – 2055 cm–1 for the 
asymmetric CO stretching vibrations and 2003 – 1994 cm–1 for symmetric CO stretching 
vibrations. The CO stretching frequencies in the α,αʹ-diaminoalkane complexes were observed 
to be at lower wavenumbers than those observed for [RpNCCH3]BF4 (2079 and 2032 cm–1). 
This is consistent with the nitrogen donor atom of the amine being more electron rich than that 
of the acetonitrile, hence the observed shift is attributed to greater charge transfer towards the 





acetonitrile. This shift is also a clear indication that acetonitrile is replaced by one of NH2 ends 
of the α,αʹ-diaminoalkanes in the reaction. The CO stretching frequencies for the complexes 3 – 
7 are lower than those reported for [Fp2NH2(CH2)nNH2](BF4)2 [49]. This is consistent with the 
ruthenium centre being more electron rich than the iron centre, hence there is increased back-
bonding to the carbonyl groups resulting in a lower ν(CO) absorption frequency. Two weak 
bands for ν(NH) were observed in the regions 3331 – 3307 cm–1 for asymmetric NH stretching 
vibrations and 3284 – 3278 cm–1 for symmetric NH stretching vibrations. The NH stretching 
frequencies for the coordinated α,αʹ-diaminoalkanes was noted to be higher than those for the 
starting α,α`-diaminoalkanes; an indication that they are coordinated to the Ru(II) center via the 
amine nitrogen. This is in agreement with the observations made for 1-
alkanaminedicarbonyl(η5-cyclopentadienyl)ruthenium(II) tetrafluoroborate  complex salts 
earlier reported [51]. A single absorption peak assignable to the C N vibration is observed in 
the region 1603 – 1611 cm–1.  
 
The NMR data for the complexes 3 – 7 recorded in acetonitrile-d3 and deuterium oxide (D2O) 
suggests that the CpRu(CO)2 units are centro-symmetrically bonded to the α,αʹ-diaminoalkane 
fragments (Fig. 1). For instance, the proton NMR data for complex 4 in acetonitrile-d3 exhibited 
a characteristic singlet peak at ca. 5.61 ppm assignable to 10H of two identical Cp anions, a 
singlet at ca. 3.65 ppm for 4H on NH2, a triplet at ca. 2.57 ppm assignable to the 4H of two 
identical α-CH2 groups positioned between β-CH2 and NH2. A multiplet assignable to 2 protons 
of the β-CH2 group was observed at ca. 1.65 ppm. The 13C NMR generally gives single signals 






















Figure 1: General structure of (µ - Alkane – α, αʹ– diamino – κ2 N : N)bis [(dicarbonyl)(η5-






3.2 Molecular structures of [Rp(CH3CN)]BF4 (1) and Rp2NH2(CH2)2NH2][BF4]2 (3) 
 
Figure 2: Structural view of complex 1 showing the atom-numbering scheme. Displacement ellipsoids 
are drawn at 50% probability level and H atoms have been omitted for clarity 
 
 
Figure 3: Structural view of the asymmetric unit of complex 3 showing half molecules and the atom-
numbering scheme. Displacement ellipsoids are drawn at 50% probability level and H atoms have been 





Crystals for compounds 1 and 3 were grown as described in Section 1.2 and used to obtain 
single crystal X-ray diffraction data. Compounds 1 and 3 crystallize as white solids in the P21/n 
space group. Compound 1 crystallizes with one [Rp(CH3CN)]+ cation and one tetrafluoroborate 
anion (Fig 2) in the asymmetric unit. Compound 3 on the other hand crystallized with three 
molecules in the asymmetric unit; two half molecules of the [Rp2NH2(CH2)2NH2]+2 cation and 
two tetrafluoroborate anions (Fig 3).  The other halves of the [Rp2NH2(CH2)2NH2]+2 cations are 
generated by an inversion symmetry on the C—C bond of the 1,2-diaminoethanes.  Both 1 and 
3 adopt a typical three-legged piano stool conformation in which the two carbonyl groups and a 
N atom of the acetonitrile (as in 1) or the diamine (as in 3) form the three legs of the stool, while 
the apical positions are occupied by the cyclopentadienyl ring completing the coordination 
around the Ru centres. The coordination around the Ru centre of 1 and 3 is similar to those 
reported for [Rp(CH3CN)]PF6 [62], [RpNH2(CH2)nCH3]+ [51] and [Rp2I]+ [64]. The two cations 
in the structure of 3 are not related by symmetry. Important bond distances and angles are 
reported in Table 2. There are no significant differences between the bond distances and angles 
of 1 and those of [Rp(CH3CN)]PF6 [62]. 
 
Table 2: Selected inter-atomic distances (Å) and angles (ᵒC) for complex 1 and 3  
Bond Parameter 1 3 (Molecule 1) 3 (Molecule 2) 
    
*Cg Ru  1.862(3) 1.866 1.872 
Ru N  2.056(2) 2.390(2) 2.147(3) 
N C  1.136(3) 1.470(4) 1.482(4) 
    
*Cg Ru N  124.93 122.25 125.20 
Ru N C  176.2(2) 116.90(2) 115.60(2) 
N C C  179.1(3) 110.90(2) 111.60(2) 
    
*Cg Ru N C 133.30 88.71 -74.03 
Ru N C C  51.00(19) -170.00(2) 177.70(2) 
N C C` N`  - 180.00(2) 180.02(2) 
Cg Ru Ru` Cg`   - 180.00 180.00 
Cg is the centroid for C1-C5 of the Cp ring 
 
Selected inter-atomic distances and angles are given in Table 2. The torsion angles 





atoms. The cyclopentadienyl ligands are trans to one another and the α,`α-diaminoethane 
ligands display a trans conformation (Fig. 4) as confirmed by the dihedral angle, 
Cg Ru Ru` Cg = 180 o and torsion angle, N C C` N` = 180 o respectively. There is no 
major difference between the Ru Cg distances in the molecules of the two polymorphs (Cg is 
the centroid of the Cp rings). The bond distances are longer than those reported for 
[Fp2NH2(CH2)2NH2](BF4)2 by about 0.1 Å [65]. The Ru Ru` distance of 7.60 Å confirms that 
the two ruthenium atoms are not bonded to each other; comparison can be made with the non-
bonded Ru Ru` distance of 3.8 Å in [RpCH2Rp] [66] and 5.12 Å in [RpCH2CH2Rp] [67]. The 
crystal structure is stabilized by N H F intermolecular interactions between the 
tetrafluoroborate anion and the cation.  
 
 
Figure 4: Complete structure of complex 3 showing trans conformation of Cp groups and 1,2-
diaminoethane in the cation with hydrogen atoms and the counter ions omitted for clarity 
 
3.3 Antimicrobial Susceptibility Tests 
 
Antimicrobial Susceptibility Tests (AST) were done for the dinuclear ruthenium(II) complexes 
3 – 6 and the mononuclear ruthenium(II) complexes 8 - 11 against six Gram-positive and five 
Gram-negative bacteria (Table 3). The activity of the complexes against the bacteria was 
compared to those of the known antibacterial drugs, tetracycline (TE30) and ampicillin 
(AMP10). Of the five dinuclear ruthenium complexes tested, only complexes 3, 5 and 6 
demonstrated good antibacterial activity against some of the bacteria tested. The 1,2-





sensitive and –resistant S. aureus, β-lactam-sensitive and –resistant E. coli and M. smegmatis 
mc2155 at 20 µg/µL. The 1,6-diaminohexane complexes [Rp2(DAH)](BF4)2 and (6) 
[Rp2(DAH)](SO3CF3)2 (5) have the same first coordination spheres and only differ by the nature 
of the counter ions, yet, the later demonstrated good activity against seven of the eleven 
bacterial strains tested (Table 3). Complex 6 demonstrated excellent antibacterial activity 
against M. smegmatis strain mc2155, a bacterial strain in the same genus as the tuberculosis 
causing bacteria, the M. tuberculosis.  The complex [Rp2(DAH)](BF4)2 (5) only displayed  good 
antibacterial activity against the Gram-positve M. smegmatis mc2155 and the two Gram-
negative E. coli strains tested. It is worth noting that the dinuclear complexes 3, 5 and 6 are 
active against the ampicillin (AMP 10)- resistant Gram-negative E.coli ATCC 35218.  
 
The mononuclear ruthenium complexes 9-11 demonstrated good antibacterial activity against a 
number of the tested bacteria, with complex 11 demonstrating very good broad spectrum 
activity against both Gram-negative and Gram-positive bacteria. Some of the complexes 
showed better activity against bacteria that are resistant to known drugs. For example, 
complexes 10 and 11 showed better activity against the ampicillin- and tetracycline-resistant 
Gram-negative K. pneumoniae ATTC 700603 and both strains of ampicillin-resistant P. 
aeruginosa tested. Complex 11 showed excellent antibacterial activity against the drug-sensitive 
E. coli ATTC 25922 and ampicillin-resistant E. coli ATTC 35218. Complexes 9 and 10 also 
showed excellent activity against the drug-sensitive E. coli ATTC 25922.  
 
Noteworthy, the antibacterial activity of the complexes increases with increase in concentration 
of the complexes. Furthermore, coordination of a ligand, with the potential to be active against 
bacteria, to a ruthenium centre triggers antibacterial activity as demonstrated by 1,2-
diaminoethane, 1,6-diaminohexane and 4-methoxybenzylamine. Even though similar 
observations have been documented for the antibacterial activity of some Cu(II), Co(II), Ni(II), 
Pd(II), and Ru(III) clomiphene complexes [68], ruthenium(II) carbonyl complexes with 
tridentate Schiff base [69] and palladium(II) and platinum(II) complexes with azomethines [70]; 
palladium(II) and platinum(II) complexes of the acetone Schiff bases of S-methyl and S-
benzyldithiocarbamate are less active than the free ligand [71]. Whereas the bacteria tested in 
this work are resistant to these ligands, they are sensitive to ruthenium complexes of the ligands. 
This is clearly shown by 4-methoxybenzylamine which does not show any antibacterial activity 
as a ligand alone, but demonstrates broad spectrum antibacterial activity against both Gram-
negative and Gram-positive bacteria when coordinated to ruthenium, as in complex 10. This is 





membrane more easily, or alternatively the mechanisms by which bacteria counter the activity 
of antibacterial molecules are not effective against the ruthenium complexes [37,72]. This 
observation may also imply that many organic molecules have the potential to kill bacteria but 
do not have the means to enter into the bacterial cell. Thus, coordination of such a molecule, 
through the nitrogen of the amine, to a ruthenium centre may activate their antibacterial activity.  
 
In general, the ruthenium complexes demonstrated antimicrobial activity against both Gram-
positive and Gram-negative bacteria. According to Li et al. [37] complexes such as 
[Ru(Me4phen)3]2+, which showed excellent activity against drug-sensitive strains were 
significantly less active against the corresponding current drug-resistant strains. The 
platinum(II) complexes of 2-acetyl pyridine thiosemicarbazone have been shown to be effective 
against Gram positive bacteria, but show no bactericidal effect on Gram negative bacteria [72].  
Noteworthy, the compounds in the present study maintained their activity against both drug-
sensitive and drug-resistant S. aureus and E. coli.  
 
4. Conclusions  
 
The new α,α`-diaminoalkane-bridged diruthenium complex salts were successfully synthesized 
and characterized. The α,α`-diaminoalkanes are coordinated to two separate ruthenium metal 
centers via the two nitrogen donor atoms. The CpRu(CO)2 units are centro-symmetrically 
bonded to the α,α`-diaminoalkane fragments. The crystal structure of the 1,2-diaminoalkane 
complex salt presents clear proof that there are no metal-metal bonds. Coordination of the 
diamines, α,α`-diaminoalkanes, and monoamines to ruthenium in the CpRu(CO)2 moiety 
triggers and/or enhances their antimicrobial activity. The trifluoromethane sulfonate counter 
anion may have augmented the antibacterial activity of the active [Rp2NH2(CH2)6NH2]2+ 
species. The antibacterial activity is directly proportional to the concentration of the complex 
salt. Activity against M. smegmatis by the 1,2-diaminoalkane and 1,6-diaminohexane ruthenium 
complexes is an indication that the complexes could be active against the TB-causing bacterium, 
Mycobacterium tuberculosis. Ruthenium appears to trigger antibacterial activity in non-
antibacterial organic amine molecules and also has the potential to augment the antibacterial 





Table 3: Antimicrobial susceptibility test results of the ruthenium complex compounds with zones of inhibition given to the nearest mm 
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[Rp2(DAH)]SO3CF3 
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0 (R) 25 (S) 0 (R) 20 (S) 0 (R) 0 (R) 
MeOBA 0 (R) 11 
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0 (R) 10 (R) 0 (R) 12 0 (R) 10 (R) 
DMSO 0 0 0  0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0  0 0 0 
Tetracycline (TE30) 36 (S)  28 (S) 36 (S) 26 (S) na 27 (S) 23 (S) 12 (R) 15 (I) 14 (R) 
Ampicillin (AMP10) 40 (S)  25 (S) 20 (S) 11 (R) na 20 (S) 0 (R) 0 (R) 0 (R) 0 (R) 
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Synthesis and characterization of new η5-cyclopentadienyldicarbonylruthenium(II) 
amine complexes: Their application as homogeneous catalysts in styrene oxidation 
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The water-soluble ruthenium(II) mononuclear complexes [CpRu(CO)2NH2R]BF4 [Cp = η5-
C5H5; R = C6H11 (1), C6H5 (2), CH2C6H5 (3), CH(CH3)C6H5 (4), CH2C6H4OCH3 (5), 
CH2C6H4CN (6), C6H2(CH3)3) (7), CH2CHCH2 (8) and CH(CH3)2 (9)] were synthesized from 
the reaction of the organometallic Lewis acid, [CpRu(CO)2]BF4, with the amine ligands at room 
temperature. These complexes are reported for the first time and have been fully characterized 
by IR, high resolution mass spectrometry, 1H and 13C NMR spectroscopy, and elemental 
analysis. Spectral data show that the amines are σ-bonded to the metal centre via the nitrogen 
atom. Crystal structures of complexes 3 and 8 were determined by single x-ray crystallography; 
they crystallize as white solids in the monoclinic space group P21/n. The 4-methoxybenzyl 
amine, 4-aminomethylbenzonitrile and allylamine preferentially bind to the metal centre via the 
amine nitrogen. The ruthenium complexes, 1, 3, 4, 5, 6, 9, [CpRu(CO)2NH2CH3]BF4 (10) and 
the dinuclear complex [CpRu(CO)2NH2(CH2)6NH2(CO)2RuCp][BF4]2 (11) demonstrated 
excellent catalytic activity in the oxidation of styrene using NaIO4 as the co-oxidant with more 
than 95 % conversion and benzaldehyde yields respectively.  
 
Keywords: cyclopentadienyl ruthenium, ruthenium(II) amine, styrene oxidation, ruthenium-






1. Introduction  
 
The development of the organometallic chemistry of ruthenium complexes is of great interest 
due to their multiple applications in many different scientific fields, ranging from biomedicine 
to catalysis [1-4]. Ruthenium complexes containing the cyclopentadienyl group have been the 
subject of investigation by many research groups during the past couple of decades because of 
their widespread applications in transition metal-catalyzed organic syntheses [5-11]. Extensive 
studies have been carried out on methods for specific catalytic oxidations of various organic 
substrates such as alcohols, amines, amides, and hydrocarbons using low-valent ruthenium 
complexes [12,13]. Oxidation catalysis represents the core of a variety of useful chemical 
processes for producing bulk and fine chemicals. One such process is the oxidation of olefins 
which can give a variety of products depending on the conditions of the reaction. Olefin 
oxidation, for example, can take place by epoxidation, dihydroxylation, vinylic and allyllic 
oxidation or C C double bond cleavage (Scheme 1). The oxidative cleaveage of a C C double 
bond involves cleaving the double bond with inclusion of oxygen into the two fragments 
forming aldehydes and/or ketones, depending on the extent of substitution. Over-oxidation of 















Scheme 1: General illustration of the oxidative cleavage of substituted alkenes 
 
Oxidative cleavage of olefinic double bonds to carbonyl compounds can be achieved by 
ozonolysis and stoichiometric oxidation processes [14-16]. It can be effected by conversion of 
olefins into 1,2-diols, followed by cleavage with NaIO4 or other co-oxidants [17], or by direct 
cleavage into a variety of functionalized products, depending on the workup conditions [18-20]. 
The direct oxidative cleavage of olefinic double bonds is largely achieved at industrial level by 
use of ozone. The large scale use of ozone for this application has major drawbacks, because of 
safety issues and the need to use expensive equipment [21]. There are relatively few alternative 
reactions that duplicate direct cleavage of olefins without formation of 1,2-diols [22,23].  
Stoichiometric amounts of some transition metal compounds have been successfully used in the 
oxidative cleavage of olefinic double bonds. KMnO4, for instance, oxidises olefins to aldehydes 




often poorly soluble in the aqueous reaction medium. Also KMnO4 cannot be used in catalytic 
amounts due to the irreversible precipitation of MnO2 after oxidation of the substrate. On the 
other hand, chromyl chloride, CrO2Cl2, [28] oxidises styrene into benzaldehyde and 
phenylacetaldehyde [29] but its use is discouraged due to the high toxicity of chromium(VI) 
salts. Osmium tetroxide, OsO4, has been successfully used in stoichiometric amounts and as a 
catalyst in the oxidation of olefins to diols and carboxylic acids, but the main drawback in its 
use is its high toxicity [30,31]. 
 
Simple ruthenium compounds, such as RuCl3.nH2O, RuO2 and RuO4, have been successfully 
used as catalysts for the direct oxidative cleavage of the olefinic double bonds to form 
aldehydes and carboxylic acids. They form a variety of reactive, high-valent oxo complexes 
with rich redox chemistry. RuCl3. nH2O, for instance, has been used as a catalyst for the 
oxidative cleavage of alkenes to acids [22,32,33]. To achieve the cleavages, NaIO4, NaOCl or 
oxone (KHSO5) were used as co-oxidants in different solvent systems. Most of the oxidative 
cleavage reactions of the olefinic double bonds gave carboxylic acids, but for the reaction where 
oxone was the primary oxidant with NaHCO3, benzaldehyde was formed [22]. Also, 
RuO2.2H2O and 2-6 equivalents NaIO4 in CCl4/H2O were used to cleave electron poor cyclic 
enolic olefins (C C bond on the β-position) to aldehydes in 35-95% yield [34].  
 
The use of catalytic amounts of ruthenium complexes in the oxidative cleavage of olefinic 
double bonds improves selectivity towards the cleavage products, while preventing side 
reactions such as epoxidation, dihydroxylation or allylic oxidation. The co-ligand coordinated to 
the metal plays a major role in improving the catalytic activity, as well as selectivity of the 
catalyst. A few ruthenium complexes, as oxidation catalysts, have demonstrated good 
selectivity, leading to the formation of C C double bond cleavage products. For example, the 
complex cis-[RuCl2(bipy)2].2H2O was reported as a good catalyst in chemoselective degradation 
of aromatic rings to acids, with NaIO4 as the co-oxidant, and oxidative cleavage of alkenes to 
acids, with IO(OH)5 as the co-oxidant, in a CCl4-MeCN-H2O biphasic solvent system [35]. The 
ruthenium complex [cis-Ru(II)(dmp)2(H2O)2]2+ (dmp = 2, 9 – dimethylphenanthroline) 
demonstrated good catalytic activity in the oxidative cleavage of terminal alkenes to aldehydes 
using H2O2 as the oxidant in acetonitrile at 55 °C [36].  Even though ruthenium complexes are 
more efficient and selective catalysts for the oxidative cleavage of alkenes to aldehydes than 
ruthenium salts and oxides, little attention has been given to their catalytic activity. There is, 
therefore, a need to synthesize ruthenium complexes with various ligands and study their 




characterization of η5-cyclopentadienyl iron and ruthenium carbonyl complexes with nitrogen-
containing species in order to develop their chemistry and also to study their catalytic and 
antimicrobial activities. The synthesis and characterization of the η5-cyclopentadienyl 
dicarbonyl iron and ruthenium complexes of n-alkanamines [37], α,ω-diaminoalkanes [38] and 
N-heterocyclic ligands (DABCO, HMTA and methyl imidazole) were reported [39,40]. 
 
We now report the synthesis of nine new water-soluble ruthenium(II) complex salts, [η5-
C5H5Ru(CO)2NH2R]Y (Y =BF4 or CF3SO3; R = C6H11 (1), C6H5 (2), CH2C6H5 (3), 
CH(CH3)C6H5 (4), CH2C6H4OCH3 (5), CH2C6H4CN (6), C6H2(CH3)3) (7), CH2CHCH2 (8) and 
CH(CH3)2 (9)) (Fig. 1), their catalytic activity and also the catalytic activity of 
[CpRu(CO)2NH2CH3]BF4 (10) and [CpRu(CO)2NH2(CH2)6NH2(CO)2RuCp][BF4]2 (11) in the 
oxidation of styrene with NaIO4. To the best of our knowledge these ruthenium complexes and 




2.1 General methods and material  
 
Standard Schlenk techniques were employed for all reactions. Chemical reagents and solvents 
were obtained from the suppliers shown in parentheses. Reagent grade Et2O (Merck) was 
distilled from sodium/benzophenone and stored over molecular sieves; dichloromethane 
(Merck) was distilled from phosphorous(V) oxide. Silver tetrafluoroborate (Alfa Aesar), 
ruthenium trichloride hydrate (DLD-Aldrich), dicyclopentadiene (Aldrich), cyclohexylamine, 
aniline, benzylamine, α-methylbenzylamine, 4-methoxybenzylamine, trimethylamine, 
allylamine (Merck), carbon monoxide (AFROX) and iodine (Unilab) were used as supplied. 4-
Aminomethylbenzonitrile was obtained from 4-aminomethylbenzonitrile hydrochloride (Merck) 
by neutralization using a stoichiometric amount of aqueous sodium hydroxide. Nitrogen gas 
(AFROX) was dried over phosphorus(V) oxide. Melting points were recorded on a Stuart 
Scientific melting point apparatus SMP3 and are uncorrected. Elemental analyses were 
performed on a Thermo-Scientific Flash 2000 CHNS/O analyser. Solid state infrared spectra 
were recorded using an ATR Perkin Elmer Spectrum 100 spectrophotometer between 4000 and 
400 cm–1. NMR spectra were recorded on Bruker Topspin 400 and 600 MHz spectrometers. The 
deuterated solvents CDCl3 (Aldrich, 99.8%), DMSO, CD3CN (Merck) and D2O (Aldrich) were 
used as purchased. Solutions for NMR spectroscopy were prepared under nitrogen using 
nitrogen-saturated solvents. The high resolution mass spectra for compounds 3, 5 and 6 were 




methanol. The precursors Ru3(CO)12 [41], [CpRu(CO)2]2 (Cp = η5-C5H5) [42], CpRu(CO)2I 
[43], [Cp(CO)2Ru]BF4 [44]  and [Cp(CO)2RuNCCH3]BF4 [45] were prepared by literature 
methods. The complexes in this work were synthesized by a modification of the method 
reported for the synthesis of the η5-cyclopentadienyldicarbonylruthenium(II) n-alkanamine 
complex salts [37]. The ruthenium complexes 10 and 11 used for the catalytic study in this work 





























































2.2 Synthesis of the complex salts [CpRu(CO)2NH2R]BF4 
 
2.2.1 Cyclohexylamine complex salt, [CpRu(CO)2NH2C6H11]BF4, ([RpCHA]B, 1) 
 
CpRu(CO)2I (0.1638 g; 0.4692 mmol), silver tetrafluoroborate (0.1261 g; 0.6478 mmol) and a 
magnetic stirrer bar were placed in a Schlenk tube wrapped in aluminium foil. The mixture was 
evacuated under reduced pressure for 3 h. Dichloromethane (DCM) (20 mL) was added and the 
mixture stirred for 1½ h. A white precipitate and orange mother liquor formed. The mother 
liquor was transferred into a clean Schlenk tube by canula filtration and a slight excess of 
cyclohexylamine (0.0820 g; 0.8268 mmol) added while stirring. The mother liquor immediately 
turned to pale yellow. The mixture was stirred for 4 h at room temperature, left to stand for ½ h 
and then canula-filtered under reduced pressure into a Schlenk tube. The solvent was completely 
removed by evaporation under reduced pressure leaving a greyish white solid. Acetonitrile (2 
mL) was added to the solid to extract the complex salt. The solution was left to stand for ½ h 
and then filtered into a pre-weighed Schlenk tube. Diethyl ether (10 mL) was added, the mixture 
shaken and left to stand for 2 h. A white flaky precipitate formed, the mother liquor was filtered 
and the precipitate dried under reduced pressure. Yield: 0.1428 g, 74%; Melts at 188.8-189.2 
°C. Anal. Found (calculated) for C13H18BF4NO2Ru; C, 38.15 (38.25); H, 4.52 (4.45); N, 3.39 
(3.43)%. IR (solid state): νmax/cm–1 2056 and 1999 (CO); 2953 and 2917 (CH3); 3295 and 3264 
(NH2). 1H NMR (400 MHz, CDCl3): δ 5.60 (s, 5H, Cp), 3.70 (s, 2H, NH2), 2.00 (m, 1H, C-1), 
1.76 (m, 2H, C-2,6), 1.59 (m, 2H, C-2,6; 2H C-4), 1.23 (m, 4H, C-3,5). 13H NMR (400 MHz, 
CDCl3): δ 195.94 (CO), 87.94 Cp), 59.90 (C-1), 33.71 (C-2,6), 24.59 (C-4), 24.23 (C-3,5).  
 
2.2.2 Phenylamine complex salt, [CpRu(CO)2NH2C6H5]BF4, ([RpPhA]B, 2) 
 
CpRu(CO)2I (0.1240 g; 0.3552 mmol) and a slight excess of silver tetrafluoroborate (0.0892 g; 
0.4582 mmol) were dried, dissolved in DCM (15 mL) and treated as described in Section 2.2.1. 
Excess of phenylamine (0.0621 g; 0.6668 mmol) was added to the filtrate obtained and the 
mixture stirred for 8 h at room temperature. The rest of the procedure was performed as 
described in Section 2.2.1 to give a white solid. Yield: 0.0845 g, 58%; Melts at 116.8-117.6 °C. 
Anal. Found (calculated) for C13H12BF4NO2Ru; C, 37.92 (38.83); H, 3.16 (3.01); N, 3.51 
(3.48)%. IR (solid state): νmax/cm–1 2050 and 1992 (CO); 3310 and 3274 (NH2).  1H NMR: (400 
MHz, CD3CN) δ 7.53-7.37 (m, 5H, C6H5), 5.68 (s, 5H, Cp), 4.41 (s, 2H, NH2). 13C NMR: (400 






2.2.3 Benzylamine complex salt, [CpRu(CO)2NH2CH2C6H5]BF4, ([RpBA]B, 3) 
 
CpRu(CO)2I (0.1760 g; 0.5042 mmol) and AgBF4 (0.1276 g; 0.6555 mmol) were placed in a 
Schlenk tube wrapped with aluminium foil and treated as described in Section 2.2.1. Excess 
benzylamine (0.0992 g; 0.9265 mmol) were added to the resulting orange filtrate and the 
mixture treated as described in Section 2.2.2 above to give a white solid. Yield: 0.0928 g, 44%; 
Melts at 136.7-137.6 °C. Anal. Found (calculated) for C14H14BF4NO2Ru; C, 40.37 (40.41); H, 
3.34 (3.31); N, 3.35 (3.37)%. M+, 330.007 (330.0068). IR (solid state): νmax/cm–1 2052 and 1986 
(CO); 3325 and 3286 (NH2). 1H NMR: (400 MHz, CD3CN) δ 7.41-7.33 (m, 5H, C6H5), 5.60 (s, 
5H, Cp), 4.04 (s, 2H, NH2), 3.78 (t, 2H, CH2). 13C NMR: (400 MHz, CD3CN) δ 195.57 (CO), 
138.27 (C-CH2), 128.57-128.12 (C6H5), 87.73 (Cp), 57.27 (CH2). 
 
2.2.4 ( )-α-Methylbenzylamine complex salt, [CpRu(CO)2NH2(CH)CH3C6H5]BF4 
([RpMBA]B, 4) 
 
CpRu(CO)2I (0.0953 g; 0.2730 mmol) and a slight excess of AgBF4 (0.0701 g; 0.3601 mmol) 
were placed in a Schlenk tube wrapped with aluminium foil and treated as described in Section 
2.2.1. Excess ( )-α-methylbenzylamine (0.0658 g; 0.5430 mmol) was added to the resulting 
orange solution and the mixture treated as described in Section 2.2.2 above to give a white solid. 
Yield: 0.0673 g, 57%; Melts at 170.1-170.7 °C. Anal. Found (calculated) for C15H16BF4NO2Ru; 
C, 41.79 (41.88); H, 3.78 (3.75); N, 3.25 (3.26)%. IR (solid state): νmax/cm–1 2054 and 1995 
(CO); 3301and 3266 (NH2). 1H NMR: (400 MHz, CD3CN) δ 7.45-7.33 (m, 5H, C6H5), 5.45 (s, 
5H, Cp), 4.28(s, 1H, NH2), 4.01 (s, 1H, NH2), 3.66 (m, 1H, CH), 1.49 (d, 3H, CH3). 13C NMR: 
(400 MHz, CD3CN) δ 195.66 (CO), 195.59 (CO), 141.99 (C-CH), 128.74 (C-ortho), 127.03 (C-
para), 129.14 (C-meta), 87.97 (Cp), 87.95 (Cp), 61.91 (CH2), 23.99 (CH3).  
 
2.2.5 4-Methoxybenzylamine complex salt, [CpRu(CO)2NH2CH2(C6H4)OCH3]BF4 
([RpMeOBA]B, 5) 
 
CpRu(CO)2I (0.0700 g; 0.2005 mmol) and a slight excess of AgBF4 (0.04893 g; 0.2513 mmol) 
were placed in a Schlenk tube wrapped with aluminium foil and treated as described in Section 
2.2.1. Excess 4-methoxybenzylamine (0.1213 g; 0.8842 mmol) was added to the resulting 
orange filtrate and stirred for 6 h. The resulting pale yellow solution was treated as described in 
Section 2.2.2 to give a white solid. Yield: 0.0508 g, 57%; Melts at 174.9-175.6 °C. Anal. Found 




M+ 360.0172 (360.0174). IR (solid state): νmax/cm–1 2053, 2001 and 1974 (CO), 3306 and 3271 
(NH2). 1H NMR: (400 MHz, CDCl3) δ 5.44 (s, 5H, Cp), 4.22 (s, 2H, NH2), 7.25 (d, 2H, =oCH ), 
6.86 (d, 2H, =mCH), 3.64 (t, JHH = 7.04 Hz, 2H, NCH2), 3.75 (s, 3H, OCH3). 13C NMR: (400 
MHz, CDCl3) δ 195.14 (CO), 87.84 (Cp), 130.52 (C-CH2), 129.45 (oCH), 114.55 (mCH), 160.1 
(C-pOCH3), 56.29 (C-NH2), 55.24 (OCH3).  
 
2.2.6 4-Aminomethylbenzonitrile complex salt, [CpRu(CO)2NH2CH2(C6H4)CN]BF4 
([RpAMBN]B, 6) 
 
CpRu(CO)2I (0.160 g; 0.4583 mmol), AgBF4 (0.1181 g; 0.6067 mmol) and a stirrer bar were 
placed in a Schlenk tube wrapped with aluminium foil and treated as described in Section 2.2.1. 
Excess 4-aminomethylbenzonitrile (0.1175 g; 0.8893 mmol) was dissolved in tetrahydrofuran 
(10 mL), added to the filtrated and the mixture stirred for 4 h. The mother liquor was filtered 
into a clean Schlenk tube by use of a canula. The solvent was completely removed by 
evaporation under reduced pressure leaving a pale yellow oil. Acetonitrile (2 mL) was added to 
the oil, the solution left to stand for ½ h and then filtered into a pre-weighed Schlenk tube. 
Diethyl ether (10 mL) was added to the filtrate, the mixture shaken and a white suspension 
appeared. The mixture was left undisturbed for 12 h. Shiny white crystals formed. The crystals 
were separated from the mother liquor and dried under reduced pressure. Yield: 0.1208 g, 59%; 
Melts at 177.2 – 178.0 °C. Anal. Found (calculated) for C15H13BF4N2O2Ru; C, 40.82 (40.84); H, 
3.01 (2.97); N, 6.28 (6.35)%. HRMS: M+ 355.0024 (355.0021). IR (solid state): νmax/cm–1 2061 
and 2006 (CO); 2229 (C8-N); 3306 and 3271 (NH2). 1H NMR: (400 MHz, DMSO) δ 7.90 (d, 
2H, mCH), 7.59 (d, 2H, oCH), 5.81 (s, 5H, Cp), 5.37 (s, 2H, NH2), 3.78 (s, 2H, CH2). 13C NMR: 
(400 MHz, DMSO) δ 196.64 (CO), 144.41 (C-CH2), 132.41 (mCH), 129.29 (oCH), 118.64 
(CN), 110.61 (C-CN), 88.60 (Cp), 56.28 (C-7).  
 
2.2.7 2,4,6-Trimethylaniline complex salt, [CpRu(CO)2NH2(CH3)3C6H2]BF4 ([RpTMA]B, 7) 
 
CpRu(CO)2I (0.0728 g; 0.2085 mmol) and AgBF4 (0.0598 g; 0.3072 mmol) were placed in a 
Schlenk tube wrapped with aluminium foil and treated as described in Section 2.2.1. Excess 
2,4,6-trimethylaniline (0.0246 g; 0.4164 mmol) were added to the resulting orange filtrate and 
the mixture treated as described in Section 2.2.2 to give a white solid. Yield: 0.0571 g, 62%; 
Decomposes at temperatures above 188 °C. Anal. Found (calculated) for C16H18BF4NO2Ru; C, 
43.24 (43.26); H, 4.05 (4.08); N, 3.17 (3.15)%. IR (solid state): νmax/cm–1 2049, 1987 and 1953 




2H, NH2), 2.29 (s, 3H, p-CH3), 2.19 (s, 6H, o-CH3). 13C NMR: (400 MHz, CDCl3) δ 194.87 
(CO), 140.98 (C-NH2), 135.28 (C-pCH3), 130.19 (CH), 126.63 (C-oCH3), 88.08 (Cp), 20.56 (p-
CH3), 17.50 (o-CH3).  
 
2.2.8 Allylamine complex salt, [CpRu(CO)2NH2CH2CHCH2]BF4 (8) 
 
To a solution of [CpRu(CO)2NCCH3]BF4 (0.1214 g; 0.3468 mmol) in DCM (20 ml), allylamine 
(0.0349 g; 0.6111 mmol) was added drop wise at room temperature and stirred for 12 h. The 
resulting pale yellow solution was evaporated to dryness and the product extracted with 
acetonitrile (5 mL). The mixture was filtered and the volume of filtrate reduced to about 2 mL. 
Diethyl ether (10 mL) was added to the extract and a white precipitate formed. Filtration, 
followed by drying of the residue under reduced pressure gave a white solid. Yield: 0.0874 g, 
72%. Decomposes at temperature > 120 ˚C Anal. Found (calculated) for C10H12BF4NO2Ru; C, 
32.84 (32.81); H, 3.29 (3.30); N, 3.81 (3.83)%. IR (solid state): νmax/cm–1 2059, 2016 (CO): 
3315, 3280 cm–1 (NH2). 1H NMR: (400 MHz, CDCl3) δ 5.88 (m, 1H, C-β); 5.60 (s, 5H, Cp); 
5.42 (d, 1Ha, C-γ trans); 5.27 (d, 1Hb, C-γ cis); 3.79 (s, 2H, NH2); 3.30 (q, 2H, C-α). 13C NMR: 
(400 MHz; CDCl3) δ 196.00 (CO); 135.17 (C-β), 118.57 (C-γ); 88.04 (Cp); 55.97 (C-α).  
 
2.2.9 Isopropylamine complex salt, [CpRu(CO)2NH2CH(CH3)2]BF4 ([RpiPrA]B, 9) 
 
CpRu(CO)2I (0.0982 g; 0.2813 mmol) and AgBF4 (0.0602 g; 0.3092 mmol) were placed in a 
Schlenk tube wrapped with aluminium foil and treated as described in Section 2.2.1. Excess 
isopropylamine (0.0325 g; 0.5498 mmol) were added to the resulting orange solution and the 
mixture treated as described in Section 2.2.2. A white solid was formed. Yield: 0.0792 g, 77%; 
Decomposes at temperatures above 188 °C. Anal. Found (calculated) for C10H18BF4NO2Ru; C, 
32.64 (32.63); H, 3.81 (3.83); N, 3.79(3.81)%. IR (solid state): νmax/cm–1 (CO) 2058, 2018 and 
2002; 3331 and 3293 (NH2). 1H NMR: (400 MHz, DMSO) δ 5.80 (s, 5H, Cp), 4.80 (s, 2H, 
NH2), 2.58 (m, 1H, CH), 1.08 (d, 6H, CH3). 13C NMR: (400 MHz, DMSO) δ 196.00 (CO); 






2.3 X-ray crystal structure determination of compounds 3 and 8 
 
Table 1: Crystal data and structure refinement for compounds 3 and 8 
 Compound 3 Compound 8 
Identification code  13bo_hbf_ne6_0m 13ub_hbf_ne7_0m 
Empirical formula  C14H14BF4NO2Ru C10 H12 B F4 N O2 Ru 
Formula weight  416.14 366.09 
Temperature  173(2) K 173(2) K 
Wavelength  0.71073 Å 0.71073 Å 
Crystal system  Monoclinic Monoclinic 
Space group  P21/n P 21/n 
 
Unit cell dimensions  
(Å, °) 
a = 10.4488(3)  α = 90 a = 8.7303(3)  α = 90 
b = 9.7788(4)  β = 99.2360(10) b = 9.7841(3)  β = 91.5250(10) 
c = 31.7901(11)  γ = 90 c = 15.4342(5)  γ = 90 
Volume 3206.10(19) Å3 1317.89(7) Å3 
Z 8 4 
Density (calculated) 1.724 Mg/m3 1.845 Mg/m3 
Absorption coefficient 1.025 mm-1 1.232 mm-1 
F(000) 1648 720 
Crystal size 0.39 x 0.28 x 0.14 mm3 0.360 x 0.250 x 0.240 mm3 
Theta range for data 
collection 
1.98 to 28.45°. 2.465 to 28.307°. 
Index ranges -13 h 14, -11 k 13, -42 l 42 -11 h 11, -12 k<=13, -20 l 20 
Reflections collected 40725 25223 
Independent reflections 8054 [R(int) = 0.0185] 3282 [R(int) = 0.0242] 
Completeness to theta = 
25.00° 
99.9 %  100.0 %  
Absorption correction Semi-empirical from equivalents Semi-empirical from equivalents 
Max. and min. 
transmission 
0.8698 and 0.6907 0.744 and 0.698 
Refinement method Full-matrix least-squares on F2 Full-matrix least-squares on F2 
Data / restraints / 
parameters 
8054 / 0 / 415 3282 / 0 / 180 
Goodness-of-fit on F2 1.090 1.050 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0238, wR2 = 0.0546 R1 = 0.0195, wR2 = 0.0455 
R indices (all data) R1 = 0.0259, wR2 = 0.0557 R1 = 0.0223, wR2 = 0.0475 




Crystals of compounds 3 and 8 suitable for single crystal X-ray diffraction studies were grown 
by the liquid diffusion method. A solution of each of the compounds 3 and 8 in acetonitrile were 
layered with a fourfold volume of diethyl ether and allowed to stand undisturbed in the dark at 
room temperature for 24 hours to give white crystals. Crystals of compounds 3 and 8 were 
selected and glued onto the tip of glass fibres separately. The crystals were then mounted in a 
stream of cold nitrogen at 100(1) K and centred in the X-ray beam using a video camera. The 
rest of the manipulations were done as per the literature method [47]. Crystal data and structure 
refinement information for compounds 3 and 8 are summarized in Table 1 
 
2.4 Catalytic studies 
 
In a typical experiment, a known amount of the co-oxidant was placed in a dry Schlenk tube 
equipped with a magnetic stirrer bar under an atmosphere of nitrogen. Deionised water (3 mL) 
was added and the mixture stirred at a selected temperature until the co-oxidant dissolved 
completely (where applicable). The η5-cyclopentadienyldicarbonylruthenium(II) amine complex 
and acetonitrile (3 mL) were added and the mixture stirred until all the ruthenium complex had 
dissolved. Styrene (0.478 mmol) and the internal standard, benzophenone (0.478 mmol), were 
added to the mixture in the Schlenk tube, stirred for 1 min and then sampled for gas 
chromatography (GC) analysis. The stirring was continued and the progress of the reaction 
monitored hourly by GC. The complex [CpRu(CO)2NH2C6H11]BF4 (1) was used as the model 
catalyst for optimization of the catalytic conditions. Its catalytic activity was investigated at 
room temperature (22 °C), 40 °C and 60 °C; with different co-oxidants at 60 °C; with different 
concentrations of NaIO4 at 60 °C; in different solvent systems at 60 °C using the best co-
oxidant; and in different reaction media (acidic – H2SO4, basic – K2CO3 and N-
methylmorpholine, or neutral). The effect of varying the catalyst concentration on conversion 
and yield was also investigated under the chosen conditions using 0.5, 1.5 and 2.5 mol% 
complex 1. The catalytic activity of the ruthenium complexes 1–6 and 9 were examined and 
compared at the optimized conditions. The percentage yield of benzaldehyde was calculated on 
the basis of the GC analysis with benzophenone as the internal standard. The time taken to 
achieve the highest conversion and benzaldehyde yield is given for each reaction, as presented 
in the bar graphs in Section 3.3. Best reaction conditions chosen were 0.478 mmols styrene, 3 
equiv. NaIO4, CH3CN:H2O (1:1; 6 mL) at 60 °C; any changed parameter is stated for each 





3. Results and discussion  
 
3.1 Synthesis and Characterization 
 
The mononuclear complexes [CpRu(CO)2NH2R]BF4 [Cp = η5-C5H5; R = C6H11 (1), C6H5 (2), 
CH2C6H5 (3), CH(CH3)C6H5 (4), CH2C6H4OCH3 (5), CH2C6H4CN (6), C6H2(CH3)3) (7), 
CH2CHCH2 (8) and CH(CH3)2 (9)] were formed in fairly good yield from the reaction of the 
organometallic Lewis acid, [CpRu(CO)2]BF4, with the respective amines at room temperature. 
The complexes form white, air-stable crystals which are generally soluble in polar solvents such 
as water, methanol, acetone, acetonitrile and dimethylsulfoxide, and in chlorinated solvents, 
chloroform and methylene chloride in some cases. They are insoluble in non-polar solvents, 
such as hexane and diethyl ether. The elemental analyses and high resolution mass spectrometry 
results for the complexes correlate with the calculated values; an indication that the complexes 
were formed as predicted. 
 
The 1H NMR data for the complexes was obtained and peaks were assigned using 2D NMR, as 
well as D2O tests for the amine protons. The 1H NMR spectra for the complexes in CDCl3, 
CD3CN and D2O showed a sharp singlet peak in the region ca. 5.60 - 5.75 ppm, assignable to 
the five equivalent Cp protons. This is an indication that the ligands in complexes 5, 6 and 8, 
which have two possible coordination sites, bonded to the metal centre via only one of the sites. 
Coordination to both sites would have shown a single peak in the same region ca. 5.60 – 5.75 
ppm but assignable to 10 protons for the Cp peaks in the 1H NMR spectrum. Regioselective 
coordination of the metal to the NH2 is clearly indicated by the downfield shift in the amine 
proton peaks, in the 1H NMR spectra of compounds 5, 6 and 8, relative to those of the 
uncoordinated ligands. For the complexes 1, 8 and 9, a singlet peak in the 1H NMR spectra 
obtained in CDCl3 was observed at ca. 3.70, 3.79 and 3.78 ppm respectively, and assigned to the 
two amine protons. The amine proton signals in the complexes were observed more downfield 
than those of the free ligand peaks (approx. 2 ppm), probably due to the de-shielding by the 
metal centre; an indication of coordination of the amines to the metal centre through the N atom 
[37]. Hydrogen bonding between the amine group protons and the fluoride atoms of the 
tetrafluoroborate counter anion can also contribute to the downfield shift of the amine protons in 
the 1H NMR spectra. The amine proton peaks for complexes 2, 3, 5, 6 and 7 were observed 
more downfield than in 1, 8 and 9 due to the electron withdrawing effect of the aromatic ring. It 
is worth noting that, whereas the amine group proton peak for the free ligand in complex 4 was 
observed as singlet peak at ca. 1.59 ppm, two singlet peaks were observed at ca. 4.28 and 4.01 




protons are diastereotopic. The reason only one NMR signal is observed for the NH2 protons in 
the free amine is rapid inversion on the N centre, which, cannot happen when the amine is 
coordinated to Ru. The 1H NMR spectrum of complex 8 shows well resolved characteristic 
olefinic peaks; a multiplet peak assignable to the single proton attached to the β-carbon atom 
was observed at ca. 5.88 ppm and two doublets observed at ca. 5.42 and 5.27 ppm, each 
integrating for 1 proton, assignable to the two non-equivalent protons, Ha and Hb respectively, 
on the γ-carbon atom (Fig. 2). These values are within the range reported for the analogous iron 
complexes [39]. The protons on the α-carbon atom exhibited a quartet at ca. 3.30 ppm, a 
downfield shift by 0.35 ppm from that reported for the iron complex analogue [39].  
 
The 13C NMR spectra of the complexes show two peaks at ca. 87.8 and 195.7 ppm, 
corresponding to the five equivalent Cp carbons and two identical carbonyls, respectively. 
Unlike the rest of the complexes, the 13C spectrum of complex 4 shows two Cp peaks at 87.97 
and 87.95 ppm and two CO peaks at 195.99 and 195.59 ppm. This is a further indication that the 
Cp as well as CO ligands are diastereostopic. The 13C NMR spectrum of 8 clearly show peaks 















Figure 2: structure of 3-aminopropyl-1-ene (allylamine) ruthenium complex, 8 
 
The IR spectra of the complexes 1-9 showed ν(CO) absorption bands in the expected region for 
terminal carbonyl groups for amine coordinated metal complexes [37,39,40,47]. The ν(CO) 




the asymmetric CO stretching vibrations and one at ca. 2016 - 1987 cm–1 for symmetric CO 
stretching vibrations. It is worth noting that the symmetric CO stretching frequency for the 
cyclohexylamine complex 1 is lower than those observed for the complexes 2 – 7, which have 
the phenyl ring as a substituent of the amine group. This can be attributed to the fact that the 
cyclohexyl group, a strong electron donor, increases electron density at the ruthenium centre 
from the amine sigma donation. The electrons are thus passed to the CO π* orbital and reflected 
in a decreased νCO stretching frequency, which corresponds to weaker CO bonds. The 
symmetric νCO stretching frequency for complex 6 is greater than for complex 5, probably 
because the nitrile group substituent in the para position of the phenyl ring in 6 is electron 
withdrawing, while the methoxy group, a para-substituent in the phenyl ring in complex 5, is 
electron donating.  
 
The IR spectra also show two characteristic absorption bands in the regions ca. 3325 – 3270 cm–
1 and 3293 – 3264 cm–1 which correspond to the NH2 asymmetric and symmetric peaks 
respectively. These bands are found at lower wavenumbers than for the uncoordinated ligands, 
due to coordination of the amine functionality to the metal centre and likely due to the 
participation of the NH2 protons in hydrogen bonding. 
 
3.2 Molecular Structure of complexes 3 and 8 
 
Single crystal X-ray diffraction was used to determine the molecular structures of complexes 3 
and 8. They crystallize as white solids in the monoclinic space group P21/n.  Complex 3 has two 
cationic molecules, [CpRu(CO)2C6H5CH2NH2]+, and two counter-anions, BF4–, in its 
asymmetric unit, while complex 8 has one cationic molecule, [CpRu(CO)2CH2CHCH2NH2]+, 
and one counter anion in its asymmetric unit. The molecular diagrams of the complexes are 
provided in Figs. 3 and 4, while Table 4 gives a comparison of important bond distances and 
angles. 
 
Table 4: Selected inter-atomic distances (Å) and angles (ᵒC) for complex 3 and 8 
Bond Parameter 3 (Molecule 1) 3 (Molecule 2) 8 
    
*Cg Ru  1.866 1.867 1.870 
Ru N  2.146(1) 2.138(2) 2.140(1) 




Bond Parameter 3 (Molecule 1) 3 (Molecule 2) 8 
NC C  1.506(3) 1.505(3) 1.492(3) 
C C     1.316(3) 
Benzene ring C C 1.393(3), 1.377(3) 1.389(3), 1.386(3)   
1.392(3), 1.374(4) 1.387(3), 1.380(3)   
1.394(3), 1.373(3) 1.389(3), 1.382(3)   
    
*Cg Ru N  122.68 122.84 124.11 
Ru N C  118.9(1) 119.4(1) 115.60(2) 
N C C  112.3(2) 113.0(2) 113.1(1) 
    
*Cg Ru N C 150.10 162.57 71.40 
Ru N C C  173.4(1) 176.1(1) 179.3(1) 





Figure 3: The molecular structure of complex 3 showing the atomic numbering scheme. Displacement 





Figure 4: The molecular structure of complex 8 showing the atomic numbering scheme. Displacement 
ellipsoids are drawn at the 50% probability level and H atoms are not shown 
 
In both cases, the amine ligands are linked to the ruthenium centre of the CpRu(CO)2 moieties 
via the nitrogen atoms by sigma bonds giving distorted octahedral coordination geometries 
around the ruthenium centres; with the Cp ligand occupying three sites, while the remaining 
three sites are occupied by the two carbonyl ligands and the amine. Ruthenium is, therefore, 
coordinated in the known “pseudo-octahedral three-legged piano-stool” fashion with the Cp 
ligand occupying the apical position of the stool (Figs. 3 and 4).   The Ru N bond lengths for 
the two complexes are almost equal and are comparable to similar Ru N bond lengths 
previously reported for η5-cyclopentadienyldicarbonylruthenium(II) n-alkanamine complexes, 
2.139(1) Å for [CpRu(CO)2NH2CH2CH3]BF4, 2.1406(12) Å for 
[CpRu(CO)2NH2(CH2)2CH3]BF4 and 2.139(1)  Å for [CpRu(CO)2NH2(CH2)3CH3]BF4 [37]. As 
is expected, due to the larger ionic radius of ruthenium, the Ru N and Cg Ru (Cg is the 
centroid of the Cp rings) bonds lengths in complex 8 are greater than those reported for the 
analogous iron complex CpFe(CO)2NH2CH2CHCH2]BF4, Cg Fe (1.715) Å and Fe N (2.018) 
[39]. The coordinated allylamine bond lengths (N C (1.484(8)), C Callyl (1.498(8)) and C C 
(1.300(9)) Å) in the iron complex are comparable to those found for complex 8. This implies 
that the metal center does not affect the bond lengths within the allylamine ligand. As 




allylamine coordinated to the ruthenium center is slightly shorter than the formal C C double 
bond (1.34 Å) [40,48]; but comparable with the calculated distances for a terminal C C bond; 
1.315 Å for ethylene, 1.316 Å for propene and 1.321 Å for 2-methylpropene [49]. It is worth 
noting that the C C bond lengths in the phenyl ring for the two independent cationic molecules 
in the asymmetric unit of complex 3 are comparable to the actual bond lengths in the benzene 
ring (1.39 Å). The phenyl ring C C bond lengths in the two molecules of complex 3 are not the 
same (Table 8). Alternate C C bond distances in molecule 1 of complex 3 differ from one 
another by about 0.018 Å, while those in molecule 2 differ by about 0.005 Å. The bond angles 
of complex 3 and 8 are comparable to each other and to those of the earlier reported η5-
cyclopentadienyldicarbonyliron(II) allylamine complex; Fe N C (117.0(3)) Å, Cg Fe N 
(123.4) Å and N C Callyl (112.3(4) Å) [39] and η5-cyclopentadienyldicarbonylruthenium(II) 
amine complexes; Cg Ru N (122.92 – 124.08 Å), Ru N C (113.2 – 118.53 Å) [37]. Figures 
5 and 6 show crystal packing diagrams for complexes 3 and 8 respectively. 
 
 
Figure 5: Crystal packing of complex 3, as viewed along b-axis, showing hydrogen bonds and other 
intermolecular interactions 
 
In the crystal structure of complex 3, the cations are directly linked together by Cp ring carbon 
and hydrogen atoms interacting with oxygen atoms of the neighbouring cationic molecule; 
C O and H O (Fig. 5), while the cations and anions are linked by hydrogen bonds (N H F), 
as well as C(C6H5) H B,  C H F, O C F, N H. . .B and C(Cp) H B. In complex 8, the 
cations mainly interact with one another through the tetrafluoroborate anions via N H F, 





Figure 6: Crystal packing of complex 8, as viewed along a-axis, showing hydrogen bonds and other 
intermolecular interactions 
 
3.3 Catalytic oxidation of styrene 
 
Oxidative cleavage of the olefinic carbon-carbon bond in styrene has been achieved in excellent 
conversions and benzaldehyde yields using sodium periodate (NaIO4) as the co-oxidant and η5-
cyclopentadienyldicarbonylruthenium(II) complexes as catalysts. Acetonitrile/water (1:1 v/v; 6 
mL) was selected as the solvent system, because of the need to have all the reagents and 
catalysts in the same phase. The solubility of the substrate and oxidant and, hence, homogeneity 
of the system depends on temperatures higher than room temperature. 
 
At room temperature, 22 °C, and a temperature of 40 °C, over 99% conversion and 90% 
benzaldehyde yield is achieved in 18 and 17 h respectively (Fig. 7). At 60 °C, a temperature at 
which a homogeneous mixture is obtained, over 99% conversion, 85% benzaldehyde and 2% 
styrene oxide yields are achieved in 3 h. The temperature of 60 °C was chosen for all catalytic 






Figure 7: Effect of temperature on the conversion and yield for the ruthenium complex-catalyzed 
oxidation of styrene; Reaction conditions: 0.478 mmols styrene, 3 equiv. NaIO4, 2.5 mol% [RpCHA]B, 
CH3CN:H2O (3 mL:3 mL). Time to achieve highest conversion is given in hours  
  
The oxidative cleavage of styrene with 3 equivalents NaIO4 in the absence of the ruthenium 
complexes affords 32% conversion and 21% benzaldehyde yield in 10 h, while in the presence 
of 2.5 mol % of the ruthenium complexes, the conversion and benzaldehyde yield rises to 99 % 
and 85% respectively in 3 h (Fig 8). This is a clear indication that the ruthenium complexes 
reported herein are effective catalysts for the oxidative cleavage of the olefinic carbon-carbon 

















































Figure 8: Effect of catalyst concentration on the oxidative cleavage of the olefinic double bond in 
styrene. Reaction conditions: 0.478 mmols styrene, 3 equiv. NaIO4, CH3CN:H2O (1:1; 6 mL) at 60 °C. 
Time taken to achieve highest conversion is given in hours  
It was noted that the conversion and yield, and the time needed for the reaction to go to 
completion, is proportional to the amount of the co-oxidant used. Studies done on the effect of 
co-oxidant concentration on the reaction progress indicate that an excess of the co-oxidant is 
necessary for the reaction to give 100 % conversion (Fig. 9). This observation augments the step 
in the proposed mechanism where the intermediate product, the metal diether, requires ‘oxygen’ 
to form the benzaldehyde (Scheme 3). Hence, 3 equivalents NaIO4 were selected as the 
optimum amount of oxidant suitable for the process. 
 
The use of hydrogen peroxide and K2S2O8 as co-oxidants in the oxidation of styrene in the 
presence of the ruthenium complex catalysts was compared with NaIO4. It was observed that 
NaIO4 gave excellent conversion and yield under the reaction conditions to afford 
benzaldehyde. Hydrogen peroxide as an oxidant gave good conversion (86 %) but very low 
yields of benzaldehyde (23 %) and styrene glycol (9 %) in 18 h (Fig. 10). The rest of the 
product was confirmed to be benzoic acid, an indication that over-oxidation of benzaldehyde 
had taken place. The styrene glycol is probably formed as an intermediate product which is 
eventually oxidized to benzaldehyde [50]. The reaction with K2S2O8 as an oxidant, for the 



































NaIO4 was thus retained as the best primary oxidant for the oxidative cleavage of the olefinic 
C C bond. 
 
 
Figure 9: Effect of NaIO4 concentration on the % conversion and % benzaldehyde yield for the 
ruthenium complex-catalyzed oxidation of styrene. Reaction conditions: 0.478 mmols styrene, x equiv. 
NaIO4, 2.5 mol% [RpCHA]B, CH3CN:H2O (3 mL:3 mL) at 60 °C. Time taken to achieve highest 



























































Scheme 3: Proposed mechanism for the ruthenium(II) complex-based catalyzed oxidation of styrene [50] 
 
The effect of basic, acidic and neutral conditions on the catalytic oxidation of styrene was 
investigated and revealed that the conversion of styrene is highest under neutral and acidic 
conditions (Fig. 11). This implies that a base is not suitable, while an acid is not essential for the 
reaction to proceed to completion. Thus, the environmentally more friendly neutral condition 






Figure 10: Oxidation products from different oxidants for the ruthenium complex-catalyzed oxidation of 
styrene. Reaction conditions: 0.478 mmols styrene, 3 equiv. oxidant, 2.5 mol% [RpCHA]B, CH3CN/H2O 
(3 mL:3 mL) at 60 °C. Time take to achieve highest conversion is given in hours 
 
Investigations on varying the amount of catalyst used for the reaction to go to completion 
indicated that the time taken decreases with increase in mol% catalyst used (Fig. 8). Once 100 
% styrene conversion is achieved, the reaction mixture changes colour from colourless to 
orange. The catalyst present in the mixture at the end of the reaction was shown to have the 
ability to catalyze the oxidation of fresh styrene to give 100 % conversion and more than 99 % 
benzaldehyde yield. Furthermore, complete conversion was achieved within a shorter time with 
the ‘re-used’ catalyst than when fresh catalyst was used.  This may imply that the η5-
cyclopentadienyldicarbonylruthenium(II) complex is not the catalyst itself, but a catalyst 
precursor which is not deactivated at the end of the reaction, thus, a more catalytically active 
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Figure 11: Effect of acidic, basic and neutral conditions on the ruthenium complex catalyzed oxidation of 
styrene. Reaction conditions: 0.478 mmols styrene, 3 equiv. NaIO4, 2.5 mol% [RpCHA]B, CH3CN:H2O 
(1:1; 6 mL) at 60 °C. Time taken to achieve highest conversion is given in hours.  
 
The UV-VIS spectrum obtained for the dark orange coloured compound recovered at the end of 
the reaction showed a peak at ca. 360 nm (Fig. 12). A similar peak was observed by Goldstein 
and Drago, at 365 nm, and was assigned to the RuVI = O species [51]. Their study was based on 
the hydroxylation of methane by hydrogen peroxide as the co-oxidant and cis-
[Ru(dmp)2S2](PF6) (dmp = 2,9 dimethyl-I, l0-phenanthroline, S = Me3CN or H2O) as the 
catalyst. The difference in peak positions may be attributed to the different coordination 
environments of the complexes reported herein and those used by Goldstein and Drago. This 
peak may, therefore, be assigned to a dioxo-ruthenium(VI) complex species formed as an 
intermediate in the catalytic oxidation of styrene. Noteworthy, the peak at 360 nm in the UV-
VIS spectrum was absent in the spectra of the fresh catalyst and the reaction mixtures sampled 
at 30 min intervals (Fig 12). This implies that the dioxo-ruthenium species is highly active and 
hence only seen in solution once styrene is depleted (Scheme 3). It is worth noting that the 
peaks observed by Goldstein and Drago at 395 and 425 nm assignable to RuIII and RuIV O 
respectively, were absent in the UV-VIS spectra of the recovered catalyst and the reaction 































Reaction medium  




the formation of RuIII and the postulated RuIV O species, these are very rapidly oxidized to 
RuVI O, and hence not detected.  
 
The solid state IR spectrum obtained for the recovered catalyst showed new peaks at 793, 769 
and 728 cm–1 possibly assignable to the symmetric and asymmetric stretches of Ru=O bonds of 
Ru(VI) dioxo species [52]. No peaks were observed in the carbonyl region (between 2056 and 
1998 cm–1), an indication that the recovered catalyst does not contain coordinated CO ligand. A 
1H NMR spectrum obtained for the recovered catalyst showed a signal at ca. δ 5.67 ppm 
assignable to the 5 Cp protons and a peak at ca. δ 4.00 ppm assignable to the amine nitrogen 
protons. Since the proposed Ru(VI) dioxo species (d2) would be paramagnetic in nature, the 
observed Cp and amine nitrogen proton  signals in the 1H NMR spectrum suggests that there is  
a diamagnetic species.   
 
 
Figure 12: Electronic spectra of samples obtained at different times into the catalyzed reaction 
 
Table 5 show the results for the catalytic oxidation by 0.5 mol% catalyst of the various 



















STYRENE OXIDATION AT 0, 150 AND 210 MINUTES 





Table 5: Ruthenium complexes (0.5 mol%) catalyzed oxidative cleavage of the styrene olefinic bonda 
Complex Time (h)b % Yield % Conversion TON TOF/h 
[RpCHA]B (1) 10 86 100 172 17 
[RpBA]B (3) 14 81 91 162 11 
[RpMBA]B (4) 12 87 100 174 14 
[RpMeOBA]B (5) 3 99 99 198 66 
[RpAMBN]B (6) 3 100 94 200 65 
[RpiPA]B (9) 16 94 100 188 12 
[RpMeNH2]B (10) 9 87 98 174 19 
[RpHMDA]B (11) 2 99 99 198 100 
No catalyst 10 21 32 0 0 
aReaction conditions: 0.478 mmols styrene, 3 equiv. NaIO4, CH3CN/H2O (1:1; 6mL) at 60 °C.  
bTime taken to achieve highest conversion is given in h. 
 
All the complexes tested afforded more than 90 % styrene conversion and over 80 % 
benzaldehyde yield. It is noteworthy that the oxidation process in the presence of the ruthenium 
dinuclear complex, [RpHMDARp]2+ (11), has the highest turnover frequency (TOF) of 100 h–1. 
This implies that the ruthenium centre is directly involved in the oxidation process, since the 
mol% in terms of ruthenium is twice as high as that for the mononuclear complexes; probably 
the oxo-species are formed at both metal centres thus doubling the catalysis rate. It is interesting 
to note that despite the complexes containing 4-methoxybenzyl amine (5) and 4-
aminomethylbenzonitrile (6) being mononuclear, with the ligand in 5 being more basic than that 
in 6, they demonstrated excellent activities with almost equal TOFs of 66 h–1 and 65 h–1 
respectively. In contrast, the TOF for the benzylamine complex (3) was noted to be 11 h–1; the 
phenyl ring increases the basicity of the amine thus increasing the π-back-bonding effect on the 
CO ligand and eventually strengthening the M–CO bond. This would decrease the rate at which 
the CO ligand is lost in the RuII to RuVI oxidation step, hence decreasing the reaction rate. This 
observation implies that the loss of CO, which is dependent on the electronic effect of the 
ligand, and the oxidation of RuII to RuVI steps may be rate determining in forming the working 
catalyst in the oxidative cleavage of the styrene olefinic double bond. It is worth noting that low 
TOFs, 12 h–1 and 14 h–1, were observed for the complexes containing isopropyl amine (9) and α-
methylbenzyl amine (4), respectively, compared to 19 h–1 observed for the methylamine 
containing complex (10). This may be due to, in addition to the mentioned factors, steric 
hindrance on the metal centre caused by the isopropyl amine and α-methylbenzyl amine, thus 





The oxidation process catalyzed by 2.5 mol % of catalyst 1, with the cyclohexylamine ligand, 
formed styrene oxide in addition to benzaldehyde. The complexes 3, 4, 5 and 6, which contain a 
phenyl ring in the amine ligand, form benzaldehyde in high yield but styrene oxide is not 




The η5-cyclopentadienyldicarbonylruthenium(II) amine complexes, [CpRu(CO)2NH2R]BF4, 
have been successfully synthesized. The amine ligands are linked to the ruthenium centre by a 
σ-bond through the nitrogen atom. The 4-methoxybenzyl amine, 4-aminomethylbenzonitrile and 
allylamine preferentially bind to the metal centre via the amine nitrogen. Some of the complexes 
have exhibited excellent catalytic activity in the oxidation of styrene with NaIO4 to give up to 
99 % benzaldehyde yield. The “pseudo-octahedral three-legged piano-stool” structure exhibited 
by the complexes seems to favour the formation of the cis-dioxo ruthenium species required for 
the formation of the important intermediate 2 + 3 metal diether ring [23]. The configuration 
displayed by the ruthenium complexes favour the oxidative cleavage of the olefinic C C bond 
of styrene and thus the formation of benzaldehyde in high yield. Bulky amine ligands seem to 
reduce the catalytic activity of the complexes. The recovered catalyst is very active in the 
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This thesis has described the synthesis, characterization and structural elucidation of new η5-
cyclopentadienyldicarbonylruthenium(II) and η5-
pentamethylcyclopentadienyldicarbonylruthenium(II) amine complexes. The possible 
application of η5-cyclopentadienyldicarbonylruthenium(II) amine as catalysts in the oxidation of 
styrene using sodium periodate as the oxidant, and possible antimicrobial activity against Gram 
positive and Gram negative bacteria has been explored.  
 
The reaction of η5-C5H5Ru(CO)2I and AgBF4 gives different products depending on; the solvent 
used, temperature of the reaction and the quantity of AgBF4 used. Two polymorphs of the iodo-
bridged ruthenium complex {[η5-C5H5Ru(CO)2]2I}BF4 have been successfully isolated from two 
different reactions, characterized and their crystal structures and packing fully elucidated for the 
first time. The reaction of η5-C5H5Ru(CO)2I with a slight excess AgBF4 in THF at 0 °C affords 
the iodo-bridged ruthenium complex {[η5-C5H5Ru(CO)2]2I}BF4, I. A different polymorph, II, of 
the iodo-bridged ruthenium complex is formed when η5-C5H5Ru(CO)2I and AgBF4, mole ratio 
of 1:1, reacts in methylene chloride at room temperature and atmospheric pressure. The two 
polymorphs have similar spectral properties, but slightly different melting points due to 
different crystal packing. The electrospray mass spectrum of the iodo-bridged ruthenium 
complex shows a fragmentation pattern where the carbonyl ligands are successively lost, 
leaving the iodo-bridged cationic fragment {[(η5-C5H5)2Ru2CO]I}+. The molecular structures of 
the two polymorphs of the iodo-bridged complex were determined by single crystal X-ray 
crystallography. They have different cell parameters and molecular geometries, crystallizes in a 
monoclinic crystal system, but with different space groups; P2/c and P21/c. The molecular 
structures show that their Ru I Ru bond angles are different by 4.93°, while the CpRu(CO)2 
moiety is staggered in both polymorphs with the dihedral angles, Cg Ru Ru Cg,  differing 
by 101.98°. The crystals of both polymorphs are stabilized by C H F intermolecular 
interactions. However, their packing patterns are vastly different.  
  
Alternatively, the reaction of η5-C5H5Ru(CO)2I with a slight excess (approx. 30% excess) 
AgBF4 in methylene chloride at room temperature gives the Lewis acid [η5-C5H5Ru(CO)2]BF4, 
which subsequently reacts with primary amines and other ligands to give the corresponding 




cyclopentadienyl)ruthenium(II) tetrafluoroborate  complex salts, [CpRu(CO)2NH2R]+BF4-, (Cp 
= η5-C5H5 (R = CnH2n+1;  n = 0 – 5), have been synthesized by the reaction of the organometallic 
Lewis acid, [CpRu(CO)2]+BF4, with slight excesses of 1-alkanamines, RNH2. The 1-alkanamine 
complexes are white, air-stable solids whose melting points increase with increase in carbon 
chain length. The sharp melting points and elemental analysis results revealed that the 
complexes are pure. NMR and IR spectral analyses showed that the 1-alkanamine ligands are 
coordinated to the ruthenium metal centre via the nitrogen atom and that an increase in the 
coordinated ligand carbon chain length weakens the C O bond of the coordinated carbonyl. 
Electrospray mass spectral analysis showed that the bond formed between the nitrogen and the 
metal is strong, since the fragment [CpRuNH2R]+ was observed to be most abundant, thus most 
stable. Single crystal X-ray diffraction revealed that the cationic species, [CpRu(CO)2NH2R]+, 
feature a “pseudo-octahedral three-legged piano stool” structure in which the ruthenium centre 
is coordinated through a sigma bond to the amine N atom and the two carbonyl ligands as the 
base of the stool and the cyclopentadienyl ring as the apex of the stool. The Ru N bond lengths 
slightly increase with increase in the ligand carbon chain length, but are longer compared to the 
Fe N bond lengths for the analogous iron complexes. The crystal structure of the complexes 
are generally stabilized by fairly strong N–H F and C–H F intermolecular interactions in 
addition to other intermolecular interactions.  
 
Five new 1-alkylamine(η5-pentamethylcyclopentadienyl)dicarbonylruthenium(II) complex salts, 
[Cp*Ru(CO)2NH2(CH2)nCH3]BF4 (Cp* = η5-C5(CH3)5; n = 0 – 4) have been synthesized by the 
reaction of the Lewis acid,  [Cp*Ru(CO)2]BF4, with the 1-alkylamines. The complexes are 
white solids, which readily dissolve in the water and are stable in aqueous state. The Cp* 
ruthenium complexes melt at a higher temperature than their analogous Cp ruthenium 
complexes. The spectral analyses showed that the 1-alkanamine ligands are coordinated to the 
metal centre via the amine nitrogen. High resolution mass spectra of the Cp* complexes salts 
have proved that they were formed. Furthermore, the molecular structure of the complex 
[Cp*Ru(CO)2NH2CH2CH3]BF4 was determined by single crystal X-ray crystallography, 
providing proof for the coordination of the ligand as predicted from the spectral analyses. The 
compound crystallized as white needle-like crystals in a triclinic crystal system, space group P-
1, with two molecules the cation [Cp*Ru(CO)2NH2CH2CH3]+ and two counter anions BF4– in 
the unit cell. The complex cation also exhibits the pseudo-octahedral “three-legged piano stool” 
geometry. The crystal structure of the complex is also stabilized by fairly strong N H F and 





The α,αʹ-diaminoalkane-bridged diruthenium complex salts {[(η5-
C5H5)Ru(CO)2]2NH2(CH2)nNH2}(BF4)2 (n = 2, 3, 4 and 6; Y = BF4 or SO3CF3) have been 
synthesized by the reaction of [RpNCCH3]Y and NH2(CH2)nNH2 in a 2:1 ratio. The complexes 
are new and have been fully characterized by IR and NMR spectroscopy, elemental analysis and 
melting point. The CpRu(CO)2 units are centro-symmetrically bonded to the α,αʹ-diaminoalkane 
ligand. The α,αʹ-diaminoalkane ligands are coordinated to the Ru(II) centres via the amine 
nitrogen. The molecular structure of the complex {[(η5-C5H5)Ru(CO)2]2NH2(CH2)2NH2}(BF4)2 
have been determined by single crystal X-ray crystallography and it confirms that the α,αʹ-
diaminoalkane is linking two ruthenium centres of the {[(η5-C5H5)Ru(CO)2 moiety. 
Antibacterial activity of the ruthenium(II) amine complexes showed that some of the complexes 
have excellent antibacterial activity. The ruthenium(II) amine complexes have hgher 
antibacterial activity than the free, uncoordinated ligand.The coordinated ruthenium metal 
centre probably triggers antibacterial activity of the non-active ligands, while enhancing the 
activity of those that are already active. In some cases, the ruthenium complexes showed higher 
antimicrobial activity against both Gram-positive and Gram-negative bacteria than the known 
antibiotic, ampicillin (AMP10). Some of the complexes demonstrated broad spectrum 
antibacterial activity  
  
The water-soluble ruthenium(II) mononuclear complexes [CpRu(CO)2NH2R]BF4 [Cp = η5-
C5H5; R =  C6H11,  C6H5,  CH2C6H5,  CH(CH3)C6H5,  CH2C6H4OCH3,  CH2C6H4CN, 
 C6H2(CH3)3,  CH2CHCH2 and  CH(CH3)2] have been successfully synthesized and fully 
characterized by IR, high resolution mass spectroscopy, 1H and 13C NMR spectroscopy, and 
elemental analysis. Despite the fact that some of the ligands, NH2CH2C6H4OCH3, 
NH2CH2C6H4CN and NH2CH2CHCH2, are heterofunctional, analysis shows that the ligands 
bonded to the ruthenium centre of the CpRu(CO)2 moiety through the amine functionality, 
giving mononuclear complexes. The molecular structures of the complexes 
[CpRu(CO)2NH2CH2CHCH2]BF4 and [CpRu(CO)2CH2C6H5]BF4 were determined by X-ray 
crystallography and confirm coordination of the ligands through the nitrogen atom of the amine 
group. The complexes are stable in air and in the aqueous state. Some of the complexes were 
tested in the catalytic oxidation of styrene, where they demonstrated excellent activity in 
oxidative cleavage of the olefin C C bond affording more than 90% styrene conversion and 
over 85% benzaldehyde yield under the reaction conditions. It is believed that the “pseudo-
octahedral three-legged piano-stool” structure exhibited by the complexes favours the cleavage 




formation of the cis-dioxo ruthenium species required for the formation of the intermediate 2 + 
3 metal diether ring. The previously synthesized mononuclear 1-methylamine ruthenium 
complex, [CpRu(CO)2NH2CH3]BF4, is also an excellent catalyst in the oxidative cleavage of the 
styrene olefinic bond, affording 98% conversion and 87% benzaldehyde yield; implying that the 
rest of the ruthenium(II) 1-alkylamine complexes synthesized in this study are also potentially 
good catalysts for the oxidative cleavage of styrene.  
 
Finally, a procedure was determined and a total of 23 new η5-
cyclopentadienyldicarbonylruthenium(II) complexes synthesized and fully characterized. In all 
the complexes, the ligands are coordinated to the ruthenium metal centre via the nitrogen atom 
of the amine group. The ionic nature and presence of the amine group in the complexes renders 
them soluble and stable in water. The molecular structures of 11 of the synthesized complexes 
were determined and they reveal that the cationic species, [CpRu(CO)2NH2R]+, feature a 
“pseudo-octahedral three-legged piano stool” geometry, similar to those portrayed by the 
analogous iron complexes, [CpFe(CO)2NH2R]+. The bonding and structures of the complexes 
have been clearly determined, compared to those of the iron analogues and possible 
explanations for similarities and differences given.  
 
The antimicrobial activities of some of the η5-cyclopentadienyldicarbonylruthenium(II) amine 
complexes have been determined. Some of the ruthenium complexes have shown better 
antimicrobial activities against both Gram-negative and Gram-positive bacteria than the 
uncoordinated ligands. It would be interesting to carry out further studies on the antibacterial 
antitumor activity of the ruthenium complexes.  Coordination of actual antimicrobial drugs to 
the ruthenium centre of the CpRu(CO)2 moiety and studying their antimicrobial activity would 
be interesting.  
 
The catalytic activities of the η5-cyclopentadienyldicarbonylruthenium(II) amine complexes, in 
the oxidation of styrene, have been determined. The ruthenium complexes have demonstrated 
excellent catalytic activity in the oxidative cleavage of the styrene olefinic bond. A possible 
mechanism for the oxidative cleavage of the olefinic bond in the presence of the ruthenium 
complex catalysts has been proposed. It would be interesting to study the catalytic activity of 
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STRUCTURE TABLES PERTAINING TO CHAPTER 2 
 




















Table B1: Crystal data and structure refinement for Polymorph I – {[η5-C5H5Ru(CO)2]2I}BF4  
Empirical formula  C14 H10 B F4 I O4 Ru2 
Formula weight  658.07 
Temperature  446(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2/c 
Unit cell dimensions a = 12.0982(5) Å = 90°. 
 b = 9.7923(4) Å = 102.9880(10)°. 
 c = 15.5321(6) Å  = 90°. 
Volume 1793.00(13) Å3 
Z 4 
Density (calculated) 2.438 Mg/m3 
Absorption coefficient 3.462 mm-1 
F(000) 1232 
Crystal size 0.43 x 0.34 x 0.16 mm3 
Theta range for data collection 1.73 to 28.45°. 
Index ranges -16<=h<=15, -13<=k<=11, -20<=l<=20 
Reflections collected 46542 
Independent reflections 4492 [R(int) = 0.0247] 
Completeness to theta = 28.45° 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.6858 and 0.4069 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4492 / 0 / 236 
Goodness-of-fit on F2 1.201 
Final R indices [I>2sigma(I)] R1 = 0.0141, wR2 = 0.0378 
R indices (all data) R1 = 0.0149, wR2 = 0.0385 
Largest diff. peak and hole 0.408 and -0.837 e.Å-3 
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Table B2: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
{[η5-C5H5Ru(CO)2]2I}BF4 U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 2034(2) 4434(2) 9976(1) 27(1) 
C(2) 1928(2) 4046(2) 10849(2) 29(1) 
C(3) 3014(2) 3657(2) 11328(1) 28(1) 
C(4) 3804(2) 3851(2) 10783(1) 25(1) 
C(5) 3176(2) 4299(2) 9939(1) 24(1) 
C(6) 3428(2) 6406(2) 12178(1) 20(1) 
C(7) 4111(2) 7101(2) 10681(1) 19(1) 
C(8) 2854(2) 10569(2) 9953(1) 23(1) 
C(9) 3268(2) 10195(2) 9211(1) 24(1) 
C(10) 2448(2) 10582(2) 8435(1) 27(1) 
C(11) 1533(2) 11233(2) 8710(1) 26(1) 
C(12) 1766(2) 11201(2) 9649(1) 24(1) 
C(13) 98(2) 8717(2) 8619(1) 19(1) 
C(14) 2130(2) 7473(2) 8640(1) 18(1) 
O(1) 3664(1) 6662(2) 12908(1) 30(1) 
O(2) 4742(1) 7807(1) 10463(1) 26(1) 
O(3) -838(1) 8576(2) 8297(1) 26(1) 
O(4) 2494(1) 6578(1) 8332(1) 25(1) 
Ru(1) 3054(1) 5858(1) 10975(1) 13(1) 
Ru(3) 1639(1) 9071(1) 9147(1) 14(1) 
I(1) 1405(1) 7749(1) 10619(1) 15(1) 
B(2) 5000 9224(3) 7500 24(1) 
F(5) 4529(1) 8393(2) 8047(1) 45(1) 
F(6) 5834(1) 10037(2) 8001(1) 50(1) 
B(1) 10000 5317(3) 2500 23(1) 
F(1) 9044(2) 6115(2) 2447(1) 58(1) 




Table B3:   Bond lengths [Å] and angles [°] for {[η5-C5H5Ru(CO)2]2I}BF4  
________________________________________________ 
C(1)-C(5)  1.401(3) 
C(1)-C(2)  1.442(3) 
C(1)-Ru(1)  2.2395(18) 
C(1)-H(1)  0.9800 
C(2)-C(3)  1.408(3) 
C(2)-Ru(1)  2.2181(18) 
C(2)-H(2)  0.9800 
C(3)-C(4)  1.424(3) 
C(3)-Ru(1)  2.2271(19) 
C(3)-H(3)  0.9800 
C(4)-C(5)  1.429(3) 
C(4)-Ru(1)  2.2132(18) 
C(4)-H(4)  0.9800 
C(5)-Ru(1)  2.2472(17) 
C(5)-H(5)  0.9800 
C(6)-O(1)  1.132(2) 
C(6)-Ru(1)  1.8989(18) 
C(7)-O(2)  1.136(2) 
C(7)-Ru(1)  1.8943(18) 
C(8)-C(9)  1.405(3) 
C(8)-C(12)  1.435(3) 
C(8)-Ru(3)  2.2482(18) 
C(8)-H(8)  0.9800 
C(9)-C(10)  1.429(3) 
C(9)-Ru(3)  2.2400(18) 
C(9)-H(9)  0.9800 
C(10)-C(11)  1.424(3) 
C(10)-Ru(3)  2.2042(18) 
C(10)-H(10)  0.9800 
C(11)-C(12)  1.423(3) 
C(11)-Ru(3)  2.2180(18) 
C(11)-H(11)  0.9800 
C(12)-Ru(3)  2.2198(18) 
C(12)-H(12)  0.9800 
C(13)-O(3)  1.139(2) 
C(13)-Ru(3)  1.8922(18) 
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C(14)-O(4)  1.134(2) 
C(14)-Ru(3)  1.9058(18) 
Ru(1)-I(1)  2.68658(18) 
Ru(3)-I(1)  2.69707(18) 
B(2)-F(6)  1.380(2) 
B(2)-F(6)#1  1.380(2) 
B(2)-F(5)#1  1.388(2) 
B(2)-F(5)  1.388(2) 
B(1)-F(1)#2  1.382(2) 
B(1)-F(1)  1.382(2) 
B(1)-F(2)  1.390(2) 














































































































































Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,y,-z+3/2    #2 -x+2,y,-z+1/2  
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Table B4: Anisotropic displacement parameters (Å2x 103)for {[η5-C5H5Ru(CO)2]2I}BF4.  The 
anisotropic displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 33(1)  15(1) 29(1)  -8(1) -1(1)  -3(1) 
C(2) 34(1)  14(1) 44(1)  -8(1) 21(1)  -9(1) 
C(3) 53(1)  13(1) 22(1)  2(1) 17(1)  3(1) 
C(4) 33(1)  17(1) 26(1)  -1(1) 10(1)  8(1) 
C(5) 41(1)  15(1) 19(1)  -3(1) 13(1)  1(1) 
C(6) 18(1)  19(1) 22(1)  0(1) 4(1)  2(1) 
C(7) 16(1)  20(1) 19(1)  0(1) 3(1)  2(1) 
C(8) 26(1)  17(1) 26(1)  -2(1) 2(1)  -9(1) 
C(9) 21(1)  18(1) 36(1)  -2(1) 10(1)  -8(1) 
C(10) 36(1)  21(1) 26(1)  2(1) 12(1)  -12(1) 
C(11) 29(1)  14(1) 32(1)  7(1) 2(1)  -5(1) 
C(12) 27(1)  14(1) 31(1)  -4(1) 9(1)  -4(1) 
C(13) 24(1)  17(1) 15(1)  1(1) 6(1)  -3(1) 
C(14) 21(1)  19(1) 16(1)  2(1) 6(1)  -5(1) 
O(1) 32(1)  38(1) 17(1)  -4(1) 2(1)  1(1) 
O(2) 18(1)  29(1) 32(1)  5(1) 8(1)  -4(1) 
O(3) 21(1)  32(1) 23(1)  2(1) 0(1)  -5(1) 
O(4) 33(1)  22(1) 25(1)  -3(1) 15(1)  0(1) 
Ru(1) 15(1)  13(1) 13(1)  0(1) 5(1)  0(1) 
Ru(3) 15(1)  12(1) 14(1)  0(1) 4(1)  -2(1) 
I(1) 15(1)  16(1) 15(1)  1(1) 5(1)  1(1) 
B(2) 22(1)  32(2) 20(1)  0 4(1)  0 
F(5) 51(1)  45(1) 49(1)  14(1) 32(1)  8(1) 
F(6) 44(1)  62(1) 36(1)  -13(1) -6(1)  -13(1) 
B(1) 32(2)  18(1) 20(1)  0 10(1)  0 
F(1) 87(1)  52(1) 44(1)  21(1) 34(1)  50(1) 




Table B5: Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for {[η5-
C5H5Ru(CO)2]2I}. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 1410 4695 9483 32 
H(2) 1220 3978 11053 34 
H(3) 3192 3285 11929 34 
H(4) 4612 3618 10937 30 
H(5) 3487 4458 9417 29 
H(8) 3253 10452 10571 28 
H(9) 4007 9775 9223 29 
H(10) 2537 10501 7825 32 
H(11) 878 11669 8321 31 

















































































































































































































Symmetry transformations used to generate equivalent atoms:  















Table B7: Crystal data and structure refinement for {[η5-C5H5Ru(CO)2]2I}. 
Identification code  12bo_hbf_ne4_0m 
Empirical formula  C14 H10 B F4 I N0 O4 Ru2 
Formula weight  658.07 
Temperature  446(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 7.00560(10) Å = 90°. 
 b = 14.1446(3) Å = 96.2390(10)°. 
 c = 18.2226(3) Å  = 90°. 
Volume 1795.01(5) Å3 
Z 4 
Density (calculated) 2.435 Mg/m3 
Absorption coefficient 3.458 mm-1 
F(000) 1232 
Crystal size 0.42 x 0.16 x 0.11 mm3 
Theta range for data collection 1.83 to 28.32°. 
Index ranges -8<=h<=9, -18<=k<=18, -24<=l<=22 
Reflections collected 42242 
Independent reflections 4471 [R(int) = 0.0244] 
Completeness to theta = 28.32° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7022 and 0.3245 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4471 / 28 / 235 
Goodness-of-fit on F2 1.111 
Final R indices [I>2sigma(I)] R1 = 0.0127, wR2 = 0.0322 
R indices (all data) R1 = 0.0135, wR2 = 0.0326 
Largest diff. peak and hole 0.462 and -0.621 e.Å-3 
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Table B8: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for {[η5-C5H5Ru(CO)2]2I}.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 4014(2) 8243(1) 7555(1) 18(1) 
C(2) 3295(2) 9160(1) 7404(1) 21(1) 
C(3) 4873(3) 9809(1) 7484(1) 20(1) 
C(4) 6556(2) 9277(1) 7715(1) 18(1) 
C(5) 6054(2) 8311(1) 7743(1) 15(1) 
C(6) 7727(2) 9153(1) 6220(1) 18(1) 
C(7) 3901(2) 9352(1) 5764(1) 15(1) 
C(8) 410(2) 7769(1) 4516(1) 28(1) 
C(9) 513(2) 7065(1) 3957(1) 24(1) 
C(10) 602(2) 6171(1) 4308(1) 23(1) 
C(11) 626(2) 6314(1) 5080(1) 24(1) 
C(12) 493(2) 7308(2) 5201(1) 28(1) 
C(13) 4909(2) 6028(1) 4444(1) 17(1) 
C(14) 4712(2) 7916(1) 4265(1) 16(1) 
B(1) 9983(2) 6359(1) 7357(1) 18(1) 
O(1) 9172(2) 9366(1) 6044(1) 27(1) 
O(2) 2971(2) 9684(1) 5281(1) 22(1) 
O(3) 5913(2) 5434(1) 4306(1) 26(1) 
O(4) 5562(2) 8472(1) 3990(1) 26(1) 
F(1) 8461(2) 6303(1) 7784(1) 29(1) 
F(2) 10002(1) 7257(1) 7037(1) 26(1) 
F(3) 9782(2) 5663(1) 6809(1) 26(1) 
F(4) 11708(1) 6222(1) 7806(1) 24(1) 
Ru(1) 3216(1) 6986(1) 4695(1) 11(1) 
Ru(2) 5394(1) 8821(1) 6593(1) 10(1) 




Table B9: Bond lengths [Å] and angles [°] for  {[η5-C5H5Ru(CO)2]2I}. 
 
_____________________________________________________ 
C(1)-C(2)  1.409(2) 
C(1)-C(5)  1.436(2) 
C(1)-Ru(2)  2.2457(15) 
C(1)-H(1)  0.9800 
C(2)-C(3)  1.431(2) 
C(2)-Ru(2)  2.2477(15) 
C(2)-H(2)  0.9800 
C(3)-C(4)  1.423(2) 
C(3)-Ru(2)  2.2025(15) 
C(3)-H(3)  0.9800 
C(4)-C(5)  1.413(2) 
C(4)-Ru(2)  2.2123(14) 
C(4)-H(4)  0.9800 
C(5)-Ru(2)  2.2178(14) 
C(5)-H(5)  0.9800 
C(6)-O(1)  1.135(2) 
C(6)-Ru(2)  1.8958(16) 
C(7)-O(2)  1.1383(19) 
C(7)-Ru(2)  1.8959(15) 
C(8)-C(12)  1.404(3) 
C(8)-C(9)  1.432(3) 
C(8)-Ru(1)  2.2488(17) 
C(8)-H(8)  0.9800 
C(9)-C(10)  1.416(2) 
C(9)-Ru(1)  2.2027(16) 
C(9)-H(9)  0.9800 
C(10)-C(11)  1.419(3) 
C(10)-Ru(1)  2.2133(16) 
C(10)-H(10)  0.9800 
C(11)-C(12)  1.428(3) 
C(11)-Ru(1)  2.2283(16) 
C(11)-H(11)  0.9800 
C(12)-Ru(1)  2.2537(17) 
C(12)-H(12)  0.9800 
C(13)-O(3)  1.141(2) 
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C(13)-Ru(1)  1.8897(16) 
C(14)-O(4)  1.1353(19) 
C(14)-Ru(1)  1.9029(16) 
B(1)-F(1)  1.389(2) 
B(1)-F(4)  1.397(2) 
B(1)-F(2)  1.398(2) 
B(1)-F(3)  1.398(2) 
Ru(1)-I(1)  2.68768(15) 












































































































































Table B10: Anisotropic displacement parameters (Å2x 103) for {[η5-C5H5Ru(CO)2]2I}. The 
anisotropic displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 19(1)  22(1) 14(1)  -1(1) 6(1)  -7(1) 
C(2) 17(1)  33(1) 14(1)  -2(1) 4(1)  9(1) 
C(3) 33(1)  15(1) 13(1)  -2(1) 3(1)  4(1) 
C(4) 20(1)  22(1) 11(1)  -3(1) 0(1)  -5(1) 
C(5) 18(1)  17(1) 10(1)  2(1) 2(1)  2(1) 
C(6) 18(1)  23(1) 14(1)  1(1) -1(1)  1(1) 
C(7) 15(1)  14(1) 16(1)  0(1) 3(1)  -2(1) 
C(8) 13(1)  21(1) 49(1)  3(1) -3(1)  2(1) 
C(9) 17(1)  35(1) 20(1)  8(1) -5(1)  -6(1) 
C(10) 19(1)  23(1) 27(1)  -3(1) -2(1)  -9(1) 
C(11) 19(1)  30(1) 23(1)  8(1) 2(1)  -8(1) 
C(12) 14(1)  41(1) 28(1)  -11(1) 4(1)  0(1) 
C(13) 24(1)  15(1) 11(1)  1(1) 3(1)  -1(1) 
C(14) 18(1)  14(1) 16(1)  -2(1) 2(1)  1(1) 
B(1) 14(1)  15(1) 23(1)  -2(1) 1(1)  0(1) 
O(1) 16(1)  41(1) 26(1)  7(1) 5(1)  -2(1) 
O(2) 22(1)  22(1) 19(1)  5(1) -3(1)  1(1) 
O(3) 39(1)  19(1) 21(1)  2(1) 11(1)  8(1) 
O(4) 31(1)  19(1) 30(1)  1(1) 11(1)  -6(1) 
F(1) 23(1)  25(1) 40(1)  -5(1) 14(1)  -4(1) 
F(2) 22(1)  20(1) 35(1)  7(1) -3(1)  -1(1) 
F(3) 27(1)  24(1) 27(1)  -10(1) -3(1)  4(1) 
F(4) 20(1)  21(1) 28(1)  -1(1) -6(1)  3(1) 
Ru(1) 14(1)  10(1) 10(1)  0(1) 1(1)  -1(1) 
Ru(2) 10(1)  11(1) 10(1)  0(1) 0(1)  0(1) 





Table B11: Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for {[η5-
C5H5Ru(CO)2]2I}. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 3248 7663 7554 21 
H(2) 1942 9329 7280 25 
H(3) 4788 10499 7444 24 
H(4) 7839 9540 7852 21 
H(5) 6921 7790 7906 18 
H(8) 254 8451 4433 34 
H(9) 395 7177 3424 29 
H(10) 574 5556 4058 28 
H(11) 621 5819 5456 29 
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Table B13: Crystal data and structure refinement for [η5-C5H5Ru(CO)2NH2CH2CH3]BF4 
Empirical formula  C9 H12 B F4 N O2 Ru 
Formula weight  354.08 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pbca 
Unit cell dimensions a = 14.6686(5) Å = 90°. 
 b = 11.3131(4) Å = 90°. 
 c = 14.9801(6) Å  = 90°. 
Volume 2485.91(16) Å3 
Z 8 
Density (calculated) 1.892 Mg/m3 
Absorption coefficient 1.303 mm-1 
F(000) 1392 
Crystal size 0.23 x 0.15 x 0.13 mm3 
Theta range for data collection 2.65 to 28.40°. 
Index ranges -19<=h<=19, -15<=k<=14, -19<=l<=19 
Reflections collected 63059 
Independent reflections 3103 [R(int) = 0.0190] 
Completeness to theta = 28.40° 99.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8489 and 0.7537 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3103 / 0 / 164 
Goodness-of-fit on F2 1.076 
Final R indices [I>2sigma(I)] R1 = 0.0148, wR2 = 0.0390 
R indices (all data) R1 = 0.0164, wR2 = 0.0409 












Table B14:  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for [η5-C5H5Ru(CO)2NH2CH2CH3]BF4.  U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 5755(1) 4314(1) 3395(1) 21(1) 
C(2) 6478(1) 4409(1) 4013(1) 22(1) 
C(3) 6317(1) 5435(1) 4555(1) 22(1) 
C(4) 5482(1) 5944(1) 4267(1) 20(1) 
C(5) 5134(1) 5265(1) 3542(1) 19(1) 
C(6) 7760(1) 6301(1) 3173(1) 17(1) 
C(7) 6263(1) 7681(1) 2982(1) 17(1) 
C(8) 5734(1) 6096(1) 1196(1) 21(1) 
C(9) 5940(1) 5990(1) 204(1) 23(1) 
B(1) 8322(1) 7742(1) 979(1) 19(1) 
F(1) 9123(1) 8172(1) 1350(1) 31(1) 
F(2) 8279(1) 8027(1) 89(1) 44(1) 
F(3) 7584(1) 8247(1) 1427(1) 39(1) 
F(4) 8281(1) 6514(1) 1084(1) 22(1) 
N(2) 6529(1) 5740(1) 1749(1) 15(1) 
O(1) 8524(1) 6445(1) 3205(1) 24(1) 
O(2) 6123(1) 8667(1) 2925(1) 25(1) 







Table B15: Bond lengths [Å] and angles [°] for [η5-C5H5Ru(CO)2NH2CH2CH3]BF4. 
_____________________________________________________ 
C(1)-C(2)  1.4117(19) 
C(1)-C(5)  1.4268(18) 
C(1)-Ru(1)  2.2540(12) 
C(1)-H(1)  0.9999 
C(2)-C(3)  1.436(2) 
C(2)-Ru(1)  2.2517(13) 
C(2)-H(2)  1.0001 
C(3)-C(4)  1.421(2) 
C(3)-Ru(1)  2.2174(13) 
C(3)-H(3)  1.0001 
C(4)-C(5)  1.4246(18) 
C(4)-Ru(1)  2.2144(13) 
C(4)-H(4)  1.0000 
C(5)-Ru(1)  2.2315(12) 
C(5)-H(5)  1.0000 
C(6)-O(1)  1.1342(17) 
C(6)-Ru(1)  1.9068(14) 
C(7)-O(2)  1.1368(16) 
C(7)-Ru(1)  1.8950(13) 
C(8)-N(2)  1.4846(16) 
C(8)-C(9)  1.5222(19) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-H(9A)  0.9800 
C(9)-H(9B)  0.9800 
C(9)-H(9C)  0.9800 
B(1)-F(2)  1.3721(17) 
B(1)-F(1)  1.3875(17) 
B(1)-F(3)  1.3961(17) 
B(1)-F(4)  1.3990(16) 
N(2)-Ru(1)  2.1388(10) 
N(2)-H(2A)  0.9199 
































































































Table B16:  Anisotropic displacement parameters (Å2x 103)for [η5-C5H5Ru(CO)2NH2CH2CH3]BF4.  
The anisotropic displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12  
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 24(1)  15(1) 22(1)  2(1) 4(1)  -5(1) 
C(2) 24(1)  19(1) 24(1)  9(1) 2(1)  0(1) 
C(3) 26(1)  26(1) 14(1)  5(1) 0(1)  -5(1) 
C(4) 23(1)  21(1) 16(1)  1(1) 7(1)  -3(1) 
C(5) 16(1)  22(1) 19(1)  2(1) 3(1)  -3(1) 
C(6) 20(1)  18(1) 14(1)  -1(1) 0(1)  1(1) 
C(7) 18(1)  19(1) 15(1)  0(1) 2(1)  0(1) 
C(8) 19(1)  27(1) 17(1)  0(1) -4(1)  3(1) 
C(9) 27(1)  26(1) 16(1)  2(1) -4(1)  -1(1) 
B(1) 21(1)  17(1) 18(1)  -1(1) 1(1)  -1(1) 
F(1) 25(1)  28(1) 39(1)  -5(1) -5(1)  -7(1) 
F(2) 80(1)  32(1) 20(1)  4(1) -9(1)  -6(1) 
F(3) 29(1)  26(1) 62(1)  -5(1) 17(1)  5(1) 
F(4) 21(1)  17(1) 29(1)  0(1) 2(1)  -1(1) 
N(2) 16(1)  17(1) 13(1)  0(1) 0(1)  0(1) 
O(1) 16(1)  31(1) 24(1)  -3(1) -1(1)  -2(1) 
O(2) 31(1)  17(1) 27(1)  1(1) 3(1)  3(1) 







Table B17: Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for [η5-
C5H5Ru(CO)2NH2CH2CH3]BF4. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
H(1) 5677 3668 2946 25 
H(2) 6995 3841 4081 26 
H(3) 6690 5695 5078 26 
H(4) 5169 6633 4552 24 
H(5) 4539 5391 3230 23 
H(8A) 5568 6923 1337 25 
H(8B) 5206 5588 1346 25 
H(9A) 6128 5179 67 34 
H(9B) 6432 6537 45 34 
H(9C) 5392 6186 -140 34 
H(2A) 6623 4945 1662 18 











































































































































Table B19: Crystal data and structure refinement for [η5-C5H5Ru(CO)2NH2(CH2)2CH3]BF4 
Empirical formula  C10 H14 B F4 N O2 Ru 
Formula weight  368.10 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 10.4412(2) Å = 90°. 
 b = 7.69910(10) Å = 97.7450(10)°. 
 c = 16.8002(3) Å  = 90°. 
Volume 1338.21(4) Å3 
Z 4 
Density (calculated) 1.827 Mg/m3 
Absorption coefficient 1.214 mm-1 
F(000) 728 
Crystal size 0.47 x 0.26 x 0.15 mm3 
Theta range for data collection 1.97 to 28.34°. 
Index ranges -13<=h<=13, -10<=k<=10, -22<=l<=21 
Reflections collected 28712 
Independent reflections 3325 [R(int) = 0.0203] 
Completeness to theta = 28.34° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8389 and 0.5992 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3325 / 0 / 173 
Goodness-of-fit on F2 1.156 
Final R indices [I>2sigma(I)] R1 = 0.0161, wR2 = 0.0442 
R indices (all data) R1 = 0.0172, wR2 = 0.0456 
Largest diff. peak and hole 0.363 and -0.699 e.Å-3 
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Table B20: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for [η5-C5H5Ru(CO)2NH2(CH2)2CH3]BF4  U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 7015(1) 2743(2) 6064(1) 26(1) 
C(2) 8243(1) 2762(2) 6568(1) 23(1) 
C(3) 9122(1) 3702(2) 6167(1) 24(1) 
C(4) 8453(2) 4287(2) 5414(1) 26(1) 
C(5) 7167(2) 3659(2) 5353(1) 28(1) 
C(6) 8631(1) 7397(2) 6699(1) 20(1) 
C(7) 6247(1) 7080(2) 5907(1) 21(1) 
C(8) 7716(1) 5568(2) 8230(1) 19(1) 
C(9) 7143(1) 5442(2) 9007(1) 20(1) 
C(10) 8220(2) 5431(2) 9719(1) 26(1) 
B(1) 3361(2) -386(2) 1934(1) 19(1) 
F(1) 3454(1) 638(1) 2618(1) 37(1) 
F(2) 2074(1) -661(1) 1637(1) 37(1) 
F(3) 3991(1) 429(1) 1359(1) 36(1) 
F(4) 3966(1) -1973(1) 2135(1) 29(1) 
N(1) 6740(1) 5563(1) 7501(1) 15(1) 
O(1) 9343(1) 8503(2) 6848(1) 29(1) 
O(2) 5523(1) 8005(2) 5567(1) 30(1) 




Table B21:  Bond lengths [Å] and angles [°] for [η5-C5H5Ru(CO)2NH2(CH2)2CH3]BF4 
____________________________________________________ 
C(1)-C(5)  1.414(2) 
C(1)-C(2)  1.439(2) 
C(1)-Ru(3)  2.2367(14) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.410(2) 
C(2)-Ru(3)  2.2481(14) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.433(2) 
C(3)-Ru(3)  2.2427(13) 
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C(3)-H(3)  1.0000 
C(4)-C(5)  1.418(2) 
C(4)-Ru(3)  2.2196(14) 
C(4)-H(4)  1.0000 
C(5)-Ru(3)  2.2338(14) 
C(5)-H(5)  1.0000 
C(6)-O(1)  1.1361(17) 
C(6)-Ru(3)  1.8953(14) 
C(7)-O(2)  1.1351(17) 
C(7)-Ru(3)  1.8965(14) 
C(8)-N(1)  1.4835(17) 
C(8)-C(9)  1.511(2) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(10)  1.527(2) 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(10)-H(10A)  0.9800 
C(10)-H(10B)  0.9800 
C(10)-H(10C)  0.9800 
B(1)-F(2)  1.3855(17) 
B(1)-F(1)  1.3868(18) 
B(1)-F(3)  1.3893(18) 
B(1)-F(4)  1.3963(16) 
N(1)-Ru(3)  2.1402(11) 
N(1)-H(1A)  0.9200 






































































































Table B22: Anisotropic displacement parameters (Å2x 103)for [η5-C5H5Ru(CO)2NH2(CH2)2CH3]BF4.  
The anisotropic displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b*U12] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 25(1)  20(1) 33(1)  -11(1) 5(1)  -4(1) 
C(2) 28(1)  17(1) 25(1)  -2(1) 4(1)  6(1) 
C(3) 19(1)  25(1) 28(1)  -4(1) 5(1)  6(1) 
C(4) 30(1)  30(1) 22(1)  -3(1) 11(1)  5(1) 
C(5) 30(1)  30(1) 23(1)  -11(1) -3(1)  4(1) 
C(6) 16(1)  24(1) 21(1)  2(1) 4(1)  0(1) 
C(7) 16(1)  25(1) 21(1)  1(1) 4(1)  -1(1) 
C(8) 16(1)  25(1) 16(1)  0(1) 1(1)  -2(1) 
C(9) 22(1)  20(1) 19(1)  1(1) 6(1)  2(1) 
C(10) 33(1)  27(1) 18(1)  2(1) 1(1)  -2(1) 
B(1) 17(1)  15(1) 25(1)  -1(1) 2(1)  0(1) 
F(1) 51(1)  23(1) 35(1)  -11(1) 5(1)  0(1) 
F(2) 17(1)  53(1) 39(1)  4(1) -3(1)  -1(1) 
F(3) 35(1)  33(1) 42(1)  12(1) 14(1)  -1(1) 
F(4) 28(1)  14(1) 45(1)  1(1) 4(1)  2(1) 
N(1) 14(1)  14(1) 18(1)  -1(1) 2(1)  -1(1) 
O(1) 24(1)  29(1) 36(1)  -1(1) 3(1)  -11(1) 
O(2) 22(1)  37(1) 30(1)  10(1) 3(1)  8(1) 







Table B23: Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for [η5-
C5H5Ru(CO)2NH2(CH2)2CH3]BF4. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 6221 2111 6174 31 
H(2) 8450 2156 7096 28 
H(3) 10062 3875 6361 29 
H(4) 8846 4916 4985 32 
H(5) 6491 3793 4875 34 
H(8A) 8230 6649 8236 23 
H(8B) 8313 4579 8199 23 
H(9A) 6626 4365 9010 24 
H(9B) 6563 6443 9054 24 
H(10A) 8815 4470 9658 39 
H(10B) 7844 5281 10218 39 
H(10C) 8692 6533 9737 39 
H(1A) 6234 6539 7509 18 











































































































































Table B25:  Crystal data and structure refinement for [η5-C5H5Ru(CO)2NH2(CH2)3CH3]BF4. 
Empirical formula  C11 H16 B F4 N O2 Ru 
Formula weight  382.13 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 9.1329(5) Å = 90°. 
 b = 8.4964(4) Å = 112.154(2)°. 
 c = 19.3325(9) Å  = 90°. 
Volume 1389.39(12) Å3 
Z 4 
Density (calculated) 1.827 Mg/m3 
Absorption coefficient 1.173 mm-1 
F(000) 760 
Crystal size 0.36 x 0.25 x 0.21 mm3 
Theta range for data collection 2.41 to 25.00°. 
Index ranges -10<=h<=10, -10<=k<=10, -22<=l<=19 
Reflections collected 20134 
Independent reflections 2417 [R(int) = 0.0377] 
Completeness to theta = 25.00° 98.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7908 and 0.6775 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2417 / 0 / 182 
Goodness-of-fit on F2 1.301 
Final R indices [I>2sigma(I)] R1 = 0.0262, wR2 = 0.0630 
R indices (all data) R1 = 0.0275, wR2 = 0.0637 
Largest diff. peak and hole 0.740 and -0.430 e.Å-3 
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Table B25: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for [η5-C5H5Ru(CO)2NH2(CH2)3CH3]BF4.  U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
Ru(1) 7132(1) 7643(1) 9358(1) 14(1) 
O(1) 6800(3) 10324(3) 10323(1) 24(1) 
O(2) 7987(3) 5237(3) 10606(1) 26(1) 
N(1) 4689(3) 6982(3) 8964(1) 16(1) 
C(1) 9503(4) 7618(4) 9297(2) 20(1) 
C(2) 8574(4) 6411(4) 8807(2) 20(1) 
C(3) 7290(4) 7141(4) 8245(2) 21(1) 
C(4) 7384(4) 8788(4) 8368(2) 21(1) 
C(5) 8762(4) 9085(4) 9014(2) 20(1) 
C(6) 7592(4) 6151(4) 10141(2) 19(1) 
C(7) 6849(4) 9294(4) 9956(2) 17(1) 
C(8) 3600(4) 7716(4) 8256(2) 18(1) 
C(9) 1961(4) 6972(4) 7986(2) 19(1) 
C(10) 909(4) 7534(4) 7207(2) 20(1) 
C(11) -686(4) 6699(5) 6915(2) 27(1) 
F(1) 5206(2) 3374(2) 9419(1) 28(1) 
F(2) 7340(2) 2668(2) 9151(1) 27(1) 
F(3) 5297(2) 4018(2) 8296(1) 25(1) 
F(4) 4971(2) 1459(2) 8553(1) 31(1) 




Table B26:  Bond lengths [Å] and angles [°] for [η5-C5H5Ru(CO)2NH2(CH2)3CH3]BF4. 
_____________________________________________________ 
Ru(1)-C(7)  1.896(3) 
Ru(1)-C(6)  1.896(3) 
Ru(1)-N(1)  2.143(3) 
Ru(1)-C(1)  2.212(3) 
Ru(1)-C(5)  2.215(3) 
Ru(1)-C(4)  2.234(3) 
Ru(1)-C(2)  2.241(3) 
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Ru(1)-C(3)  2.251(3) 
O(1)-C(7)  1.138(4) 
O(2)-C(6)  1.139(4) 
N(1)-C(8)  1.491(4) 
N(1)-H(1A)  0.9200 
N(1)-H(1B)  0.9200 
C(1)-C(5)  1.425(5) 
C(1)-C(2)  1.436(5) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.407(5) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.417(5) 
C(3)-H(3)  1.0000 
C(4)-C(5)  1.422(5) 
C(4)-H(4)  1.0000 
C(5)-H(5)  1.0000 
C(8)-C(9)  1.524(4) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(10)  1.526(4) 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(10)-C(11)  1.524(5) 
C(10)-H(10A)  0.9900 
C(10)-H(10B)  0.9900 
C(11)-H(11A)  0.9800 
C(11)-H(11B)  0.9800 
C(11)-H(11C)  0.9800 
F(1)-B(1)  1.399(4) 
F(2)-B(1)  1.399(4) 
F(3)-B(1)  1.401(4) 















































































































Table B27:  Anisotropic displacement parameters (Å2x 103) for [η5-
C5H5Ru(CO)2NH2(CH2)3CH3]BF4. The anisotropic displacement factor exponent takes the form: -
2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
Ru(1) 13(1)  15(1) 14(1)  0(1) 5(1)  2(1) 
O(1) 25(1)  22(1) 24(1)  -4(1) 9(1)  2(1) 
O(2) 26(1)  26(1) 24(1)  8(1) 8(1)  8(1) 
N(1) 15(1)  15(1) 18(1)  0(1) 6(1)  1(1) 
C(1) 15(2)  27(2) 20(2)  1(1) 8(1)  2(1) 
C(2) 18(2)  22(2) 25(2)  -2(1) 14(1)  3(1) 
C(3) 16(2)  31(2) 18(2)  -4(1) 9(1)  -3(1) 
C(4) 19(2)  28(2) 20(2)  5(1) 12(1)  3(1) 
C(5) 19(2)  22(2) 23(2)  1(1) 12(1)  -3(1) 
C(6) 12(2)  22(2) 23(2)  -4(1) 7(1)  1(1) 
C(7) 12(2)  20(2) 18(2)  4(1) 5(1)  1(1) 
C(8) 16(2)  20(2) 16(2)  3(1) 4(1)  1(1) 
C(9) 17(2)  22(2) 19(2)  2(1) 7(1)  2(1) 
C(10) 21(2)  22(2) 17(2)  2(1) 7(1)  0(1) 
C(11) 21(2)  36(2) 21(2)  5(2) 3(1)  1(2) 
F(1) 30(1)  32(1) 27(1)  1(1) 16(1)  6(1) 
F(2) 18(1)  35(1) 26(1)  1(1) 6(1)  4(1) 
F(3) 31(1)  20(1) 22(1)  2(1) 6(1)  2(1) 
F(4) 31(1)  18(1) 36(1)  -2(1) 4(1)  -1(1) 







Table B28: Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for [η5-
C5H5Ru(CO)2NH2(CH2)3CH3]BF4. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1A) 4317 7213 9333 19 
H(1B) 4631 5907 8900 19 
H(1) 10534 7467 9725 24 
H(2) 8829 5262 8842 24 
H(3) 6467 6590 7817 25 
H(4) 6661 9599 8039 25 
H(5) 9180 10147 9216 24 
H(8A) 4049 7593 7866 21 
H(8B) 3510 8856 8338 21 
H(9A) 1450 7236 8341 23 
H(9B) 2068 5813 7980 23 
H(10A) 736 8682 7221 24 
H(10B) 1455 7343 6859 24 
H(11A) -1224 6870 7262 41 
H(11B) -523 5568 6873 41 

















































































































Table B30: Crystal data and structure refinement for [η5-C5H5Ru(CO)2NH2(CH2)4CH3]BF4. 
Identification code  12bo_hbf_ne2b_0m 
Empirical formula  C12 H18 B F4 N O2 Ru 
Formula weight  396.15 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 14.4432(3) Å = 90°. 
 b = 14.1166(3) Å = 115.978(2)°. 
 c = 17.0859(4) Å  = 90°. 
Volume 3131.65(12) Å3 
Z 8 
Density (calculated) 1.680 Mg/m3 
Absorption coefficient 1.044 mm-1 
F(000) 1584 
Crystal size 0.13 x 0.23 x 0.50 mm3 
Theta range for data collection 1.96 to 28.42°. 
Index ranges -19<=h<=19, -18<=k<=18, -22<=l<=22 
Reflections collected 52347 
Independent reflections 7542 [R(int) = 0.0329] 
Completeness to theta = 28.42° 95.9 %  
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7542 / 0 / 381 
Goodness-of-fit on F2 1.131 
Final R indices [I>2sigma(I)] R1 = 0.0257, wR2 = 0.0648 
R indices (all data) R1 = 0.0372, wR2 = 0.0728 




Table B31: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for [η5-C5H5Ru(CO)2NH2(CH2)4CH3]BF4. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 5371(2) 801(2) 2794(2) 24(1) 
C(2) 5723(2) 1574(2) 2453(2) 22(1) 
C(3) 5712(2) 1274(2) 1661(2) 25(1) 
C(4) 5352(2) 324(2) 1498(2) 29(1) 
C(5) 5148(2) 30(2) 2203(2) 29(1) 
C(6) 2933(2) 395(2) 1069(2) 21(1) 
C(7) 3451(2) 1978(2) 2080(2) 20(1) 
C(8) 3720(2) 3096(2) 514(2) 22(1) 
C(9) 3184(2) 3663(2) -319(2) 20(1) 
C(10) 3457(2) 4713(2) -153(2) 22(1) 
C(11) 2906(2) 5355(2) -944(2) 22(1) 
C(12) 3184(2) 5156(2) -1689(2) 33(1) 
C(13) 10709(2) 1626(2) 2545(2) 21(1) 
C(14) 10743(2) 1390(2) 1756(2) 23(1) 
C(15) 10405(2) 433(2) 1539(2) 24(1) 
C(16) 10175(2) 76(2) 2213(2) 25(1) 
C(17) 10343(2) 811(2) 2830(2) 21(1) 
C(18) 7949(2) 430(2) 1147(2) 20(1) 
C(19) 8428(2) 2111(2) 2007(2) 21(1) 
C(20) 8805(2) 2980(2) 331(2) 19(1) 
C(21) 8213(2) 3437(2) -557(2) 19(1) 
C(22) 8644(2) 4412(2) -610(2) 20(1) 
C(23) 8088(2) 4869(2) -1505(2) 23(1) 
C(24) 8587(2) 5787(2) -1591(2) 27(1) 
B(1) 5605(2) 2814(2) 4505(2) 22(1) 
B(2) 10674(2) 2976(2) 4531(2) 20(1) 
F(1) 4852(1) 3396(1) 4559(1) 28(1) 
F(2) 5241(1) 1898(1) 4318(1) 40(1) 
F(3) 5887(2) 3150(1) 3880(1) 48(1) 
F(4) 6477(1) 2816(1) 5311(1) 35(1) 
F(5) 9972(1) 3582(1) 4629(1) 32(1) 
F(6) 11462(1) 2772(1) 5355(1) 35(1) 
F(7) 11122(1) 3406(1) 4045(1) 34(1) 
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F(8) 10201(1) 2148(1) 4142(1) 45(1) 
N(1) 3503(1) 2064(1) 388(1) 17(1) 
N(2) 8500(1) 1973(1) 335(1) 16(1) 
O(1) 2269(1) -132(1) 826(1) 30(1) 
O(2) 3121(1) 2407(1) 2459(1) 29(1) 
O(3) 7283(1) -93(1) 932(1) 28(1) 
O(4) 8064(2) 2606(1) 2318(1) 31(1) 
Ru(1) 4094(1) 1209(1) 1545(1) 15(1) 





Table 32:  Bond lengths [Å] and angles [°] for [η5-C5H5Ru(CO)2NH2(CH2)4CH3]BF4 
_____________________________________________________ 
C(1)-C(5)  1.423(4) 
C(1)-C(2)  1.432(3) 
C(1)-Ru(1)  2.199(2) 
C(1)-H(1)  0.9801 
C(2)-C(3)  1.411(3) 
C(2)-Ru(1)  2.238(2) 
C(2)-H(2)  0.9799 
C(3)-C(4)  1.421(4) 
C(3)-Ru(1)  2.259(2) 
C(3)-H(3)  0.9800 
C(4)-C(5)  1.422(4) 
C(4)-Ru(1)  2.235(2) 
C(4)-H(4)  0.9800 
C(5)-Ru(1)  2.202(2) 
C(5)-H(5)  0.9800 
C(6)-O(1)  1.138(3) 
C(6)-Ru(1)  1.897(2) 
C(7)-O(2)  1.133(3) 
C(7)-Ru(1)  1.902(2) 
C(8)-N(1)  1.487(3) 
C(8)-C(9)  1.515(3) 
C(8)-H(8A)  0.9700 
C(8)-H(8B)  0.9700 
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C(9)-C(10)  1.528(3) 
C(9)-H(9A)  0.9700 
C(9)-H(9B)  0.9700 
C(10)-C(11)  1.529(3) 
C(10)-H(10A)  0.9700 
C(10)-H(10B)  0.9700 
C(11)-C(12)  1.519(3) 
C(11)-H(11A)  0.9700 
C(11)-H(11B)  0.9700 
C(12)-H(12A)  0.9600 
C(12)-H(12B)  0.9600 
C(12)-H(12C)  0.9600 
C(13)-C(14)  1.411(3) 
C(13)-C(17)  1.438(3) 
C(13)-Ru(2)  2.250(2) 
C(13)-H(13)  0.9800 
C(14)-C(15)  1.428(3) 
C(14)-Ru(2)  2.256(2) 
C(14)-H(14)  0.9800 
C(15)-C(16)  1.423(3) 
C(15)-Ru(2)  2.229(2) 
C(15)-H(15)  0.9800 
C(16)-C(17)  1.422(3) 
C(16)-Ru(2)  2.212(2) 
C(16)-H(16)  0.9800 
C(17)-Ru(2)  2.210(2) 
C(17)-H(17)  0.9800 
C(18)-O(3)  1.138(3) 
C(18)-Ru(2)  1.896(2) 
C(19)-O(4)  1.137(3) 
C(19)-Ru(2)  1.902(2) 
C(20)-N(2)  1.489(3) 
C(20)-C(21)  1.520(3) 
C(20)-H(20A)  0.9700 
C(20)-H(20B)  0.9700 
C(21)-C(22)  1.530(3) 
C(21)-H(21A)  0.9700 
C(21)-H(21B)  0.9700 
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C(22)-C(23)  1.523(3) 
C(22)-H(22A)  0.9700 
C(22)-H(22B)  0.9700 
C(23)-C(24)  1.521(3) 
C(23)-H(23A)  0.9700 
C(23)-H(23B)  0.9700 
C(24)-H(24A)  0.9600 
C(24)-H(24B)  0.9600 
C(24)-H(24C)  0.9600 
B(1)-F(2)  1.381(3) 
B(1)-F(3)  1.384(3) 
B(1)-F(1)  1.398(3) 
B(1)-F(4)  1.401(3) 
B(2)-F(8)  1.371(3) 
B(2)-F(5)  1.391(3) 
B(2)-F(7)  1.395(3) 
B(2)-F(6)  1.399(3) 
N(1)-Ru(1)  2.1484(18) 
N(1)-H(1A)  0.9000 
N(1)-H(1B)  0.9000 
N(2)-Ru(2)  2.1452(18) 
N(2)-H(2A)  0.9000 





























































































































































































































Table 33:  Anisotropic displacement parameters (Å2x 103)for [η5-C5H5Ru(CO)2NH2(CH2)4CH3]BF4.  
The anisotropic displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 18(1)  36(1) 17(1)  6(1) 5(1)  7(1) 
C(2) 14(1)  25(1) 21(1)  -3(1) 2(1)  1(1) 
C(3) 13(1)  41(1) 21(1)  5(1) 6(1)  2(1) 
C(4) 17(1)  38(1) 26(1)  -12(1) 5(1)  7(1) 
C(5) 20(1)  22(1) 38(1)  5(1) 7(1)  5(1) 
C(6) 20(1)  24(1) 18(1)  0(1) 8(1)  1(1) 
C(7) 16(1)  25(1) 17(1)  1(1) 6(1)  2(1) 
C(8) 23(1)  20(1) 18(1)  0(1) 5(1)  -3(1) 
C(9) 18(1)  21(1) 18(1)  1(1) 6(1)  -1(1) 
C(10) 22(1)  23(1) 20(1)  -3(1) 9(1)  -3(1) 
C(11) 23(1)  18(1) 24(1)  -2(1) 9(1)  1(1) 
C(12) 43(2)  32(1) 26(1)  4(1) 17(1)  9(1) 
C(13) 15(1)  24(1) 19(1)  -2(1) 2(1)  0(1) 
C(14) 13(1)  34(1) 21(1)  3(1) 6(1)  2(1) 
C(15) 16(1)  32(1) 23(1)  -4(1) 6(1)  7(1) 
C(16) 20(1)  22(1) 26(1)  1(1) 5(1)  5(1) 
C(17) 19(1)  25(1) 16(1)  3(1) 4(1)  3(1) 
C(18) 20(1)  23(1) 19(1)  1(1) 10(1)  3(1) 
C(19) 22(1)  26(1) 15(1)  2(1) 7(1)  2(1) 
C(20) 17(1)  19(1) 19(1)  -1(1) 5(1)  -2(1) 
C(21) 16(1)  21(1) 19(1)  0(1) 5(1)  -2(1) 
C(22) 19(1)  19(1) 22(1)  -2(1) 9(1)  -2(1) 
C(23) 21(1)  21(1) 22(1)  -1(1) 6(1)  -3(1) 
C(24) 30(1)  21(1) 30(1)  2(1) 12(1)  -1(1) 
B(1) 22(1)  23(1) 22(1)  0(1) 12(1)  1(1) 
B(2) 20(1)  23(1) 21(1)  1(1) 12(1)  -1(1) 
F(1) 28(1)  32(1) 32(1)  7(1) 19(1)  9(1) 
F(2) 35(1)  28(1) 51(1)  -12(1) 13(1)  -8(1) 
F(3) 72(1)  45(1) 55(1)  17(1) 53(1)  20(1) 
F(4) 18(1)  49(1) 32(1)  -14(1) 7(1)  0(1) 
F(5) 33(1)  34(1) 41(1)  12(1) 26(1)  12(1) 
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F(6) 21(1)  59(1) 24(1)  6(1) 10(1)  8(1) 
F(7) 40(1)  36(1) 41(1)  13(1) 31(1)  5(1) 
F(8) 48(1)  48(1) 54(1)  -29(1) 34(1)  -26(1) 
N(1) 14(1)  21(1) 16(1)  1(1) 6(1)  -1(1) 
N(2) 14(1)  19(1) 16(1)  -1(1) 6(1)  -1(1) 
O(1) 26(1)  32(1) 30(1)  -5(1) 12(1)  -10(1) 
O(2) 29(1)  36(1) 26(1)  -2(1) 15(1)  8(1) 
O(3) 23(1)  29(1) 34(1)  -3(1) 13(1)  -8(1) 
O(4) 37(1)  32(1) 28(1)  -1(1) 19(1)  10(1) 
Ru(1) 13(1)  18(1) 13(1)  -1(1) 5(1)  0(1) 
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Table B35. Crystal data and structure refinement for [η5-C5(CH3)5Ru(CO)2NH2CH2CH3]BF4. 
Empirical formula  C14 H22 B F4 N O2 Ru 
Formula weight  424.21 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.5561(2) Å = 106.1380(10)°. 
 b = 11.3098(3) Å = 99.5730(10)°. 
 c = 16.0927(4) Å  = 105.3010(10)°. 
Volume 1719.56(7) Å3 
Z 4 
Density (calculated) 1.639 Mg/m3 
Absorption coefficient 0.957 mm-1 
F(000) 856 
Crystal size 0.46 x 0.24 x 0.12 mm3 
Theta range for data collection 1.36 to 28.42°. 
Index ranges -14<=h<=14, -14<=k<=15, -21<=l<=21 
Reflections collected 44322 
Independent reflections 8618 [R(int) = 0.0206] 
Completeness to theta = 28.42° 99.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8939 and 0.6674 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8618 / 7 / 427 
Goodness-of-fit on F2 1.025 
Final R indices [I>2sigma(I)] R1 = 0.0165, wR2 = 0.0415 
R indices (all data) R1 = 0.0193, wR2 = 0.0437 






Table B36: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for [η5-C5(CH3)5Ru(CO)2NH2CH2CH3]BF4.  U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 2626(1) 2248(1) 1218(1) 16(1) 
C(2) 2850(1) 3138(1) 2097(1) 15(1) 
C(3) 4216(1) 4003(1) 2381(1) 15(1) 
C(4) 4869(1) 3627(1) 1673(1) 16(1) 
C(5) 3894(1) 2534(1) 964(1) 17(1) 
C(6) 1371(1) 1106(1) 698(1) 26(1) 
C(7) 1818(1) 3117(1) 2633(1) 24(1) 
C(8) 4912(1) 4997(1) 3293(1) 23(1) 
C(9) 6348(1) 4217(1) 1738(1) 26(1) 
C(10) 4122(2) 1720(1) 129(1) 26(1) 
C(11) 4326(1) 5927(1) 1251(1) 19(1) 
C(12) 2557(1) 3769(1) -140(1) 19(1) 
C(13) 1695(1) 5992(1) 2159(1) 20(1) 
C(14) 352(1) 6106(1) 2320(1) 27(1) 
O(1) 5089(1) 6904(1) 1338(1) 30(1) 
O(2) 2240(1) 3394(1) -901(1) 27(1) 
Ru(1) 3181(1) 4240(1) 1125(1) 12(1) 
N(1) 1507(1) 4946(1) 1302(1) 16(1) 
C(15) -3040(1) 2892(1) 4184(1) 16(1) 
C(16) -2580(1) 2527(1) 3399(1) 16(1) 
C(17) -3691(1) 1512(1) 2702(1) 16(1) 
C(18) -4855(1) 1289(1) 3063(1) 15(1) 
C(19) -4462(1) 2120(1) 3979(1) 16(1) 
C(20) -2230(2) 3951(1) 5051(1) 25(1) 
C(21) -1193(1) 3137(1) 3307(1) 24(1) 
C(22) -3705(2) 930(1) 1738(1) 23(1) 
C(23) -6263(1) 388(1) 2548(1) 22(1) 
C(24) -5395(1) 2308(1) 4574(1) 23(1) 
C(25) -4371(1) -1003(1) 3451(1) 16(1) 
C(26) -2908(1) 876(1) 5058(1) 18(1) 
C(27) -1356(2) -365(2) 2773(1) 34(1) 
C(28) 4(2) -545(2) 2757(1) 29(1) 
O(3) -2774(1) 1025(1) 5800(1) 27(1) 
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O(4) -5129(1) -2029(1) 3222(1) 24(1) 
Ru(2) -3264(1) 769(1) 3834(1) 11(1) 
N(2) -1474(1) 233(1) 3685(1) 16(1) 
B(1) 8635(2) 7388(2) 4505(1) 21(1) 
F(1) 9886(1) 8155(1) 4470(1) 42(1) 
F(2) 7634(1) 7864(1) 4194(1) 35(1) 
F(3) 8689(1) 7480(1) 5395(1) 34(1) 
F(4) 8351(1) 6107(1) 3982(1) 41(1) 
B(2) -1649(2) 2561(2) 8(1) 21(1) 
F(5) -765(1) 2361(1) -517(1) 51(1) 
F(6) -1886(1) 3719(1) 28(1) 45(1) 
F(7) -2849(1) 1543(1) -323(1) 43(1) 




Table B37: Bond lengths [Å] and angles [°] for [η5-C5(CH3)5Ru(CO)2NH2CH2CH3]BF4. 
_____________________________________________________ 
C(1)-C(2)  1.4290(17) 
C(1)-C(5)  1.4454(17) 
C(1)-C(6)  1.5008(16) 
C(1)-Ru(1)  2.2268(12) 
C(2)-C(3)  1.4260(16) 
C(2)-C(7)  1.4972(17) 
C(2)-Ru(1)  2.2715(11) 
C(3)-C(4)  1.4484(17) 
C(3)-C(8)  1.4993(17) 
C(3)-Ru(1)  2.2523(12) 
C(4)-C(5)  1.4291(17) 
C(4)-C(9)  1.5005(17) 
C(4)-Ru(1)  2.2144(12) 
C(5)-C(10)  1.4997(17) 
C(5)-Ru(1)  2.2153(12) 
C(6)-H(6A)  0.9800 
C(6)-H(6B)  0.9800 
C(6)-H(6C)  0.9800 
C(7)-H(7A)  0.9800 
94 
 
C(7)-H(7B)  0.9800 
C(7)-H(7C)  0.9800 
C(8)-H(8A)  0.9800 
C(8)-H(8B)  0.9800 
C(8)-H(8C)  0.9800 
C(9)-H(9A)  0.9800 
C(9)-H(9B)  0.9800 
C(9)-H(9C)  0.9800 
C(10)-H(10A)  0.9800 
C(10)-H(10B)  0.9800 
C(10)-H(10C)  0.9800 
C(11)-O(1)  1.1388(16) 
C(11)-Ru(1)  1.9047(13) 
C(12)-O(2)  1.1365(16) 
C(12)-Ru(1)  1.9043(13) 
C(13)-N(1)  1.4893(16) 
C(13)-C(14)  1.5148(18) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
Ru(1)-N(1)  2.1520(10) 
N(1)-H(1A)  0.9200 
N(1)-H(1B)  0.9200 
C(15)-C(16)  1.4212(17) 
C(15)-C(19)  1.4514(17) 
C(15)-C(20)  1.4991(17) 
C(15)-Ru(2)  2.2462(11) 
C(16)-C(17)  1.4447(17) 
C(16)-C(21)  1.4965(17) 
C(16)-Ru(2)  2.2686(12) 
C(17)-C(18)  1.4379(17) 
C(17)-C(22)  1.5036(17) 
C(17)-Ru(2)  2.2375(12) 
C(18)-C(19)  1.4314(17) 
C(18)-C(23)  1.5015(17) 
C(18)-Ru(2)  2.2231(12) 
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C(19)-C(24)  1.4981(17) 
C(19)-Ru(2)  2.2156(12) 
C(20)-H(20A)  0.9800 
C(20)-H(20B)  0.9800 
C(20)-H(20C)  0.9800 
C(21)-H(21A)  0.9800 
C(21)-H(21B)  0.9800 
C(21)-H(21C)  0.9800 
C(22)-H(22A)  0.9800 
C(22)-H(22B)  0.9800 
C(22)-H(22C)  0.9800 
C(23)-H(23A)  0.9800 
C(23)-H(23B)  0.9800 
C(23)-H(23C)  0.9800 
C(24)-H(24A)  0.9800 
C(24)-H(24B)  0.9800 
C(24)-H(24C)  0.9800 
C(25)-O(4)  1.1389(15) 
C(25)-Ru(2)  1.8972(12) 
C(26)-O(3)  1.1368(16) 
C(26)-Ru(2)  1.9059(13) 
C(27)-N(2)  1.4769(17) 
C(27)-C(28)  1.5051(19) 
C(27)-H(27A)  0.9900 
C(27)-H(27B)  0.9900 
C(28)-H(28A)  0.9800 
C(28)-H(28B)  0.9800 
C(28)-H(28C)  0.9800 
Ru(2)-N(2)  2.1612(10) 
N(2)-H(2A)  0.9200 
N(2)-H(2B)  0.9200 
B(1)-F(4)  1.3813(18) 
B(1)-F(2)  1.3893(17) 
B(1)-F(1)  1.3948(17) 
B(1)-F(3)  1.3961(18) 
B(2)-F(7)  1.3708(17) 
B(2)-F(5)  1.3807(18) 
B(2)-F(6)  1.3903(17) 
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Table B38: Anisotropic displacement parameters (Å2x 103)for [η5-
C5(CH3)5Ru(CO)2NH2CH2CH3]BF4.  The anisotropic displacement factor exponent takes the form: -
2π2[ h2a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 15(1)  13(1) 17(1)  5(1) 1(1)  4(1) 
C(2) 16(1)  15(1) 17(1)  8(1) 5(1)  6(1) 
C(3) 16(1)  13(1) 14(1)  5(1) 2(1)  5(1) 
C(4) 14(1)  17(1) 19(1)  9(1) 4(1)  6(1) 
C(5) 20(1)  18(1) 15(1)  6(1) 4(1)  10(1) 
C(6) 21(1)  16(1) 29(1)  4(1) -5(1)  0(1) 
C(7) 24(1)  28(1) 28(1)  15(1) 15(1)  11(1) 
C(8) 28(1)  17(1) 18(1)  2(1) -3(1)  6(1) 
C(9) 14(1)  29(1) 39(1)  20(1) 9(1)  7(1) 
C(10) 39(1)  30(1) 17(1)  7(1) 10(1)  23(1) 
C(11) 18(1)  22(1) 22(1)  10(1) 7(1)  9(1) 
C(12) 20(1)  21(1) 20(1)  9(1) 6(1)  11(1) 
C(13) 19(1)  19(1) 21(1)  2(1) 3(1)  8(1) 
C(14) 24(1)  27(1) 30(1)  4(1) 11(1)  13(1) 
O(1) 27(1)  24(1) 39(1)  15(1) 11(1)  2(1) 
O(2) 32(1)  36(1) 17(1)  9(1) 6(1)  16(1) 
Ru(1) 11(1)  13(1) 12(1)  5(1) 3(1)  4(1) 
N(1) 14(1)  17(1) 16(1)  5(1) 4(1)  6(1) 
C(15) 20(1)  12(1) 17(1)  4(1) 5(1)  5(1) 
C(16) 18(1)  14(1) 21(1)  8(1) 7(1)  6(1) 
C(17) 19(1)  17(1) 14(1)  7(1) 6(1)  9(1) 
C(18) 16(1)  15(1) 16(1)  7(1) 4(1)  7(1) 
C(19) 19(1)  14(1) 17(1)  7(1) 7(1)  8(1) 
C(20) 31(1)  16(1) 21(1)  0(1) 2(1)  4(1) 
C(21) 19(1)  22(1) 34(1)  13(1) 12(1)  5(1) 
C(22) 32(1)  26(1) 15(1)  7(1) 9(1)  15(1) 
C(23) 17(1)  22(1) 24(1)  9(1) 0(1)  5(1) 
C(24) 27(1)  24(1) 26(1)  11(1) 16(1)  13(1) 
C(25) 15(1)  18(1) 17(1)  7(1) 3(1)  7(1) 
C(26) 16(1)  17(1) 19(1)  7(1) 4(1)  5(1) 
C(27) 30(1)  56(1) 20(1)  6(1) 8(1)  27(1) 
C(28) 28(1)  29(1) 38(1)  12(1) 18(1)  16(1) 
O(3) 29(1)  34(1) 17(1)  11(1) 6(1)  7(1) 
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O(4) 20(1)  16(1) 30(1)  6(1) 1(1)  2(1) 
Ru(2) 12(1)  11(1) 11(1)  3(1) 3(1)  3(1) 
N(2) 15(1)  16(1) 17(1)  6(1) 4(1)  6(1) 
B(1) 17(1)  24(1) 22(1)  8(1) 2(1)  5(1) 
F(1) 20(1)  61(1) 28(1)  8(1) 5(1)  -7(1) 
F(2) 28(1)  33(1) 48(1)  23(1) 2(1)  12(1) 
F(3) 36(1)  42(1) 25(1)  16(1) 8(1)  10(1) 
F(4) 48(1)  29(1) 41(1)  4(1) 7(1)  17(1) 
B(2) 19(1)  22(1) 22(1)  8(1) 5(1)  7(1) 
F(5) 45(1)  79(1) 50(1)  30(1) 33(1)  33(1) 
F(6) 79(1)  35(1) 37(1)  21(1) 19(1)  34(1) 
F(7) 29(1)  42(1) 37(1)  6(1) -4(1)  -7(1) 





Table B39: Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for [η5-
C5(CH3)5Ru(CO)2NH2CH2CH3]BF4. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(6A) 1431 345 860 38 
H(6B) 1291 914 56 38 
H(6C) 570 1312 840 38 
H(7A) 1866 2521 2969 36 
H(7B) 907 2820 2229 36 
H(7C) 2005 3995 3051 36 
H(8A) 4234 5282 3570 35 
H(8B) 5571 5747 3241 35 
H(8C) 5384 4611 3667 35 
H(9A) 6886 3852 2089 38 
H(9B) 6631 5163 2030 38 
H(9C) 6492 4021 1135 38 
H(10A) 5019 2150 64 40 
H(10B) 3418 1616 -391 40 
H(10C) 4080 862 169 40 
H(13A) 2263 6834 2146 24 
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H(13B) 2184 5802 2661 24 
H(14A) -102 6363 1850 41 
H(14B) 516 6766 2905 41 
H(14C) -227 5264 2309 41 
H(1A) 1288 5248 841 19 
H(1B) 769 4248 1243 19 
H(20A) -1270 4009 5145 38 
H(20B) -2568 3751 5545 38 
H(20C) -2320 4783 5031 38 
H(21A) -1061 4048 3359 36 
H(21B) -1104 2663 2721 36 
H(21C) -505 3100 3781 36 
H(22A) -4336 34 1491 34 
H(22B) -2789 928 1697 34 
H(22C) -4000 1448 1396 34 
H(23A) -6721 29 2949 33 
H(23B) -6206 -325 2059 33 
H(23C) -6779 870 2300 33 
H(24A) -5671 3063 4553 34 
H(24B) -4922 2455 5190 34 
H(24C) -6202 1528 4368 34 
H(27A) -1508 192 2414 41 
H(27B) -2077 -1223 2486 41 
H(28A) 724 302 3034 44 
H(28B) 25 -932 2136 44 
H(28C) 148 -1123 3092 44 
H(2A) -728 971 3968 19 





















































































































































































































































































































































Table B41: Hydrogen bonds for [η5-C5(CH3)5Ru(CO)2NH2CH2CH3]BF4 [Å and °]. 
_________________________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
N(1)-H(1A)…F(6) 0.92 2.13  2.9638(15)  150  1-x,1-y,-z 
N(1)-H(1B)…F(8) 0.92 2.11 3.0196(15) 170 -1+x,y,z 
N(2)-H(2A)…F(3) 0.92 2.24 3.1521(15) 169 1+x,y,z  
N(2)-H(2B)…F(2) 0.92 2.16  2.9801(16) 148 1-x,-y,1-z 
C(21)-H(21A)…F(4) 0.98 2.55 3.4191(19) 148 1-x,1-y,1-z 
C(21)-H(21C)…F(3) 0.98 2.48  3.4338(18) 163 1+x,y,z 
_________________________________________________________________________________________ 
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Table B42: Crystal data and structure refinement for [η5-C5H5Ru(CO)2NCCH3]BF4 
 
Empirical formula  C9 H8 B F4 N O2 Ru 
Formula weight  350.04 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 6.8540(2) Å = 90°. 
 b = 15.1790(5) Å = 94.9170(10)°. 
 c = 11.5373(4) Å  = 90°. 
Volume 1195.89(7) Å3 
Z 4 
Density (calculated) 1.944 Mg/m3 
Absorption coefficient 1.353 mm-1 
F(000) 680 
Crystal size 0.35 x 0.16 x 0.15 mm3 
Theta range for data collection 2.22 to 27.99°. 
Index ranges -7<=h<=9, -19<=k<=19, -15<=l<=14 
Reflections collected 18373 
Independent reflections 2798 [R(int) = 0.0336] 
Completeness to theta = 27.99° 97.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8228 and 0.6488 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2798 / 0 / 164 
Goodness-of-fit on F2 1.119 
Final R indices [I>2sigma(I)] R1 = 0.0264, wR2 = 0.0693 
R indices (all data) R1 = 0.0290, wR2 = 0.0719 






Table B43: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for [η5-C5H5Ru(CO)2NCCH3]BF4.  U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 5134(6) 2399(3) 5106(3) 52(1) 
C(2) 3452(7) 1974(2) 5325(3) 51(1) 
C(3) 1970(5) 2267(3) 4537(3) 50(1) 
C(4) 2702(6) 2898(2) 3812(3) 47(1) 
C(5) 4762(6) 2980(2) 4173(3) 49(1) 
C(6) 753(4) 3382(2) 6477(2) 22(1) 
C(7) 2488(4) 4602(2) 5128(2) 23(1) 
C(8) 5689(4) 4121(2) 7768(2) 21(1) 
C(9) 6922(4) 4491(2) 8730(2) 28(1) 
N(1) 4735(3) 3837(1) 7004(2) 20(1) 
O(1) -598(3) 3319(1) 6971(2) 30(1) 
O(2) 2252(3) 5299(1) 4798(2) 32(1) 
B(1) 1646(5) 5648(2) 8086(3) 33(1) 
F(1) 3497(3) 5891(1) 7834(2) 51(1) 
F(2) 413(4) 5470(2) 7127(2) 62(1) 
F(3) 841(3) 6288(1) 8763(2) 45(1) 
F(4) 1852(3) 4860(1) 8734(2) 45(1) 




Table B44: Bond lengths [Å] and angles [°] for [η5-C5H5Ru(CO)2NCCH3]BF4. 
_____________________________________________________ 
C(1)-C(2)  1.363(6) 
C(1)-C(5)  1.398(6) 
C(1)-Ru(1)  2.232(3) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.378(6) 
C(2)-Ru(1)  2.223(3) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.393(5) 
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C(3)-Ru(1)  2.188(3) 
C(3)-H(3)  1.0000 
C(4)-C(5)  1.443(6) 
C(4)-Ru(1)  2.179(3) 
C(4)-H(4)  1.0000 
C(5)-Ru(1)  2.218(3) 
C(5)-H(5)  1.0000 
C(6)-O(1)  1.132(3) 
C(6)-Ru(1)  1.909(3) 
C(7)-O(2)  1.132(3) 
C(7)-Ru(1)  1.910(3) 
C(8)-N(1)  1.136(3) 
C(8)-C(9)  1.449(4) 
C(9)-H(9A)  0.9800 
C(9)-H(9B)  0.9800 
C(9)-H(9C)  0.9800 
N(1)-Ru(1)  2.056(2) 
B(1)-F(2)  1.361(4) 
B(1)-F(1)  1.376(4) 
B(1)-F(3)  1.390(4) 






















































































Table B45: Anisotropic displacement parameters (Å2x 103)for [η5-C5H5Ru(CO)2NCCH3]BF4.  The 
anisotropic displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 49(2)  58(2) 47(2)  -29(2) -11(2)  28(2) 
C(2) 97(3)  24(2) 35(2)  -4(1) 18(2)  8(2) 
C(3) 46(2)  49(2) 57(2)  -35(2) 20(2)  -23(2) 
C(4) 74(3)  44(2) 21(2)  -12(1) -9(2)  17(2) 
C(5) 61(2)  37(2) 56(2)  -27(2) 42(2)  -22(2) 
C(6) 21(1)  22(1) 23(1)  1(1) -2(1)  2(1) 
C(7) 18(1)  29(1) 21(1)  2(1) -1(1)  -2(1) 
C(8) 18(1)  24(1) 21(1)  1(1) 3(1)  3(1) 
C(9) 26(1)  31(1) 24(1)  -3(1) -3(1)  -4(1) 
N(1) 17(1)  23(1) 22(1)  -1(1) 2(1)  3(1) 
O(1) 22(1)  34(1) 35(1)  7(1) 7(1)  3(1) 
O(2) 29(1)  29(1) 37(1)  10(1) -2(1)  -1(1) 
B(1) 27(2)  43(2) 28(2)  -10(1) 1(1)  1(1) 
F(1) 35(1)  45(1) 77(2)  2(1) 16(1)  -2(1) 
F(2) 61(1)  80(2) 42(1)  -10(1) -19(1)  0(1) 
F(3) 52(1)  39(1) 44(1)  -6(1) 12(1)  14(1) 
F(4) 50(1)  39(1) 48(1)  4(1) 7(1)  3(1) 








 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 6447 2295 5532 63 
H(2) 3333 1503 5921 62 
H(3) 601 2033 4462 60 
H(4) 1984 3180 3118 56 
H(5) 5746 3341 3791 59 
H(9A) 7941 4857 8427 41 
H(9B) 7535 4013 9203 41 


















































































































Cyclopentadienyl ruthenium(II) 1,2-diethylamine complex – {[η5-
C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2 (Polymorph 1) 
 
 
          
 
Four grown cations and four anions 
 
 













Table B47: Crystal data and structure refinement for {[η5-C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2. 
Formula weight  678.08 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 11.7324(3) Å = 92.8290(10)°. 
 b = 13.9727(3) Å = 93.3210(10)°. 
 c = 14.1296(3) Å  = 98.9230(10)°. 
Volume 2280.44(9) Å3 
Z 4 
Density (calculated) 1.975 Mg/m3 




Crystal size 0.45 x 0.33 x 0.26 mm3 
Theta range for data collection 1.45 to 28.00°. 
Index ranges -15<=h<=15, -18<=k<=18, -18<=l<=18 
Reflections collected 53134 
Independent reflections 10821 [R(int) = 0.0213] 
Completeness to theta = 28.00° 98.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7098 and 0.5684 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10821 / 0 / 613 
Goodness-of-fit on F2 1.048 
Final R indices [I>2sigma(I)] R1 = 0.0357, wR2 = 0.0873 
R indices (all data) R1 = 0.0465, wR2 = 0.0938 
Largest diff. peak and hole 2.155 and -1.092 e.Å-3 
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Table B48: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for {η5-C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2.  U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 9800(4) 5015(3) 3818(3) 31(1) 
C(2) 10907(4) 5220(3) 3480(3) 31(1) 
C(3) 11260(4) 6248(3) 3507(3) 30(1) 
C(4) 10340(4) 6679(3) 3893(3) 28(1) 
C(5) 9447(4) 5921(3) 4087(3) 31(1) 
C(6) 8047(3) 5588(3) 2252(2) 23(1) 
C(7) 9671(3) 7015(3) 1849(2) 22(1) 
C(8) 9885(3) 5367(3) 382(2) 20(1) 
C(9) 9369(4) 901(3) 954(3) 33(1) 
C(10) 9548(4) -63(3) 1149(3) 28(1) 
C(11) 10708(4) -15(3) 1485(3) 30(1) 
C(12) 11254(4) 962(4) 1514(3) 40(1) 
C(13) 10419(5) 1523(3) 1176(3) 42(1) 
C(14) 8229(3) 750(3) 2762(3) 25(1) 
C(15) 10196(3) 2092(3) 3214(3) 24(1) 
C(16) 9810(3) 328(3) 4627(2) 20(1) 
C(17) 6057(4) 8112(3) 161(4) 43(1) 
C(18) 6484(4) 8076(4) 1105(4) 51(1) 
C(19) 5878(5) 8671(3) 1679(4) 47(1) 
C(20) 5090(4) 9048(3) 1086(3) 37(1) 
C(21) 5190(4) 8700(3) 143(3) 33(1) 
C(22) 4470(4) 6762(3) 2124(3) 31(1) 
C(23) 3007(4) 7531(3) 960(3) 32(1) 
C(24) 5126(3) 5437(3) 352(2) 21(1) 
C(25) 5744(4) 3974(3) 4997(3) 32(1) 
C(26) 5957(4) 4130(3) 4022(3) 37(1) 
C(27) 4914(4) 3847(3) 3474(3) 39(1) 
C(28) 4037(4) 3492(3) 4091(3) 38(1) 
C(29) 4567(4) 3588(3) 5031(3) 31(1) 
C(30) 6979(3) 2340(3) 4273(3) 27(1) 
C(31) 5077(3) 1798(3) 2963(3) 29(1) 
C(32) 5213(3) 388(3) 4662(3) 24(1) 
B(1) 7707(4) 8048(4) 3859(4) 33(1) 
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B(2) 7437(4) 3048(4) 1564(3) 31(1) 
B(3) 2697(4) 9016(4) 3213(3) 33(1) 
B(4) 2578(4) 3898(3) 1261(3) 30(1) 
N(1) 10030(3) 5012(2) 1342(2) 20(1) 
N(2) 10245(3) 99(2) 3689(2) 20(1) 
N(3) 4338(3) 6144(2) 142(2) 22(1) 
N(4) 4850(3) 1328(2) 4927(2) 26(1) 
O(1) 9628(2) 7701(2) 1460(2) 30(1) 
O(2) 7054(2) 5443(2) 2133(2) 35(1) 
O(3) 10443(3) 2829(2) 3605(2) 33(1) 
O(4) 7257(2) 654(2) 2853(2) 33(1) 
O(5) 2069(3) 7635(3) 945(3) 49(1) 
O(6) 4384(3) 6361(3) 2808(2) 45(1) 
O(7) 7939(3) 2286(2) 4379(2) 38(1) 
O(8) 4843(3) 1394(2) 2250(2) 39(1) 
F(1) 8667(2) 8316(2) 3352(2) 49(1) 
F(2) 8015(3) 7685(4) 4673(3) 88(1) 
F(3) 6959(4) 7347(3) 3321(3) 89(1) 
F(4) 7184(3) 8835(3) 3974(3) 79(1) 
F(5) 7906(2) 3657(2) 872(2) 35(1) 
F(6) 8137(3) 3220(2) 2397(2) 53(1) 
F(7) 7324(2) 2091(2) 1237(2) 43(1) 
F(8) 6340(2) 3272(2) 1723(2) 37(1) 
F(9) 3428(3) 8381(2) 3500(2) 51(1) 
F(10) 3110(2) 9472(2) 2427(2) 50(1) 
F(11) 2661(2) 9735(3) 3929(2) 61(1) 
F(12) 1591(2) 8526(2) 2995(2) 37(1) 
F(13) 2602(2) 4898(2) 1164(2) 38(1) 
F(14) 3700(2) 3711(2) 1428(2) 37(1) 
F(15) 2104(2) 3402(2) 426(2) 39(1) 
F(16) 1908(3) 3624(2) 2005(2) 48(1) 
Ru(1) 9652(1) 5880(1) 2546(1) 17(1) 
Ru(2) 9811(1) 891(1) 2487(1) 20(1) 
Ru(3) 4616(1) 7464(1) 1020(1) 21(1) 






Table B49: Bond lengths [Å] and angles [°] for  {[η5-C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2. 
_____________________________________________________ 
C(1)-C(2)  1.402(6) 
C(1)-C(5)  1.433(6) 
C(1)-Ru(1)  2.228(4) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.430(6) 
C(2)-Ru(1)  2.253(4) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.435(6) 
C(3)-Ru(1)  2.236(4) 
C(3)-H(3)  1.0000 
C(4)-C(5)  1.418(6) 
C(4)-Ru(1)  2.203(4) 
C(4)-H(4)  1.0000 
C(5)-Ru(1)  2.202(4) 
C(5)-H(5)  1.0000 
C(6)-O(2)  1.152(5) 
C(6)-Ru(1)  1.882(4) 
C(7)-O(1)  1.135(4) 
C(7)-Ru(1)  1.906(4) 
C(8)-N(1)  1.477(4) 
C(8)-C(8)#1  1.516(6) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(13)  1.402(7) 
C(9)-C(10)  1.432(6) 
C(9)-Ru(2)  2.199(4) 
C(9)-H(9)  1.0000 
C(10)-C(11)  1.405(6) 
C(10)-Ru(2)  2.236(4) 
C(10)-H(10)  1.0000 
C(11)-C(12)  1.412(6) 
C(11)-Ru(2)  2.263(4) 
C(11)-H(11)  1.0000 
C(12)-C(13)  1.422(7) 
C(12)-Ru(2)  2.235(4) 
C(12)-H(12)  1.0000 
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C(13)-Ru(2)  2.199(4) 
C(13)-H(13)  1.0000 
C(14)-O(4)  1.143(5) 
C(14)-Ru(2)  1.901(4) 
C(15)-O(3)  1.133(5) 
C(15)-Ru(2)  1.901(4) 
C(16)-N(2)  1.486(4) 
C(16)-C(16)#2  1.522(7) 
C(16)-H(16A)  0.9900 
C(16)-H(16B)  0.9900 
C(17)-C(21)  1.402(6) 
C(17)-C(18)  1.404(8) 
C(17)-Ru(3)  2.241(4) 
C(17)-H(17)  1.0000 
C(18)-C(19)  1.427(8) 
C(18)-Ru(3)  2.220(5) 
C(18)-H(18)  1.0000 
C(19)-C(20)  1.392(7) 
C(19)-Ru(3)  2.195(4) 
C(19)-H(19)  1.0000 
C(20)-C(21)  1.414(6) 
C(20)-Ru(3)  2.193(4) 
C(20)-H(20)  1.0000 
C(21)-Ru(3)  2.218(4) 
C(21)-H(21)  1.0000 
C(22)-O(6)  1.142(5) 
C(22)-Ru(3)  1.886(4) 
C(23)-O(5)  1.132(5) 
C(23)-Ru(3)  1.901(4) 
C(24)-N(3)  1.482(4) 
C(24)-C(24)#3  1.518(7) 
C(24)-H(24A)  0.9900 
C(24)-H(24B)  0.9900 
C(25)-C(29)  1.407(6) 
C(25)-C(26)  1.435(6) 
C(25)-Ru(4)  2.240(4) 
C(25)-H(25)  1.0000 
C(26)-C(27)  1.401(7) 
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C(26)-Ru(4)  2.199(4) 
C(26)-H(26)  1.0000 
C(27)-C(28)  1.433(7) 
C(27)-Ru(4)  2.207(4) 
C(27)-H(27)  1.0000 
C(28)-C(29)  1.425(6) 
C(28)-Ru(4)  2.234(4) 
C(28)-H(28)  1.0000 
C(29)-Ru(4)  2.259(4) 
C(29)-H(29)  1.0000 
C(30)-O(7)  1.142(5) 
C(30)-Ru(4)  1.899(4) 
C(31)-O(8)  1.128(5) 
C(31)-Ru(4)  1.906(4) 
C(32)-N(4)  1.480(5) 
C(32)-C(32)#4  1.527(7) 
C(32)-H(32A)  0.9900 
C(32)-H(32B)  0.9900 
B(1)-F(2)  1.333(6) 
B(1)-F(4)  1.347(6) 
B(1)-F(3)  1.374(6) 
B(1)-F(1)  1.382(5) 
B(2)-F(7)  1.378(6) 
B(2)-F(6)  1.384(5) 
B(2)-F(8)  1.399(5) 
B(2)-F(5)  1.408(5) 
B(3)-F(12)  1.381(5) 
B(3)-F(10)  1.383(6) 
B(3)-F(9)  1.385(5) 
B(3)-F(11)  1.397(5) 
B(4)-F(15)  1.380(6) 
B(4)-F(16)  1.381(5) 
B(4)-F(14)  1.391(5) 
B(4)-F(13)  1.407(5) 
N(1)-Ru(1)  2.147(3) 
N(1)-H(1A)  0.9200 
N(1)-H(1B)  0.9200 
N(2)-Ru(2)  2.151(3) 
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N(2)-H(2A)  0.9200 
N(2)-H(2B)  0.9200 
N(3)-Ru(3)  2.142(3) 
N(3)-H(3A)  0.9200 
N(3)-H(3B)  0.9200 
N(4)-Ru(4)  2.148(3) 
N(4)-H(4A)  0.9200 











































































































































































































































































































































Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,-y+1,-z    #2 -x+2,-y,-z+1    #3 -x+1,-y+1,-z  







Table B50:  Anisotropic displacement parameters (Å2x 103)for  {[η5-
C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2.  The anisotropic displacement factor exponent takes the form: 
-2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 50(2)  28(2) 16(2)  5(2) -5(2)  7(2) 
C(2) 44(2)  32(2) 21(2)  -2(2) -9(2)  20(2) 
C(3) 31(2)  36(2) 24(2)  -4(2) -10(2)  9(2) 
C(4) 38(2)  28(2) 17(2)  -5(1) -8(2)  10(2) 
C(5) 46(2)  36(2) 12(2)  0(2) 1(2)  13(2) 
C(6) 29(2)  24(2) 16(2)  2(1) 2(1)  6(1) 
C(7) 26(2)  24(2) 16(2)  -4(1) 0(1)  6(1) 
C(8) 24(2)  22(2) 13(2)  0(1) 1(1)  5(1) 
C(9) 54(3)  33(2) 17(2)  4(2) 3(2)  19(2) 
C(10) 39(2)  26(2) 20(2)  0(1) 4(2)  8(2) 
C(11) 39(2)  37(2) 18(2)  1(2) 9(2)  16(2) 
C(12) 36(2)  56(3) 26(2)  -3(2) 17(2)  -2(2) 
C(13) 76(3)  28(2) 20(2)  5(2) 18(2)  -1(2) 
C(14) 34(2)  23(2) 19(2)  1(1) -1(1)  7(2) 
C(15) 31(2)  23(2) 21(2)  6(1) 7(1)  5(2) 
C(16) 24(2)  22(2) 15(2)  0(1) 4(1)  7(1) 
C(17) 44(3)  25(2) 62(3)  2(2) 29(2)  0(2) 
C(18) 33(2)  37(3) 83(4)  23(3) 0(2)  2(2) 
C(19) 62(3)  31(2) 38(2)  5(2) -10(2)  -20(2) 
C(20) 48(3)  20(2) 45(3)  1(2) 16(2)  4(2) 
C(21) 40(2)  25(2) 33(2)  3(2) 5(2)  0(2) 
C(22) 35(2)  31(2) 23(2)  -3(2) 0(2)  -3(2) 
C(23) 31(2)  34(2) 31(2)  -9(2) 7(2)  3(2) 
C(24) 22(2)  22(2) 19(2)  2(1) -1(1)  5(1) 
C(25) 43(2)  30(2) 24(2)  4(2) 1(2)  6(2) 
C(26) 51(3)  31(2) 32(2)  8(2) 12(2)  11(2) 
C(27) 63(3)  35(2) 23(2)  4(2) -1(2)  21(2) 
C(28) 40(2)  42(3) 34(2)  -3(2) -4(2)  16(2) 
C(29) 43(2)  27(2) 26(2)  0(2) 7(2)  10(2) 
C(30) 29(2)  34(2) 19(2)  0(2) 3(1)  3(2) 
C(31) 29(2)  32(2) 24(2)  6(2) 4(2)  1(2) 
C(32) 21(2)  30(2) 19(2)  3(2) 1(1)  2(1) 
B(1) 26(2)  29(2) 41(3)  -1(2) 3(2)  2(2) 
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B(2) 33(2)  30(2) 28(2)  6(2) -4(2)  7(2) 
B(3) 27(2)  43(3) 30(2)  -12(2) -3(2)  13(2) 
B(4) 27(2)  29(2) 36(2)  4(2) 9(2)  8(2) 
N(1) 25(2)  21(2) 14(1)  -2(1) 1(1)  7(1) 
N(2) 25(2)  22(2) 16(1)  2(1) 6(1)  8(1) 
N(3) 25(2)  22(2) 20(1)  0(1) -1(1)  6(1) 
N(4) 24(2)  32(2) 23(2)  6(1) 5(1)  6(1) 
O(1) 36(2)  25(1) 29(1)  6(1) 3(1)  9(1) 
O(2) 26(2)  42(2) 38(2)  2(1) 2(1)  6(1) 
O(3) 44(2)  23(1) 30(2)  -1(1) 5(1)  2(1) 
O(4) 26(2)  35(2) 37(2)  1(1) 2(1)  6(1) 
O(5) 28(2)  65(2) 53(2)  -22(2) 5(1)  10(2) 
O(6) 61(2)  49(2) 23(2)  8(1) 3(1)  -3(2) 
O(7) 28(2)  51(2) 32(2)  -7(1) 0(1)  5(1) 
O(8) 46(2)  42(2) 25(2)  -2(1) 1(1)  -5(1) 
F(1) 40(2)  38(2) 69(2)  -5(1) 24(1)  0(1) 
F(2) 63(2)  136(4) 65(2)  54(2) -3(2)  7(2) 
F(3) 87(3)  104(3) 52(2)  8(2) -1(2)  -58(2) 
F(4) 75(2)  72(2) 105(3)  15(2) 50(2)  40(2) 
F(5) 29(1)  38(1) 35(1)  3(1) 5(1)  -3(1) 
F(6) 58(2)  53(2) 43(2)  6(1) -25(1)  5(1) 
F(7) 45(2)  29(1) 57(2)  1(1) -5(1)  11(1) 
F(8) 37(1)  46(2) 33(1)  14(1) 9(1)  11(1) 
F(9) 47(2)  68(2) 45(2)  -7(1) -10(1)  34(2) 
F(10) 39(2)  49(2) 64(2)  7(1) 16(1)  6(1) 
F(11) 33(1)  90(2) 59(2)  -47(2) -15(1)  29(2) 
F(12) 30(1)  37(1) 42(1)  2(1) -2(1)  4(1) 
F(13) 29(1)  29(1) 56(2)  6(1) 7(1)  6(1) 
F(14) 30(1)  51(2) 33(1)  6(1) -1(1)  15(1) 
F(15) 34(1)  39(1) 43(1)  1(1) -4(1)  10(1) 
F(16) 55(2)  40(2) 51(2)  4(1) 31(1)  5(1) 
Ru(1) 23(1)  17(1) 12(1)  -1(1) 0(1)  6(1) 
Ru(2) 26(1)  17(1) 16(1)  2(1) 5(1)  5(1) 
Ru(3) 24(1)  20(1) 17(1)  -1(1) 3(1)  3(1) 






Table B51:  Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for 
{[η5-C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 9363 4355 3904 37 
H(2) 11380 4724 3263 38 
H(3) 12024 6598 3338 37 
H(4) 10354 7387 4048 33 
H(5) 8724 6004 4401 37 
H(8A) 10424 5980 339 24 
H(8B) 9087 5505 273 24 
H(9) 8649 1087 653 40 
H(10) 8968 -667 1025 33 
H(11) 11088 -580 1660 36 
H(12) 12090 1206 1691 48 
H(13) 10572 2231 1065 50 
H(16A) 8955 246 4568 24 
H(16B) 10106 1014 4833 24 
H(17) 6339 7788 -407 52 
H(18) 7136 7741 1328 61 
H(19) 6037 8832 2376 57 
H(20) 4585 9526 1287 45 
H(21) 4764 8882 -438 39 
H(24A) 5029 5223 1004 25 
H(24B) 5938 5754 319 25 
H(25) 6317 4148 5555 39 
H(26) 6701 4447 3784 44 
H(27) 4791 3922 2777 47 
H(28) 3198 3273 3905 46 
H(29) 4164 3423 5621 37 
H(32A) 6068 475 4673 28 
H(32B) 4903 172 4007 28 
H(1A) 10784 4913 1434 24 
H(1B) 9571 4416 1347 24 
H(2A) 9989 -548 3532 24 
H(2B) 11038 178 3767 24 
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H(3A) 3591 5843 194 27 
H(3B) 4403 6300 -480 27 
H(4A) 5095 1488 5554 31 
































































































































































































































































































































































































































Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,-y+1,-z    #2 -x+2,-y,-z+1    #3 -x+1,-y+1,-z  




Table B53: Hydrogen bonds for {[η5-C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2 [Å and °]. 
 
D-H…A   [ARU]  D – H  H...A  D...A  D - H...A 
 
N(1)  --H(1A)  ..F(13) [2566.08] 0.92  2.19  3.072(4)  160 
N(1)  --H(1B)  ..F(5)  [2666.06]  0.92  2.13  2.908(4)  142 
N(2)  --H(2A)  ..F(1)   [2656.05]        0.92        2.03     2.866(4)         150 
N(2)  --H(2B)  ..F(11)   [2756.07]        0.92        2.09     2.960(4)         156 
N(3)  --H(3B)  ..F(8)    [2665.06]        0.92        2.07     2.900(4)         149 
N(4)  --H(4A)  ..F(9)    [        ]        0.92        2.11     2.885(4)         142 
C(2)  --H(2)   ..F(16)   [2566.08]        1.00        2.46     3.367(5)         150 
C(8)  --H(8B)  ..F(15)   [1556.08]        0.99        2.43     3.292(4)         145 
C(17) --H(17)  ..F(14)   [2665.08]        1.00        2.48     3.368(6)         148 
C(27) --H(27)  ..F(14)   [         ]        1.00        2.21     3.132(5)         152 
C(29) --H(29)  ..F(3)    [        ]        1.00        2.25     3.224(6)         163 
 
 
Translation of ARU-code to Equivalent Position Code 
=================================================== 
   [  2666. ]  = 1-x,1-y,1-z 
   [  2566. ]  = -x,1-y,1-z 
   [  1556. ]  = x,y,1+z 
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   [  2656. ]  = 1-x,-y,1-z 
   [  1655. ]  = 1+x,y,z 
   [  2756. ]  = 2-x,-y,1-z 
   [  2665. ]  = 1-x,1-y,-z 
  




Cyclopentadienyl ruthenium(II) 1,2-diethylamine complex – {[η5-









Table B54: Crystal data and structure refinement for {[η5-C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2. 
Empirical formula  C16 H18 B2 F8 N2 O4 Ru2 
Formula weight  678.08 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 12.5336(5) Å = 90°. 
 b = 12.9444(5) Å = 93.562(2)°. 
 c = 13.7516(5) Å  = 90°. 
Volume 2226.75(15) Å3 
Z 4 
Density (calculated) 2.023 Mg/m3 
Absorption coefficient 1.450 mm-1 
F(000) 1320 
Crystal size 0.37 x 0.19 x 0.14 mm3 
Theta range for data collection 2.13 to 25.00°. 
Index ranges -14<=h<=14, -15<=k<=14, -16<=l<=16 
Reflections collected 28701 
Independent reflections 3915 [R(int) = 0.0321] 
Completeness to theta = 25.00° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8228 and 0.6161 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3915 / 0 / 307 
Goodness-of-fit on F2 1.026 
Final R indices [I>2sigma(I)] R1 = 0.0238, wR2 = 0.0572 
R indices (all data) R1 = 0.0268, wR2 = 0.0595 






Table B55: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for [η5-C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 1615(3) 40(3) 55(3) 38(1) 
C(2) 1540(3) -511(3) 913(3) 35(1) 
C(3) 1056(3) 120(3) 1590(3) 37(1) 
C(4) 815(3) 1051(3) 1153(3) 39(1) 
C(5) 1161(3) 1044(3) 194(3) 45(1) 
C(6) 2791(3) 2258(3) 1691(2) 26(1) 
C(7) 3354(3) 336(2) 2357(2) 24(1) 
C(8) 7532(3) 2678(2) 547(2) 25(1) 
C(9) 8266(3) 2719(2) 1365(2) 24(1) 
C(10) 9178(2) 3284(2) 1091(2) 23(1) 
C(11) 8997(2) 3572(2) 96(2) 25(1) 
C(12) 7968(3) 3205(2) -236(2) 25(1) 
C(13) 8067(2) 5642(3) 408(2) 24(1) 
C(14) 7951(3) 4865(2) 2255(2) 26(1) 
C(15) 4519(2) -60(2) 308(2) 22(1) 
C(16) 5608(2) 5002(2) -8(2) 19(1) 
N(1) 3972(2) 940(2) 441(2) 21(1) 
N(3) 6105(2) 4588(2) 907(2) 23(1) 
O(1) 2863(2) 3087(2) 1950(2) 37(1) 
O(2) 3762(2) -11(2) 3044(2) 35(1) 
O(3) 8291(2) 6384(2) 30(2) 37(1) 
O(4) 8084(2) 5139(2) 3036(2) 39(1) 
B(1) 9427(3) 7579(3) 2353(3) 30(1) 
B(2) 5038(3) 7410(3) 1421(3) 24(1) 
F(1) 9327(2) 8646(2) 2237(2) 64(1) 
F(2) 9656(2) 7382(2) 3324(2) 64(1) 
F(3) 8445(2) 7181(2) 2047(2) 56(1) 
F(4) 10219(2) 7232(2) 1789(2) 55(1) 
F(5) 4788(2) 7280(2) 431(1) 35(1) 
F(6) 5392(2) 6478(1) 1840(1) 33(1) 
F(7) 5837(2) 8147(2) 1541(2) 40(1) 
F(8) 4146(2) 7738(2) 1871(2) 53(1) 
Ru(1) 2562(1) 876(1) 1250(1) 17(1) 
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Ru(2) 7794(1) 4335(1) 962(1) 15(1) 
________________________________________________________________________________  
 
Table B56: Bond lengths [Å] and angles [°] for [η5-C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2. 
_____________________________________________________ 
C(1)-C(2)  1.386(5) 
C(1)-C(5)  1.436(6) 
C(1)-Ru(1)  2.245(3) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.406(5) 
C(2)-Ru(1)  2.237(3) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.371(6) 
C(3)-Ru(1)  2.202(3) 
C(3)-H(3)  1.0000 
C(4)-C(5)  1.415(6) 
C(4)-Ru(1)  2.197(3) 
C(4)-H(4)  1.0000 
C(5)-Ru(1)  2.219(4) 
C(5)-H(5)  1.0000 
C(6)-O(1)  1.132(4) 
C(6)-Ru(1)  1.905(3) 
C(7)-O(2)  1.138(4) 
C(7)-Ru(1)  1.899(3) 
C(8)-C(9)  1.409(5) 
C(8)-C(12)  1.413(5) 
C(8)-Ru(2)  2.239(3) 
C(8)-H(8)  1.0000 
C(9)-C(10)  1.427(4) 
C(9)-Ru(2)  2.235(3) 
C(9)-H(9)  1.0000 
C(10)-C(11)  1.423(4) 
C(10)-Ru(2)  2.203(3) 
C(10)-H(10)  1.0000 
C(11)-C(12)  1.423(5) 
C(11)-Ru(2)  2.213(3) 
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C(11)-H(11)  1.0000 
C(12)-Ru(2)  2.224(3) 
C(12)-H(12)  1.0000 
C(13)-O(3)  1.136(4) 
C(13)-Ru(2)  1.895(3) 
C(14)-O(4)  1.132(4) 
C(14)-Ru(2)  1.905(3) 
C(15)-N(1)  1.482(4) 
C(15)-C(15)#1  1.524(6) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(16)-N(3)  1.471(4) 
C(16)-C(16)#2  1.527(5) 
C(16)-H(16A)  0.9900 
C(16)-H(16B)  0.9900 
N(1)-Ru(1)  2.148(2) 
N(1)-H(1A)  0.9200 
N(1)-H(1B)  0.9200 
N(3)-Ru(2)  2.139(2) 
N(3)-H(3A)  0.9200 
N(3)-H(3B)  0.9200 
B(1)-F(2)  1.372(4) 
B(1)-F(4)  1.372(4) 
B(1)-F(3)  1.376(5) 
B(1)-F(1)  1.395(5) 
B(2)-F(8)  1.378(4) 
B(2)-F(7)  1.385(4) 
B(2)-F(5)  1.388(4) 







































































































































































Symmetry transformations used to generate equivalent atoms:  




Table B57: Anisotropic displacement parameters (Å2x 103)for {[η5-
C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2.  The anisotropic displacement factor exponent takes the form: 
-2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 28(2)  58(3) 30(2)  -19(2) 9(2)  -13(2) 
C(2) 34(2)  20(2) 50(2)  -6(2) 1(2)  -4(1) 
C(3) 26(2)  50(2) 36(2)  -2(2) 11(2)  -13(2) 
C(4) 21(2)  44(2) 52(2)  -19(2) -3(2)  10(2) 
C(5) 44(2)  38(2) 48(2)  18(2) -26(2)  -16(2) 
C(6) 26(2)  29(2) 22(2)  0(1) 4(1)  1(1) 
C(7) 27(2)  24(2) 23(2)  -1(1) 9(1)  2(1) 
C(8) 28(2)  18(2) 30(2)  -8(1) 3(1)  -2(1) 
C(9) 30(2)  16(2) 25(2)  -1(1) 1(1)  2(1) 
C(10) 20(2)  22(2) 28(2)  -2(1) -1(1)  8(1) 
C(11) 23(2)  25(2) 28(2)  -2(1) 9(1)  7(1) 
C(12) 29(2)  24(2) 20(2)  -8(1) 1(1)  8(1) 
C(13) 22(2)  25(2) 26(2)  -2(1) -4(1)  1(1) 
C(14) 29(2)  21(2) 28(2)  -2(1) 2(1)  9(1) 
C(15) 22(2)  21(2) 23(2)  -1(1) 7(1)  1(1) 
C(16) 16(2)  20(2) 21(2)  0(1) 2(1)  1(1) 
N(1) 23(1)  21(1) 19(1)  1(1) 7(1)  -1(1) 
N(3) 17(1)  30(2) 20(1)  1(1) 2(1)  4(1) 
O(1) 48(2)  21(1) 42(2)  -9(1) 1(1)  -1(1) 
O(2) 45(2)  37(1) 24(1)  4(1) -1(1)  6(1) 
O(3) 40(1)  27(1) 42(2)  9(1) -3(1)  -7(1) 
O(4) 59(2)  38(2) 19(1)  -8(1) -3(1)  12(1) 
B(1) 36(2)  31(2) 24(2)  -8(2) 10(2)  -4(2) 
B(2) 28(2)  21(2) 22(2)  -2(1) 0(1)  -3(1) 
F(1) 101(2)  39(1) 56(2)  -4(1) 32(2)  -6(1) 
F(2) 57(2)  108(2) 26(1)  7(1) 4(1)  37(2) 
F(3) 48(1)  62(2) 57(2)  -16(1) 4(1)  -12(1) 
F(4) 46(1)  84(2) 34(1)  -19(1) 11(1)  20(1) 
F(5) 54(1)  26(1) 23(1)  -1(1) -7(1)  -5(1) 
F(6) 50(1)  24(1) 24(1)  2(1) 0(1)  1(1) 
F(7) 47(1)  37(1) 34(1)  11(1) -15(1)  -19(1) 
F(8) 48(1)  59(2) 53(1)  5(1) 22(1)  14(1) 
Ru(1) 19(1)  16(1) 17(1)  0(1) 5(1)  1(1) 
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Table B58:  Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for 
{[η5-C5H5Ru(CO)2]2NH2(CH2)2NH2}(BF4)2. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 1896 -228 -561 46 
H(2) 1762 -1247 1020 42 
H(3) 856 -96 2253 45 
H(4) 413 1626 1450 47 
H(5) 1044 1597 -309 53 
H(8) 6829 2311 518 30 
H(9) 8181 2379 2009 28 
H(10) 9851 3398 1505 28 
H(11) 9520 3927 -311 30 
H(12) 7637 3261 -914 30 
H(15A) 4009 -556 -13 26 
H(15B) 4757 -345 953 26 
H(16A) 5827 4579 -562 23 
H(16B) 5861 5718 -104 23 
H(1A) 3789 1213 -164 25 
H(1B) 4450 1388 753 25 
H(3A) 5779 3969 1034 27 




















































































































































































































Symmetry transformations used to generate equivalent atoms:  
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Table B60: Crystal data and structure refinement for [η5-C5H5Ru(CO)2NH2CH2C6H5]BF4. 
Empirical formula  C14 H14 B F4 N O2 Ru 
Formula weight  416.14 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 10.4488(3) Å = 90°. 
 b = 9.7788(4) Å = 99.2360(10)°. 
 c = 31.7901(11) Å  = 90°. 
Volume 3206.10(19) Å3 
Z 8 
Density (calculated) 1.724 Mg/m3 
Absorption coefficient 1.025 mm-1 
F(000) 1648 
Crystal size 0.39 x 0.28 x 0.14 mm3 
Theta range for data collection 1.98 to 28.45°. 
Index ranges -13<=h<=14, -11<=k<=13, -42<=l<=42 
Reflections collected 40725 
Independent reflections 8054 [R(int) = 0.0185] 
Completeness to theta = 28.45° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8698 and 0.6907 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8054 / 0 / 415 
Goodness-of-fit on F2 1.090 
Final R indices [I>2sigma(I)] R1 = 0.0238, wR2 = 0.0546 
R indices (all data) R1 = 0.0259, wR2 = 0.0557 






Table B61: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for [η5-C5H5Ru(CO)2NH2CH2C6H5]BF4..  U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 5946(3) 4080(3) 2972(1) 48(1) 
C(2) 4674(2) 3648(3) 3014(1) 38(1) 
C(3) 4676(2) 2205(3) 3007(1) 34(1) 
C(4) 5913(2) 1741(3) 2959(1) 40(1) 
C(5) 6710(2) 2918(3) 2932(1) 47(1) 
C(6) 5252(2) 4538(2) 2045(1) 31(1) 
C(7) 5917(2) 1848(2) 2013(1) 26(1) 
C(8) 2715(2) 3084(2) 1652(1) 27(1) 
C(9) 1447(2) 2472(2) 1444(1) 26(1) 
C(10) 286(2) 2826(3) 1579(1) 35(1) 
C(11) -875(2) 2243(3) 1385(1) 44(1) 
C(12) -885(2) 1313(3) 1060(1) 44(1) 
C(13) 255(2) 963(3) 925(1) 46(1) 
C(14) 1422(2) 1544(3) 1117(1) 36(1) 
C(15) 5487(2) 9168(2) 947(1) 30(1) 
C(16) 5745(2) 8708(2) 541(1) 32(1) 
C(17) 5986(2) 7291(2) 571(1) 28(1) 
C(18) 5888(2) 6849(2) 989(1) 25(1) 
C(19) 5587(2) 8024(2) 1222(1) 26(1) 
C(20) 2867(2) 7098(2) 1078(1) 28(1) 
C(21) 2749(2) 8935(2) 415(1) 32(1) 
C(22) 1879(2) 5657(3) 220(1) 36(1) 
C(23) 1477(2) 4647(2) -134(1) 26(1) 
C(24) 1406(2) 3262(2) -48(1) 27(1) 
C(25) 1034(2) 2337(2) -375(1) 28(1) 
C(26) 741(2) 2786(2) -791(1) 27(1) 
C(27) 810(2) 4165(2) -880(1) 28(1) 
C(28) 1177(2) 5094(2) -553(1) 28(1) 
N(1) 3229(1) 2416(2) 2065(1) 22(1) 
N(2) 3230(1) 6136(2) 240(1) 21(1) 
O(1) 5424(2) 5509(2) 1868(1) 49(1) 
O(2) 6463(2) 1155(2) 1818(1) 38(1) 
O(3) 2268(2) 6747(2) 1326(1) 45(1) 
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O(4) 2056(2) 9722(2) 244(1) 53(1) 
B(1) 973(2) 3786(3) 2754(1) 29(1) 
B(2) 5292(2) 2862(3) 684(1) 31(1) 
F(1) -364(1) 3719(2) 2647(1) 45(1) 
F(2) 1301(1) 4414(2) 3150(1) 41(1) 
F(3) 1491(1) 4570(1) 2454(1) 37(1) 
F(4) 1506(1) 2483(1) 2759(1) 38(1) 
F(5) 4165(2) 2133(2) 629(1) 87(1) 
F(6) 6247(1) 2107(1) 530(1) 43(1) 
F(7) 5686(2) 3176(2) 1101(1) 79(1) 
F(8) 5117(1) 4054(1) 439(1) 40(1) 
Ru(1) 5125(1) 2969(1) 2385(1) 21(1) 




Table B62: Bond lengths [Å] and angles [°] for [η5-C5H5Ru(CO)2NH2CH2C6H5]BF4. 
_____________________________________________________ 
C(1)-C(5)  1.406(4) 
C(1)-C(2)  1.422(3) 
C(1)-Ru(1)  2.210(2) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.411(4) 
C(2)-Ru(1)  2.227(2) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.401(3) 
C(3)-Ru(1)  2.233(2) 
C(3)-H(3)  1.0000 
C(4)-C(5)  1.432(4) 
C(4)-Ru(1)  2.230(2) 
C(4)-H(4)  1.0000 
C(5)-Ru(1)  2.201(2) 
C(5)-H(5)  1.0000 
C(6)-O(1)  1.133(3) 
C(6)-Ru(1)  1.894(2) 
C(7)-O(2)  1.132(3) 
C(7)-Ru(1)  1.898(2) 
C(8)-N(1)  1.487(2) 
C(8)-C(9)  1.506(3) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(14)  1.377(3) 
C(9)-C(10)  1.393(3) 
C(10)-C(11)  1.391(3) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.374(4) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.374(4) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.393(3) 
C(13)-H(13)  0.9500 
C(14)-H(14)  0.9500 
C(15)-C(19)  1.412(3) 
C(15)-C(16)  1.433(3) 
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C(15)-Ru(2)  2.2132(19) 
C(15)-H(15)  1.0000 
C(16)-C(17)  1.408(3) 
C(16)-Ru(2)  2.2361(19) 
C(16)-H(16)  1.0000 
C(17)-C(18)  1.418(3) 
C(17)-Ru(2)  2.2360(18) 
C(17)-H(17)  1.0000 
C(18)-C(19)  1.428(3) 
C(18)-Ru(2)  2.2247(18) 
C(18)-H(18)  1.0000 
C(19)-Ru(2)  2.2101(18) 
C(19)-H(19)  1.0000 
C(20)-O(3)  1.136(3) 
C(20)-Ru(2)  1.893(2) 
C(21)-O(4)  1.134(3) 
C(21)-Ru(2)  1.890(2) 
C(22)-N(2)  1.479(2) 
C(22)-C(23)  1.505(3) 
C(22)-H(22A)  0.9900 
C(22)-H(22B)  0.9900 
C(23)-C(24)  1.386(3) 
C(23)-C(28)  1.389(3) 
C(24)-C(25)  1.387(3) 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.381(3) 
C(25)-H(25)  0.9500 
C(26)-C(27)  1.382(3) 
C(26)-H(26)  0.9500 
C(27)-C(28)  1.388(3) 
C(27)-H(27)  0.9500 
C(28)-H(28)  0.9500 
N(1)-Ru(1)  2.1464(15) 
N(1)-H(1A)  0.9200 
N(1)-H(1B)  0.9200 
N(2)-Ru(2)  2.1378(15) 
N(2)-H(2A)  0.9200 
N(2)-H(2B)  0.9200 
181 
 
B(1)-F(1)  1.386(3) 
B(1)-F(4)  1.390(3) 
B(1)-F(2)  1.393(3) 
B(1)-F(3)  1.399(3) 
B(2)-F(7)  1.359(3) 
B(2)-F(5)  1.364(3) 
B(2)-F(6)  1.392(3) 















































































































































































































Table B63: Anisotropic displacement parameters (Å2x 103)for [η5-C5H5Ru(CO)2NH2CH2C6H5]BF4.  
The anisotropicdisplacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 56(2)  62(2) 25(1)  -14(1) 4(1)  -31(1) 
C(2) 39(1)  54(2) 20(1)  -12(1) 7(1)  -4(1) 
C(3) 32(1)  53(1) 17(1)  1(1) 6(1)  -9(1) 
C(4) 38(1)  60(2) 22(1)  9(1) 2(1)  7(1) 
C(5) 24(1)  94(2) 22(1)  -1(1) -1(1)  -11(1) 
C(6) 32(1)  32(1) 30(1)  -2(1) 8(1)  -6(1) 
C(7) 20(1)  34(1) 26(1)  2(1) 5(1)  -3(1) 
C(8) 26(1)  32(1) 21(1)  5(1) 1(1)  -5(1) 
C(9) 23(1)  31(1) 24(1)  9(1) -1(1)  -4(1) 
C(10) 28(1)  44(1) 32(1)  7(1) 3(1)  4(1) 
C(11) 22(1)  58(2) 49(1)  22(1) 3(1)  2(1) 
C(12) 29(1)  48(2) 51(1)  18(1) -11(1)  -14(1) 
C(13) 41(1)  47(2) 47(1)  -7(1) -5(1)  -15(1) 
C(14) 27(1)  44(1) 36(1)  -6(1) 2(1)  -7(1) 
C(15) 26(1)  24(1) 37(1)  -3(1) -3(1)  -5(1) 
C(16) 23(1)  41(1) 31(1)  9(1) 2(1)  -10(1) 
C(17) 15(1)  41(1) 30(1)  -7(1) 7(1)  -3(1) 
C(18) 15(1)  27(1) 31(1)  0(1) -1(1)  2(1) 
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C(19) 19(1)  33(1) 23(1)  -3(1) -2(1)  -2(1) 
C(20) 19(1)  43(1) 22(1)  -7(1) 1(1)  -2(1) 
C(21) 30(1)  30(1) 33(1)  -3(1) 0(1)  5(1) 
C(22) 20(1)  52(1) 39(1)  -24(1) 11(1)  -12(1) 
C(23) 15(1)  37(1) 26(1)  -11(1) 6(1)  -4(1) 
C(24) 17(1)  41(1) 24(1)  1(1) 1(1)  -2(1) 
C(25) 20(1)  26(1) 36(1)  1(1) -1(1)  -1(1) 
C(26) 21(1)  30(1) 29(1)  -8(1) -1(1)  0(1) 
C(27) 28(1)  33(1) 23(1)  0(1) 2(1)  2(1) 
C(28) 26(1)  24(1) 34(1)  -2(1) 7(1)  -1(1) 
N(1) 18(1)  27(1) 20(1)  2(1) 3(1)  -1(1) 
N(2) 15(1)  27(1) 21(1)  -5(1) 4(1)  -1(1) 
O(1) 68(1)  34(1) 48(1)  7(1) 19(1)  -10(1) 
O(2) 34(1)  44(1) 40(1)  -1(1) 17(1)  5(1) 
O(3) 32(1)  81(1) 25(1)  -8(1) 11(1)  -16(1) 
O(4) 50(1)  42(1) 62(1)  8(1) -10(1)  20(1) 
B(1) 28(1)  30(1) 30(1)  1(1) 11(1)  2(1) 
B(2) 29(1)  33(1) 33(1)  13(1) 10(1)  5(1) 
F(1) 26(1)  51(1) 60(1)  -2(1) 12(1)  2(1) 
F(2) 53(1)  42(1) 29(1)  -2(1) 11(1)  0(1) 
F(3) 46(1)  37(1) 33(1)  4(1) 18(1)  0(1) 
F(4) 40(1)  31(1) 46(1)  4(1) 12(1)  6(1) 
F(5) 36(1)  76(1) 150(2)  43(1) 21(1)  -8(1) 
F(6) 42(1)  37(1) 52(1)  10(1) 15(1)  15(1) 
F(7) 100(2)  111(2) 24(1)  11(1) 11(1)  36(1) 
F(8) 61(1)  29(1) 36(1)  10(1) 20(1)  14(1) 
Ru(1) 17(1)  28(1) 18(1)  -1(1) 4(1)  -4(1) 







Table B64: Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) for [η5-
C5H5Ru(CO)2NH2CH2C6H5]BF4. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 6260 5048 2986 57 
H(2) 3938 4250 3063 45 
H(3) 3925 1609 3044 40 
H(4) 6200 765 2961 48 
H(5) 7659 2913 2917 57 
H(8A) 3360 2991 1456 32 
H(8B) 2591 4072 1700 32 
H(10) 287 3467 1803 42 
H(11) -1664 2488 1478 52 
H(12) -1679 914 930 53 
H(13) 249 324 700 56 
H(14) 2207 1296 1022 43 
H(15) 5340 10137 1028 36 
H(16) 5795 9296 287 38 
H(17) 6227 6702 339 34 
H(18) 6067 5906 1106 30 
H(19) 5517 8045 1532 31 
H(22A) 1289 6455 179 43 
H(22B) 1785 5225 495 43 
H(24) 1613 2944 237 33 
H(25) 982 1390 -313 33 
H(26) 492 2151 -1015 32 
H(27) 607 4478 -1166 34 
H(28) 1223 6041 -616 34 
H(1A) 3227 1487 2019 26 
H(1B) 2652 2585 2249 26 
H(2A) 3314 6460 -25 25 























































































































































































































































Table B66: Crystal data and structure refinement for [η5-C5H5Ru(CO)2NH2CH2CHCH2]BF4. 
Identification code  shelx 
Empirical formula  C10 H12 B F4 N O2 Ru 
Formula weight  366.09 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21/n 
Unit cell dimensions a = 8.7303(3) Å = 90°. 
 b = 9.7841(3) Å = 91.5250(10)°. 
 c = 15.4342(5) Å  = 90°. 
Volume 1317.89(7) Å3 
Z 4 
Density (calculated) 1.845 Mg/m3 
Absorption coefficient 1.232 mm-1 
F(000) 720 
Crystal size 0.360 x 0.250 x 0.240 mm3 
Theta range for data collection 2.465 to 28.307°. 
Index ranges -11<=h<=11, -12<=k<=13, -20<=l<=20 
Reflections collected 25223 
Independent reflections 3282 [R(int) = 0.0242] 
Completeness to theta = 25.242° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.744 and 0.698 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3282 / 0 / 180 
Goodness-of-fit on F2 1.050 
Final R indices [I>2sigma(I)] R1 = 0.0195, wR2 = 0.0455 
R indices (all data) R1 = 0.0223, wR2 = 0.0475 
Extinction coefficient n/a 
Largest diff. peak and hole 0.850 and -0.661 e.Å-3 
197 
 
Table B67: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for [η5-C5H5Ru(CO)2NH2CH2CHCH2]BF4. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 5687(2) 1776(2) 9857(1) 30(1) 
C(2) 4095(2) 1708(2) 9674(2) 36(1) 
C(3) 3874(2) 1086(2) 8846(2) 38(1) 
C(4) 5329(2) 779(2) 8521(1) 30(1) 
C(5) 6457(2) 1212(2) 9140(1) 27(1) 
C(6) 6508(2) 4444(2) 9099(1) 26(1) 
C(7) 3445(2) 4264(2) 8624(1) 28(1) 
C(8) 4470(2) 3022(2) 6734(1) 28(1) 
C(9) 4895(2) 3330(2) 5824(1) 29(1) 
C(10) 4972(2) 2400(3) 5211(1) 37(1) 
N(1) 5666(2) 3438(2) 7385(1) 20(1) 
O(1) 7340(2) 5205(2) 9402(1) 42(1) 
O(2) 2381(2) 4936(2) 8605(1) 44(1) 
B(1) -332(2) 2228(2) 7552(1) 26(1) 
F(1) 655(2) 2500(2) 6908(1) 76(1) 
F(2) 339(2) 1316(1) 8132(1) 45(1) 
F(3) -770(1) 3412(1) 7972(1) 37(1) 
F(4) -1648(2) 1574(2) 7229(1) 61(1) 







Table B68: Bond lengths [Å] and angles [°] for [η5-C5H5Ru(CO)2NH2CH2CHCH2]BF4. 
_____________________________________________________ 
C(1)-C(2)  1.412(3) 
C(1)-C(5)  1.421(3) 
C(1)-Ru(1)  2.2092(18) 
C(1)-H(1)  1.0000 
C(2)-C(3)  1.425(3) 
C(2)-Ru(1)  2.2029(19) 
C(2)-H(2)  1.0000 
C(3)-C(4)  1.410(3) 
C(3)-Ru(1)  2.2320(19) 
C(3)-H(3)  1.0000 
C(4)-C(5)  1.419(3) 
C(4)-Ru(1)  2.2509(18) 
C(4)-H(4)  1.0000 
C(5)-Ru(1)  2.2300(17) 
C(5)-H(5)  1.0000 
C(6)-O(1)  1.132(2) 
C(6)-Ru(1)  1.8989(19) 
C(7)-O(2)  1.138(2) 
C(7)-Ru(1)  1.8958(18) 
C(8)-N(1)  1.487(2) 
C(8)-C(9)  1.492(3) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(10)  1.316(3) 
C(9)-H(9)  0.9500 
C(10)-H(10A)  0.9500 
C(10)-H(10B)  0.9500 
N(1)-Ru(1)  2.1399(14) 
N(1)-H(1A)  0.85(2) 
N(1)-H(1B)  0.85(2) 
B(1)-F(1)  1.359(2) 
B(1)-F(2)  1.383(2) 
B(1)-F(3)  1.386(2) 
































































































Table B69: Anisotropic displacement parameters (Å2 x 103)for [η5-
C5H5Ru(CO)2NH2CH2CHCH2]BF4. The anisotropic displacement factor exponent takes the form: -
2π2[ h2a*2U11 + ... + 2 h k a* b* U12] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 43(1)  21(1) 26(1)  9(1) 2(1)  2(1) 
C(2) 36(1)  25(1) 48(1)  15(1) 18(1)  3(1) 
C(3) 31(1)  23(1) 59(1)  13(1) -8(1)  -7(1) 
C(4) 45(1)  12(1) 34(1)  1(1) 0(1)  1(1) 
C(5) 27(1)  20(1) 34(1)  8(1) 1(1)  6(1) 
C(6) 38(1)  22(1) 19(1)  4(1) -2(1)  0(1) 
C(7) 32(1)  26(1) 25(1)  4(1) 6(1)  6(1) 
C(8) 26(1)  34(1) 24(1)  -1(1) -6(1)  -5(1) 
C(9) 30(1)  33(1) 24(1)  3(1) -6(1)  0(1) 
C(10) 31(1)  52(1) 27(1)  -6(1) -6(1)  5(1) 
N(1) 19(1)  19(1) 21(1)  -1(1) 0(1)  -1(1) 
O(1) 61(1)  33(1) 31(1)  -1(1) -14(1)  -17(1) 
O(2) 41(1)  45(1) 47(1)  9(1) 9(1)  24(1) 
B(1) 24(1)  28(1) 25(1)  2(1) 1(1)  5(1) 
F(1) 83(1)  71(1) 77(1)  33(1) 58(1)  28(1) 
F(2) 59(1)  32(1) 45(1)  9(1) -12(1)  9(1) 
F(3) 43(1)  24(1) 43(1)  -2(1) 5(1)  1(1) 
F(4) 33(1)  72(1) 78(1)  -48(1) -20(1)  17(1) 































Gas chromatography-based calculation of % conversion and % yield 
1. Calculate the Response factor (RF) for the substrate, all possible products and the 
internal standard (IS). 
Response Factor (RF) =                      
2. Calculate the relative response factor (RRF) for the substrate and each product 
 
RRF =            
 
NB: RRF for the internal standard = 1 
 
3. Calculate the RF for the internal standard for each reaction and use it to, calculate 
the moles of substrate left at the end of each reaction and the moles of each product 
formed 
a) Calculate the response factor for each product and substrate at the end of 
each reaction 
 
RF =               
 
b) Calculate moles of each product formed and substrate left at the end of the 
reaction  
 
i. Moles =              
 
ii. % yield =                                            
 
iii. % Conversion = 
 
                                   
                          
 















Sample photos illustrating antimicrobial activity of 1,6-diaminohexane ruthenium and 
iron complexes against the gram positive bacteria M. smegmatis mc2155
 
 
                                                                
 
Figure 1D: Zone inhibition by (A) 1,6-diaminohexane and [Rp2NH2(CH2)6NH2](SO3CF3)2  (B) against the bacteria M. smegmatis mc2155 






M. smegmatis mc2155 
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Figure 2D: Zone inhibition by [Fp2NH2(CH2)6NH2](SO3CF3)2  (top) (C) and [Rp2NH2(CH2)6NH2](BF43)2  (top) (D) against the bacteria M. smegmatis mc2155 
Bottom discs in each plate contain the free ligand, 1,6-diaminohexane 
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